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ABSTRACT 
 
A new methodology for monitoring post-translational modifications of histone H3 
in living cells was developed using genetically encoded fluorescent reporters. These 
reporters were constructed for sensing histone phosphorylation and methylation by 
fluorescence resonance energy transfer (FRET). These reporters are four-part chimeric 
proteins with the domains from N- to C-terminus as follows: a cyan fluorescent protein 
(CFP), a phosphoserine recognition domain (14-3-3 tau) or a methyllysine recognition 
domain (HP1 or Pc chromodomain), a peptide whose sequence corresponds to the N-
terminus of histone H3, and a yellow fluorescent protein. The histone phosphorylation 
reporter exhibited a 25 % YFP/CFP emission ratio increase upon phosphorylation in vitro 
by Msk-1 kinase. Site-directed mutagenesis studies suggested that Ser28 phosphorylation 
gave rise to the reporter FRET response. When tested in living HeLa cells, the reporter 
exhibited a rapid increase in the emission ratio 5-15 min prior to the nuclear membrane 
breakdown and the FRET peaked during cell division. Another reporter, in which the 14-
3-3 tau and the H3 peptide were swapped, exhibited the FRET response to both Ser10 
and Ser28 phosphorylation.  
Two methylation reporters, K9 and K27, were constructed for sensing H3-lysine9 
and H3-lysine27 methylation. The reporters gave 60 % (K9) and 28 % (K27) emission 
ratio changes after in vitro methylation, catalyzed by the histone methyltransferase vSET. 
Applying the K9 reporter in cells showed different levels of reporter FRET in fibroblasts 
either expressing or lacking methyltransferases Suv39h1 and Suv39h2. 
 Site-specific incorporation of biophysical probes onto cell surface proteins is 
critical for the study of protein trafficking. One general solution to achieve labeling 
specificity is the use of enzymes for the ligation of probes to a substrate peptide tagged 
onto a protein of interest. Transglutaminase incorporates amine probes to cell surface 
proteins expressing a 6- or 7-amino acid consensus sequence (Q-tag). A variety of probes 
such as biotin cadaverine and fluorescein cadaverine were incorporated to Q-tag-CFP and 
Q-tag-EGF receptor constructs expressed on the surface of living HeLa and HEK cells. 
The NFκB p50 transcription factor fused to a Q-tag was labeled with a benzophenone 
photo-affinity probe in vitro. Upon UV irradiation, elevated levels of p50 
homodimerization were observed in the presence of DNA or the interacting protein 
myotrophin.  
Thesis Supervisor: Alice Y. Ting 
Title: Pfizer-Laubach Assistant Professor of Chemistry 
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Chapter 1  
Methodology development for imaging histone modifications and for site-specific 
protein labeling in vitro and on the surface of living cells 
 
Histone modifications 
 
Introduction 
Histones are scaffolding proteins for packaging DNA in the nucleus. The structure 
of the nucleosome, the fundamental unit of chromatin that constitutes the chromosome, 
shows a histone core wrapped around by 146 base pairs of DNA (Fig. 1.1a). Formation 
of the histone core requires the assembly of two subunits each of H2A, H2B, H3, and H4 
to form the protein octamer. A noticeable feature of this structure is the presence of N-
terminal histone tails protruding away from the core. These tails were later identified  as 
the target regions for post-translational modifications, which were first shown to take 
place on histone proteins in 19641.  
Diverse covalent modifications occurring on the histone tails have been identified, 
including phosphorylation2,3, acetylation1,4, methylation1,5, poly (ADP-ribosylation)6, 
ubiquitination7 and biotinylation8. These modifications can alter nucleosome structure as 
well as recruit9,10 or exclude11 the “effector” molecules that influence the patterns of gene 
expression. In fact, the histones H3 and H4 are especially susceptible to a great variety of 
modifications that result in distinct downstream consequences (Fig. 1.1b).  For instance, 
lysine residues are the target sites of acetylation. The levels of histone acetylation are 
higher in euchromatin, where genes are actively transcribed, than in heterochromatin that 
is condensed and transcriptionally restricted12,13.  
Methylation takes place on both lysines and arginines, and some lysines (K9 in 
histone H3, for example) are also known acetylation sites. In addition, lysines can be 
mono-, di-, or trimethylated, whereas arginines can be mono- or dimethylated. Therefore, 
the presence of differential methylation states on a single residue adds another layer of 
complexity to the existing patterns of methylation occurring at distinct modification sites. 
Methylation of lysine 9 and 27 in histone H3 is associated with gene repression14, 
whereas methylation of lysine 4 in histone H3 leads to gene activation15. To “write” and 
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“read” the methylation markers on specific residues requires separate sets of proteins. 
Histone methyltransferases and the recently discovered histone demethylases are 
responsible for depositing and retrieving the methyl groups, respectively. Coupling the 
underlying information of histone methylation to gene activity occurs via interactions of 
effector proteins with the methylated residues. Heterochromatin protein 1 (which 
recognizes methylated K9)16,17 and polycomb (which binds methylated K27)18,19 are two 
examples.   
 Phosphorylation is another class of histone modification that has long been 
studied. In particular, phosphorylation of Ser1020,21 and Ser2822 in histone H3 is linked to 
chromosome condensation during mitosis, meosis, DNA damage, and apoptosis. On the 
other hand, histone phosphorylation is also known to parallel the immediate-early gene 
response upon mitogen stimulation23, which is a consequence of chromosome 
decondensation. The reason and significance underlying the dual roles of histone 
phosphorylation, however, remain to be fully elucidated.  
 
 
 
Figure 1.1. a) The structure of nucleosome where the core histone octamer, consisting of two 
copies each of H2A, H2B, H3, and H4, is surrounded by 146 base pairs of DNA. b) N-terminal 
histone tails are highly susceptible to post-translational modifications such as acetylation, 
methylation, and phosphorylation.   
 
The complex nature of histone modification patterns and their underlying 
consequences prompted the “histone code” hypothesis12,13. This hypothesis states that 
multiple modifications, acting in a combinatorial or sequential manner, correspond to 
specific downstream functions. Alternative views suggested an analogy between receptor 
H2B 
H3 
H2A 
H4 
N 
Luger K. et.al. Nature (1997) 
H3 tail: A
M PM A A A M P M
M
H4 tail: M A A A A M
M methylaio A Acetylatio P Phosphorylation 
a)  b)  
Modified from Fischle W. et al. Curr. Opin. Cell Biol. (2003) 2, 172 
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tyrosine kinase signaling cascades and how histone modifications elicit the consequent 
responses24.  
 
Detections of histone modifications 
Existing methods for detecting histone modifications sacrifice the temporal and/or 
spatial resolution of the signals. For instance, chromatin immunoprecipitation (ChIP) and 
immunofluorescence (IF) are two commonly used methods. Both of them rely on 
antibodies that are specific to particularly modified histone isoforms. ChIP requires in 
vivo DNA-protein crosslinking first, followed by cell lysis and fragmentation of DNA. 
The mixture is then probed with antibodies specific for modified histones to 
immunoprecipitate the crosslinked DNA, followed by detection of the nucleic acid 
sequences by PCR amplification. As such, ChIP has the great advantage to monitor the 
histone modifications with DNA sequence specificity, pinpointing the modifications 
occurring at particular DNA promoters or intragenic regions. However, ChIP has the 
drawback that it requires cell destruction for sample preparation. This approach averages 
the signal across the cell population (typically ~107 to 109 cells) and inevitably loses both 
the spatial and temporal resolution of histone modification detection. For this reason, 
ChIP is also unable to reveal the individual heterogeneity in histone modifications among 
cells. On the other hand, IF provides single-cell resolution for detection of histone 
modification, using primary antibodies specific for modified histone isoforms and 
fluorophore-conjugated secondary antibodies. Despite the advantage of retaining spatial 
resolution, the requirement of cell fixation prior to antibody staining destroys the 
temporal resolution of IF. Another powerful method that can offer detailed molecular 
signatures of histone modifications is mass spectrometry. Unfortunately, it also suffers 
from the same prerequisite of cell lysis for sample preparation. Therefore, there is a great 
need to develop a new method that can offer both spatial and temporal resolution for 
detecting histone modifications, especially in the context of living cells. Demonstrated in 
this thesis are examples of using genetically encoded FRET reporters as an approach 
toward this goal.   
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Figure 1.2. Selected examples of the genetically encoded FRET reporters. a) The design principle 
of reporters, which respond to input stimuli and display a FRET efficiency change as the readout. 
b) One class of FRET reporters possess two separate domains joined intramolecularly, the 
interaction of which is modulated by an input signal that either covalently modifies the reporter or 
provides a ligand, triggering a conformational change of these two domains. c) Another class of 
reporters embeds a single domain derived from a natural protein for ligand detection. d) Reporters 
include a substrate peptide for sensing endopeptidase activity. A decrease in FRET is anticipated 
upon enzymatic cleavage of the reporter. (References:  Reporter 1)25, 2)26, 3)27, 4)28, 5)29, 6)30, 
7)31, 8)32, 9)33, 10) 34, 11) 35, 12)36, 13)37, 14)38, and 15)39.  
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Genetically encoded FRET reporters 
Genetically encoded fluorescent reporters, which permit the real-time cellular 
imaging of post-translational protein modifications, provide an alternative strategy for 
studying histone modifications. Previously, individual reporters based on fluorescence 
resonance energy transfer (FRET) have been devised to monitor kinase activities 
associated with Src26, and Abl25, protein kinase A (PKA)27, protein kinase C (PKC)40, 
insulin receptor41, and Crk42. In addition, other FRET-based reporters were also designed 
to monitor the Ras and Rap134 activation, the Ran-GTP gradient43, the stathmin-tubulin 
interaction44, the adrenergic receptor activation45,46, and to detect small-molecules such as 
Ca2+47, NO48, and GMP38. The same principle was applied in designing reporters for 
sensing histone phosphorylation29 and methylation30 as described in Chapter 2 and 3, 
respectively.  
These reporters feature a common functional mechanism: coupling the underlying 
protein interaction/enzyme activity of interest to a conformational change within the 
reporter. The resultant difference in FRET efficiency is used as the signal readout (Fig. 
1.2a). FRET is a physical phenomenon that takes place when two particular fluorophores 
are proximal to each other (typically <~80 Å)49. As a requirement for FRET, the emission 
spectrum of donor fluorophore should spectroscopically overlap with the excitation 
spectrum of the acceptor fluorophore. Variation in the distance between the donor and 
acceptor fluorophores leads to a change of FRET efficiency. According to this principle, 
many FRET-based intramolecular reporters use a FRET pair of CFP (cyan fluorescent 
protein) and YFP (yellow fluorescent protein), as opposed to BFP (blue fluorescent 
protein) and GFP (green fluorescent protein) in early cases suffering  from compromised 
photoproperties such as dim fluorescence and susceptibility to photobleaching50. Selected 
examples of FRET reporters with different design strategies are shown in Figure 1.2. 
One class of reporters incorporates two sensing modules, and the interaction between 
these two modules can be enhanced or reduced upon enzymatic reaction or binding to an 
analyte (Fig. 1.2b). For instance, phosphorylation reporters for EGFR, Src, PKA, and 
PKC each contain a substrate peptide for the corresponding kinase, and this peptide is 
connected to a binding domain specific for the phosphorylated residue. Upon 
phosphorylation of the substrate peptide on the reporter by the kinase, the binding domain 
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is recruited. This new fold, in turn, leads to a change of FRET efficiency. Instead of 
direct modifications of the reporters as a driving force to trigger the FRET change, other 
indicators detect the physiological analyte (for example, Ca2+) or molecules derived from 
the enzymatic reactions such as GTP and PtdInsP3 (phosphatidylinositol-3,4,5-
trisphosphate) via non-covalent binding between these two domains. An alternative 
reporter design is to incorporate a single recognition domain that undergoes a large 
conformational change itself upon ligand binding (Fig. 1.2c). Lastly, a reporter has been 
constructed with a substrate of endopeptidase, which upon cleavage by the protease 
results in separation of both fluorescent proteins, and a decrease in FRET (Fig. 1.2d).  
The design principle, which coupled enzymatic activity with reporter 
conformational change, was applied to develop FRET-based reporters for sensing 
position-specific histone modifications. For instance, the histone phosphorylation reporter 
is a four-part chimeric protein as shown in Figure 1.2b. At the two flanking ends of the 
reporter are a cyan fluorescent protein (CFP) and a yellow fluorescent protein (YFP), 
respectively. Between these two proteins is a peptide substrate corresponding to the N-
terminal histone H3 tail that can be phosphorylated by enzymes such as Msk-1 kinase. 
Through a flexible linker, this peptide is connected to a recognition domain 14-3-3τ that 
is specific for the phosphorylated peptide isoform but not for the unmodified counterpart. 
The reporter serving as a surrogate substrate will thus be modified by an enzymatic 
reaction, causing a subsequent reporter conformational change and an alteration of the 
FRET efficiency. In the presence of an opposing enzyme-phosphatase, the phosphate 
group previously deposited on the substrate peptide can be removed. Therefore, the 
reporter FRET change will then be reversed.  
Compared to the conventional approaches such as IP and IF, genetically encoded 
reporters offer the following advantages for studying histone modifications:  
• Expression and imaging of the reporter are compatible with living cells.  
• This method provides a real-time readout with a single living cell resolution. 
• This method can provide high spatial resolution. Reporters can be targeted to 
organelles (nucleus for examples) or particular proteins (e.g. full-length histone H3), 
via a genetic fusion, to reflect the histone modifications in their endogenous milieu.    
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• Producing reporters in cells is straightforward. Cells are only required to be 
transfected with the reporter gene, and the reporters will be readily expressed after 
8~12 hr.  
• The reporter design is general and extendable. Replacing the recognition domain with 
others, which are specific to other particular isoforms of histones, can create new 
reporters for monitoring histone modifications at different residues. For example, the 
combination of a chromodomain and its corresponding peptide with specific 
methylatable lysines can be used to create a histone methylation reporter. In principle, 
histone acetylation reporters can be similarly constructed by using a bromodomain 
and its substrate peptide containing the lysine of interest. Described in Chapter 5a are 
the preliminary results of designing a histone acetylation reporter.  
 
On the other hand, the reporter approach also possesses limitations that one needs to 
always take into account when using this method.  
• Optical diffraction limit: In a typical microscopy setup, imaging reporters with visible 
light (400~700 nm) has the diffraction limit 200~350 nm (~λ/2). This represents the 
limit of the spatial resolution of this approach, which cannot possibly differentiate 
two objects present within this range unless a sophisticated instrument is 
implemented to breakdown the limit51. It is conceivably difficult, if not impossible, to 
apply the reporters to study systems with a small spatial dimension such as synaptic 
vesicles that have a diameter ~40 nm.      
• Transfection: Expression of the reporters in cells requires transfection with the 
reporter gene. Compared to microinjection, gene transfection is a more friendly 
method in terms of producing reporters in cells for the subsequent imaging work. 
However, introduction of foreign genes mat not be compatible with all cells. For 
instance, primary cells are known to be difficult to transfect and they exhibit a 100 
fold lower transfection efficiency by lipofection compared to the immortal cell line 
NIH3T352. The transfection efficiency of the reporter gene largely depends on the 
intrinsic nature of the cell lines. For instance, the efficiency of transfecting HeLa cells 
in all of my experiments ranged 10~40 %, while the 80~90% efficiency was observed 
in the case for HEK (human embryonic kidney) cells.  
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• Reporter expression level in cells: Another concern associated with the gene 
transfection is the expression of the reporters. Currently, all the reporter plasmids 
used in my experiments embed the CMV (cytomegalovirus) promoter to afford the 
high yet uncontrollable level of reporter expression. As a result, there is cell-to-cell 
variation in the amount of reporter protein expressed in the entire population of cells. 
One potential yet unexplored solution to modulate the protein expression level is to 
place the reporter gene downstream an inducible promoter whose activity can be 
controlled by exogenously added chemicals. For instance, the Tet-On system fuses 
the tetracycline-responsive promoter element upstream the target gene. The 
upregulated transcriptional activity of the promoter responses to binding the reverse 
tetracycline-controlled transactivator, whose activity is elevated by interacting with 
the effector doxycycline53. Therefore, the protein expression level can be controlled 
by different concentrations of doxycycline. 
• Room for rational design. Conceptually, FRET reporters are similar in their geometry 
containing a recognition module that is sandwiched by a pair of fluorescent proteins 
(Fig. 1.2b and c). To judiciously choose the recognition domain is a key to the 
success of the reporter design. However, it is perhaps difficult to construct the 
reporter and predict its performance purely based on a rational basis. Existing protein 
motifs that naturally bind the molecule of interest can be candidates for the sensing 
module of the reporter. For example, the phosphoserine binding domain, 14-3-3τ, is 
used for the histone phosphorylation reporter (Chapter 2); chromodomains that 
selectively bind the methylated histone peptides are included in the histone 
methylation reporters (Chapter 3). However, their binding specificity can be geometry 
dependent (described in Chapter 2) and be altered due to the intramolecular linkage to 
their substrate in the reporter context (described in Chapter 3). Engineering the 
binding specificity will require intensive empirical optimization via approaches such 
as molecular evolution and high-throughput screening. Another consideration is the 
choice of linker for connecting the binding domain and the modified substrate 
peptide. In both histone phosphorylation and methylation reporters, the linkers were 
chosen because of their 1) flexibility (made of glycines), 2) protease resistance 
(proline included), and 3) sufficient length to permit the binding domain to fold. 
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Based on the worm-like chain model54, the end-to-end distance that one linker can 
span in space is a function of the linker length. The underlying assumptions are the 
sequence-independence and the total flexibility of the linker. Conceivably, the result 
calculated from this model may not well predict the optimized linker length in reality. 
Empirical optimization of both linker length and composition is more likely an 
efficient approach to enhance the reporter performance. 
  In Chapter 2 and 3, I describe the development of FRET reporters for sensing 
histone phosphorylation and methylation, respectively. Instead of monitoring the activity 
of a particular enzyme (a kinase, phosphatase, or methyltransferase), these reporters 
should reveal the information on the overall extent of modification of specific residues 
within the histone H3 tail such as Ser28 phosphorylation and K9 and K27 methylation. 
Reporters were first tested in vitro in response to enzymatic reactions, followed by 
characterization using site-directed mutagenesis to identify the residues whose 
modification contributed to the reporter FRET response. For the subsequent cellular 
applications, the histone H3 Ser28 phosphorylation specific reporter in cells was 
monitored during cell division. Similarly, both K9 and K27 histone methylation reporters 
were examined in vitro first, and the K9 reporters were further introduced into two cell 
lines, the wide-type and the one with two methyltransferases knockout, to reveal the 
different levels of histone H3 K9 methylation. To potentially increase the spatial 
resolution of the histone modifications that the reporter can indicate, both categories of 
the reporters were fused to the full-length histone H3 to target them to the histone cores. 
Although the preliminary data showed that the H3-fusion is compatible with cell 
viability, no FRET response of these reporters has been observed. Future re-design of 
these reporters will be required.   
  Current methods detecting histone modifications are at the expense of cell lysis or 
destruction. ChIP can monitor the gene-specific histone modification patterns, and the 
underlying spatial resolution is better than that obtained by immunofluorescence 
detection. IF stains the chromatin and provide the spatial resolution in the scale of the 
entire chromosome (~1 µm), similar to the limit of the reporter approach. It is 
conceivably difficult to deliver the reporter to specific loci on the chromosome in a 
general and systematic manner, and thus the spatial resolution of the reporter approach is 
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not anticipated to be better than what ChIP has been offering. On the other hand, reporter 
can be used to continuously monitor the histone modification with the temporal 
resolution in the order of seconds, better than both ChIP and IF that do not collect the 
data at more than one time point. This temporal resolution is compatible with slow 
process such as the cell division (~1 hr), but it may be challenging for studying fast 
processes such as neuron firing. 
Although the procedure for constructing FRET reporters has been standardized, 
efforts for optimizing the reporter performance still continue. In recent years, the 
improvement in the photophysical properties of the fluorescent proteins has produced the 
brighter and more photostable variants. For instance, the circularly permuted Venus, a 
YFP variant, gave rise to a ~600 % emission ratio change in the Ca2+ reporter context. 
The dynamic range was 20~40 fold than that of a typical existing reporter. In addition, 
the monomeric cerulean55 is 2.5 fold brighter than CFP, and it has the single-exponential 
instead of the complicated two-exponential fluorescence lifetime of CFP. Both of the 
new protein variants are anticipated to replace the current CFP/YFP pair used for 
constructing reporters (Chapter 5). New indicators should be capable of probing more 
complex biological systems. One such task is to detect neuronal neurotransmitters, such 
as dopamine, and monitor their transient and perhaps marginal changes in concentration 
as a result of extracellular stimuli. The ultimate goal for such a reporter is to use the 
FRET signal to provide quantitative information of concentration changes in space and 
time. Described in Chapter 5b is the recent progress on developing a FRET reporter for 
sensing dopamine. 
 
Site-specific protein labeling 
 
Introduction 
 Cell imaging has largely advanced with the discovery and utilization of GFP56. 
Tagging proteins of interest with GFP enables the direct visualization of cellular protein 
localization by fluorescence. As shown in the cases of FRET reporters, application of two 
color variants of GFP also greatly benefits the detection of enzyme activities and histone 
modifications in living cells. However, many fundamental limitations of GFP application 
 24
still exist. For instance, the large protein size of GFP (238 amino acids) can interfere with 
the localization of the fusion protein57, and the spectroscopic properties of GFP does not 
permit readouts other than fluorescence. The fluorescence of single GFP is also very dim 
and requires sophisticated instrumentation to allow tracking of proteins at the single-
molecule level. In terms of chemical diversity and underlying usefulness, small 
molecules offer a much broader range of advantages compared to GFP. In particular, 
these small-molecule probes allow cell imaging to be performed with a wide range of 
wavelengths other than visible light, offering the levels of information from molecule to 
whole organism. For example, photo-crosslinkers are applicable to probing protein-
protein interactions; multi-photon imaging probes enable fluorescence detection with 
greater tissue penetration; singlet oxygen generators are useful for electron 
microscopy58,59, which offers finer structural detail beyond the diffraction limit of visible 
light; contrast reagents are important for magnetic resonance imaging to enhance the 
diagnostic precision; radionuclide-conjugated molecules are vital for positron emission 
tomography, which also has great value in clinical diagnostics and therapeutics.  
Despite the great advantages that small-molecule probes can offer, application of 
them in cells is difficult due to the lack of targeting specificity to the proteins of interest. 
The complex nature of cellular environment also presents numerous competitors that can 
further challenge the probe use. Conventional methods for bioconjugation mainly rely on 
cysteine or, less frequently, lysine sidechains. These reactions proceed at alkaline pH and 
exhibit no selectivity when multiple targets are present. Therefore, they are incompatible 
with the conditions for labeling proteins in the cellular environment. Numerous efforts 
have been invested in developing new methodology to tackle the problem of labeling 
specificity. Most of them require tagging the protein target with a protein or peptide 
handle, for recruitment of probes. There is great variation of strengths and weaknesses 
among these strategies (summarized in Table 1.1), for mediating the tag-probe 
interaction to achieve site-specific protein labeling60. In general, there is a tradeoff 
between the tag size and the labeling specificity, and a bigger tag renders the probe 
incorporation more specifically. One possible solution is to use enzymes to confer the 
labeling specificity for a peptide-sized tag. For instance, Chen et al. demonstrated the use 
of E. coli. biotin ligase (BirA) to label proteins tagged with a 15-amino-acid peptide61.  In 
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addition to biotin, BirA also accepts a biotin analog bearing a ketone handle for the 
subsequent chemoselective reaction with hydrazide or hydroxylamine derivatives61. This 
peptide epitope for probe conjugation to proteins is derived from the BirA’s minimal 
peptide substrate, whose specificity is similar to the natural substrate BCCP (biotin 
carboxyl carrier protein)62 and previously identified by a combinatorial method63.  
Described in Chapter 4 is an alternative strategy for site-specifically labeling 
proteins using transglutaminase, which is a large family of enzymes that naturally 
crosslinks a glutamine and a lysine sidechain from two different proteins and forms an 
amide bond in a calcium dependent manner. The guinea pig liver tissue transglutaminase 
(gpTGase) is one of the most studied transglutaminases since 195964. The disparate 
specificity of the substrates makes gpTGase a valuable tool for protein labeling 
applications; it exhibits high specificity for its glutamine-containing protein substrate, but 
still has wide tolerance for the structure of the amine-containing substrate65. In addition to 
reactive lysines in the substrate proteins, gpTGase also accepts small-molecule amines as 
diverse as fluorescein cadaverine66 and biotin cadaverine67. Despite the lack of 
gpTGase’s structure, a series of small-molecule amine substrates has been examined to 
map the enzyme active site. The optimal substrates contain five methylene groups 
between the hydrophobic substituent and the nucleophilic nitrogen, corresponding to 
~7.2-7.6 Å separation65. This result suggests that gpTGase possesses a narrow crevice in 
the primary substrate binding site of gpTGase, as such a crevice can accommodate the 
linear amines better than bulky divergent structures65.  
The glutamine-containing substrate proteins can also be reduced to a peptide 
(called a Q-tag). For instance, the previous truncation study of the extracellualr matrix 
protein BM-40 identified the minimal peptide APQQEAL, a “Q-tag” like sequence that 
could be efficiently modified by gpTGase. However, this tag did not enable the probe 
incorporation when it was fused to an unrelated protein68. Sato et al. later demonstrated 
that the sequence PKPQQFM could be labeled by gpTGase both in isolation and when it 
was fused to interleukin-2, using monodansyl cadaverine69 and a amine derivative of 
poly(oxyethylene)69. Despite the long history of using TGase to label proteins by 
modifying the endogenous glutamines, this result represented a new use of TGases for 
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site-specifically labeling Q-tagged proteins. However, labeling the Q-tagged proteins in 
the cellular environment has not been reported. 
 In Chapter 4, I demonstrated the in vitro labeling of the recombinant proteins 
fusing CFP to either one of the three different Q-tags: Q1 (PNPQLPF), a fragment of 
wheat protein gliadin70; Q2 (PKPQQFM), derived from the substance P protein169; and 
Q3 (GQQQLG), empirically determined for hydrogel formation71. Both fluorophores and 
biotin probes, including fluorescein cadaverine and biotin cadaverine, were site-
specifically incorporated into these Q-tags. These Q-tag sequences were then transferred 
to the transmembrane domain of the platelet-derived growth factor receptor or the full-
length epidermal growth factor receptor for testing the site-specific labeling on a cell 
surface. To prevent cell endocytosis and to site-specifically label the cell surface Q-
tagged proteins with fluorophores required optimized reaction conditions, including 
reduced the reaction temperature to 4 °C and the high calcium concentration ~10 mM. To 
demonstrate that gpTGase can also incorporate probes in addition to fluorophores and 
biotin derivatives, the photo-crosslinker, benzophenone-spermine (BP-spermine), was 
used for studying the protein-protein interaction. As a proof of principle, the p50 
transcription factor that could undergo homodimerization was fused to the Q2-tag and 
labeled with BP-spermine. The apparent ratios of the photo-crosslinked p50 homodimer 
to the monomer from different samples, which were incubated with DNA or myotrophin 
prior to the photoreaction, were analyzed as a qualitative measurement for the protein-
protein interaction.  
 The current use of gpTGase for site-specifically labeling proteins shows 
limitations. First, gpTGase did not exclusively label the Q-tag. To a lesser extent it also 
modified other glutamine residues under the labeling conditions in vitro and on the cell 
surface. Second, the requirement of high Ca2+ concentration and low temperature for 
labeling cell surface proteins with fluorophores may not be compatible with some 
sensitive cell types. Third, the attachment site for the Q-tag epitopes in the present study 
is at the N- terminus, the C- terminus, or immediately following a N-terminal (His)6 
sequence. Future work will require exploring other subtypes of TGase, for instance the 
microbial TGase that does not require Ca2+ for activation72 and fXIIIa73 that is known to 
be more specific than gpTGase, or engineering of the enzyme active site to overcome the 
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concerns of labeling specificity and reaction conditions. In addition, it is also important to 
rigorously test the tolerance of the Q-tag inserted into different locations of a given target 
protein.  
Included in Chapter 5c is another labeling method based on using the kinase PKA, 
with the preliminary data presented. Collectively, these results showed that the enzyme-
mediated probe conjugation could be a plausible and general approach for site-specific 
protein labeling.   
   
Table 1.1. Comparison of methods for site-specific protein labeling with small-molecule probes*  
Method Tag sizea Labeling specificity Covalent linkage and signal stability Other comments  
GFP 238 Excellent Yes Restricted to fluorescence 
applications 
DHFR 157 Labels endogenous DHFR No (ligand 
dissociation occurs) 
Requires DHFR-deficient cell lines 
FKBP12 (F36V) 108 Excellent 
No (ligand 
dissociation occurs) 
 
hAGT 207 Labels endogenous AGT Yes Requires AGT-deficient cell lines 
Intein/NCL ~150 – 1b   
Competition of thioester 
probes with endogenous 
cysteines 
Yes 
Requires reducing environment; 
slow process 
ACP(PCP)/PPtase  77 Excellent Yes Cell surface protein labeling 
Texas-Red-
Binding peptide 
23-28 Excellent No (ligand 
dissociation  occurs) 
Binds to Texas Red only 
Biotin ligase 15 Excellent Yes Two-step cell surface protein 
labeling 
α-Bungarotoxin-
binding-Peptide 
13 Excellent 
No (ligand 
dissociation  occurs) Cell surface protein labeling 
ybbR tag/Sfp 11 Excellent Yes Not demonstrated in living cells 
Tetracysteine 
biarsenicals  
6-10 Background due to 
affinity for monothiols 
Yes 
Applications in fluorescent 
imaging and electron microscopy; 
possible residual arsenic toxicity 
His6/Ni-NTA 6 Unclear  No (noticeable  loss 
of signal over time) 
Fast off-rate; Ni quenches 
fluorescence 
Incorporation of 
Unnatural amino 
acids 
0 Excellent  Yes 
Technically challenging; requiring 
the selection of an orthogonal pair 
of tRNA and aminoacyl-tRNA 
synthetase for each probe   
a) The tag size refers to the number of amino acids. b) The temporary tag is cleaved off inside the 
cells. *This table is modified from the original source60.   
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Chapter 2  
Histone phosphorylation reporter 
 
A significant portion of the work described in this chapter has been published in: 
Lin, C.-W. & Ting, A.Y. A genetically encoded fluorescent reporter of histone 
phosphorylation in living cells. Angew. Chem. Int. Ed Engl. 43, 2940-2943 (2004). 
 
Introduction 
Phosphorylation is the best studied post-translational protein modification and is 
involved in nearly all cell signaling pathways. In eukaryotes, phosphorylation of N-
terminal histone tails plays important roles in many significant cellular processes such as 
mitosis22, meiosis74,  and regulation of gene transcription75.  In particular, the initial 
discovery of the association between histone H3 phosphorylation at Ser10 and mitosis 
has received extensive attention because of its strong association with chromosome 
condensation and segregation when cells divide3,76. This covalent modification marker is 
also essential for cell-cycle progression in Tetrahymena thermophila74, maize77, and 
mammalian cells20. Furthermore, identifications of histone H3 phosphorylation at 
Ser2822, Thr378, and Thr1179 add another layer of complexity. Whether these 
modification markers specify orthogonal downstream functions or they are causally 
linked remain unclear.  
Histone phosphorylation is also dynamically inducible80,81, in addition to its 
special association with mitosis. In response to extracellular stimuli such as growth 
factors and phorbol esters, a transient and rapid elevation of histone phosphorylation 
levels was observed. This “nucleosome response” coincides with the activation of the 
immediate-early genes c-fos and c-jun, providing an early implication that the histone H3 
Ser10 phosphorylation plays a role in induction of gene transcription82. Further evidence 
for supporting this view was accumulated from several studies. For instance, treating 
ovarian granulose cells with follicle-stimulating hormone resulted in rapid histone H3 
phosphorylation, alongside transcription of genes in cell differentiation pathways83. 
Similar changes in histone phosphorylation and gene transcription were also observed 
when hippocampul neurons were treated with agonists to activate the dopamine receptor, 
muscarinic acetylcholine receptor, and ionotropic glutamate receptor84. However, certain 
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stimuli causing rapid and transient gene transcription only targeted a small population of 
the histone H3, distinct from the global histone H3 phosphorylation at Ser10 taking place 
during mitosis2,21,23,85,86.     
Despite fewer reports of Ser28 phosphorylation, this modification can also occur 
in response to stress (UV for instance)87-89 and mitosis22. Msk-1 and Msk-2 (mitogen- and 
stress-activated kinases 1 and 2) phosphorylate Ser10 as well as Ser28. Modifications of 
these two residues were indicated to take place at different pools of histone tails in cells, 
even though the in vitro experiment showed that both phosphorylation events could 
readily occur on the same substrate90. Phosphorylation of these two residues also differs 
in time during mitosis. Ser10 phosphorylation initiates at the pericentromeric 
heterochromatin during late G2 phase, and it becomes spatially widespread and sustains 
from prophase to telophase91. Ser28 phosphorylation is relatively transient occurring 
from prophase to anaphase92.  
To date, many questions remain challenging to our detailed understanding of 
histone phosphorylation. The dual role of histone phosphorylation seems to be the most 
puzzling one. As mentioned, histone phosphorylation is involved in mitotic chromosome 
condensation, accompanied by a restriction of the access to genes. However, it also 
correlates to the rapid activation of gene transcription in response to extracellular stimuli, 
which presumably requires a better access to genes. How the coherence between histone 
phosphorylation and the gene accessibility is properly controlled remains unanswered. In 
addition, multiple residues on the histone tails have been identified as the modification 
centers. One great challenge is to understand how cells orchestrate the histone 
phosphorylation sequence in a spatially and temporally regulated fashion. Only limited 
numbers of players involved in histone phosphorylation have been found. The list 
includes kinases such as the Aurora B, Msk-1, Rsk-2, as well as phosphatase PP1. In 
order to understand how phosphorylation reversibly takes place on specific residues, 
there is a need to identify additional histone kinases and phosphatases as well as to 
characterize how they balance their opposing actions.       
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Results 
 
Construction of a histone phosphorylation reporter based on 14-3-3τ  
  Direct imaging of histone modifications in living cells should help to address 
some of the challenging questions mentioned above. For this purpose, a FRET-based 
reporter was constructed for monitoring the histone phosphorylation. The entire reporter 
gene includes four parts (from N- to C-terminus): CFP, 14-3-3τ domain as a 
phosphoserine recognition module, the first 30 amino acids of the histone H3 tail, and 
YFP. Because there was no literature precedent describing a recognition domain specific 
for the phosphorylated histone H3, one logical choice was to select a candidate from the 
existing database of known binding motifs for the phosphorylated serine and threonine 
residues. Such possible choices include 14-3-3τ93,94, WW95, WD4096, and FHA97,98. In 
particular, 14-3-3τ was successfully utilized in the FRET reporter design for sensing the 
protein kinase A (PKA) activity inside cells27. 14-3-3τ was also shown to bind tightly to 
its optimized substrate, R(R/K)(F/R/S/Y)(R/H/K)pS(W/Y/F/L)P27 (where pS denotes the 
phosphorylated serine residue), with a dissociation constant ~56 nM94. An Arg residue 
present in the -3 or -4 position (closer to the N-terminus) with respect to the serine is 
crucial for 14-3-3τ recognition, replacing this residue by alanine results in ~30-fold 
weaker binding (KI = 1400 nM)94. In the histone H3 peptide, the two known 
phosphorylation sites have the sequences: TARKS10TG and AARKS28AP, respectively. 
One concern was the sequence dissimilarity between the histone H3 tail and the 
consensus peptide required for the optimal 14-3-3 binding. However, there was also an 
example where the 14-3-3τ recognized the Cbl protein, despite the sequence differing 
from the consensus99. Therefore, it would be interesting to attempt turning this 14-3-3τ 
binding promiscuity into recognition of the phosphorylated histone tail in the reporter 
context.  
Standard cloning methods were applied to constructing the histone 
phosphorylation reporter gene (GenBank accession no. AY422821; Fig. 2.1a). In brief, 
the insert containing 14-3-3τ, a linker, and the histone H3 peptide were assembled using 
two successive PCRs, followed by cloning into the pRSETB vector (derived from the 
EGFR reporter plasmid25 with the CFP and YFP already incorporated) via the SphI and 
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SacI restriction sites. This plasmid automatically introduced a (His)6-tag for protein 
purification upstream the N-terminus of the reporter protein. Borrowing from the 
previous PKA reporter design27, the linker sequence, AGGTGGSL, between 14-3-3τ and 
histone H3 was chosen due to its putative flexibility. To obtain the reporter protein for 
use in vitro, the resultant plasmid was first introduced to E. coli. by heat shock 
transformation. The His6-tagged recombinant protein was then expressed in bacteria, 
followed by purification using the Ni-NTA affinity chromatography. Subsequently, this 
~85 kD recombinant protein was analyzed on SDS-PAGE to confirm its integrity. More 
than 90 % of the protein remained full-length with a minor fraction of proteolyzed 
products (Fig. 2.4a, the lane labeled with “original”). This purified reporter exhibited 
both CFP emission (476nm) and YFP emission (527nm) when excited at 433nm, as an 
indication of FRET occurring between these two fluorescent proteins. This FRET 
signature was further confirmed by digestion of the reporter protein with trypsin, which 
cleaved the reporter while leaving the CFP and YFP intact100, and it led to the loss of the 
YFP emission peak when exciting at 433 nm (Fig. 2.1b). Although the exact trypsin 
cleavage sites were not identified by mass spectrometry, the basic residues of the 14-3-3τ 
and the H3 peptide were likely to be the targets according to the size mapping from the 
gel shown in Figure 2.1b.    
 
In vitro characterization of the histone phosphorylation reporter 
 To test the reporter FRET signal in response to the enzymatic reaction, in vitro 
assays were performed by incubation with different kinases such as Aurora B92 and Msk-
1101. Both enzymes are known to phosphorylate serine 10 and 28 of the histone H3.  
Results showed that the reporter displayed a 25 % increase in YFP/CFP emission ratio 
(defined as I527nm/I476nm) (Figures 2.1b and 2.2a) over the course of Msk-1 
phosphorylation. By contrast, incubation with Aurora B did not produce an evident 
reporter FRET signal, probably due to the unoptimized enzyme preparation condition or 
its intrinsic lower activity in modifying histone H3 comparing to Msk-1. The detailed 
explanations remained to be further elucidated. Therefore, only Msk-1 was used 
thereafter. Experiments were repeated with either the ATP or the enzyme omitted as 
negative controls, and in both cases the reporter FRET change was abolished (Figure 
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2.1a and 2.2b). To examine whether this FRET response was reversible, the reporter 
protein pre-phosphorylated by Msk-1 was subsequently treated with protein phosphatase 
1 (PP1) that had a broad specificity toward phospho-serine/threonine102. Over about 2 hr, 
the FRET signal was reversed to the original level (Figure 2.2a), indicating that the 
reporter FRET change was fully reversible.  To independently confirm that the observed 
FRET change reflects the actual reporter phosphorylation and dephosphorylation extents, 
each reaction sample at the end-point of the FRET measurement was also analyzed by 
immunoblot. To detect the residue-specific phosphorylation of the reporter, two 
commercial antibodies were used: a) the anti-phospho-H3-S10 antibody, which was 
raised from mice using the antigen of a synthetic peptide corresponding to residues 
around Ser10 of human histone H3 (detailed information was not disclosed), and b) anti-
phospho-H3-S28, which was raised from rabbits using a synthetic peptide corresponding 
to amino acids 25-37 of human Histone H3 (ARKpSAPATGGVKK-C, pS denotes the 
phosphorylated Ser10 and the cysteine in the C-terminus is introduced for protein 
conjugation). These antibodies were shown to recognize only their anticipated 
phosphorylated residues but not the unphosphorylated counterpart. Results showed that 
the reporter was indeed phosphorylated by Msk-1 at both serine 10 and 28, indicating a 
good correspondence between FRET levels and this traditional method for determination 
of protein phosphorylation state. Compared to the phosphorylation rate examined by 
immunoblot, in vitro phosphorylation of the reporter proceeded as efficiently as 
modification of the full-length histone H3 under identical conditions (Fig. 2.3), indicating 
that the reporter was indeed a good mimic of the endogenous histone substrate. 
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Figure 2.1. a) Schematic design and domain structure of the histone phosphorylation reporter. 
The underlined two serines that can be phosphorylated are labeled in red. The (His)6 tag for 
protein purification is upstream the CFP unit (not shown in this figure; the detailed sequence in 
listed in Appendix). b) Emission spectra of the reporter before (-ATP) or after (+ATP) incubation 
with the phosphorylation condition. In response to reporter phosphorylation, the YFP emission 
(527nm) increases with a concomitant decrease of the CFP emission (476nm). Excitation 
wavelength = 433nm. Upon trypsin digestion, the reporter exhibits a loss of YFP fluorescence 
while maintains the CFP emission. Digestion was also examined on the SDS-PAGE, comparing 
the reporters treated or untreated with trypsin. Note that intense bands around 40 kD appeared, 
presumably corresponding to the fragment containing the intact CFP or YFP moiety.      
 
 
 
 
 
Figure 2.2. a) Reporter FRET response upon Msk-1 phosphorylation. The histone 
phosphorylation reporter (5 µM) incubated with Msk-1 (4 µM) and ATP (0.6 mM) displayed a 
~25 % YFP/CFP emission ratio increase, which was reversed to the basal level by addition of 
PP1. Omitting either ATP or Msk-1 completely abolished the reporter FRET change. b) 
Immunoblot analysis of samples in a). Antibodies specific to phospho-H3-Ser28 and -Ser10, 
respectively, were applied to monitor the phosphorylation status on these serine residues. Both 
Ser10 and Ser28 of the reporter were phosphorylated by Msk-1, and the phosphorylated Ser28 
was subsequently dephosphorylated by PP1.           
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Figure 2.3. In vitro phosphorylation of the full-length histone H3 and the reporter. a) The histone 
phosphorylation reporter (1 µM) or full-length histone H3 protein was incubated with Msk-1 (0.8 
µM) and ATP (0.6 mM). Immunoblot analysis using the anti-phospho-H3-Ser28 antibody showed 
that both proteins were similarly phosphorylated. The phosphorylation extent peaked at 2.5hr, 
consistent with the time required for reaching the maximal FRET response in b). b) The histone 
phosphorylation reporter incubated with conditions in a) was monitored to record the FRET 
response. Compared to Figure 2.2a, a similar ~25 % YFP/CFP emission ratio increase was 
observed. ATP was added to initiate the reporter phosphorylation at the reference time point 
defined as 0 hr.  
 
 
 
Site-directed mutagenesis studies of the histone phosphorylation reporter 
Because the reporter contained two potential phosphorylation sites (serine 10 and 
serine 28) in the histone H3 substrate region, site-directed mutagenesis was performed to 
determine which residues were responsible for the overall FRET response. Four reporter 
mutants were constructed and similarly purified from bacteria (Fig. 2.4a). Together with 
the original reporter, they were incubated with Msk-1 and their maximal YFP/CFP 
emission ratio changes at the end-point were recorded.  The mutant with a charge-
reversal replacement K49E in the binding pocket of 14-3-3τ, anticipated to interrupt its 
interaction with the phosphoserine93, abolished the FRET response. While deleting Ser28 
or both serines suppressed the FRET signals as expected, mutation at Ser10 did not result 
in an observable effect (Fig. 2.4b and 2.4c). Collectively, these findings suggested that 
the reporter responded specifically to the Ser28 phosphorylation.  
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Figure 2.4. Expression and in vitro characterization of reporter mutants. a) Coomassie staining of 
four mutants, which have a molecular weight ~85kD similar to that of the original reporter. 50 
pmole protein was loaded onto the gel. b) The maximal emission ratio change of mutants and the 
reporter in response to the Msk-1 phosphorylation. Compared to the original reporter, the S10A 
mutant displayed a similar magnitude of emission ratio change. Other mutants did not show any 
FRET response. c) Immunoblot analysis using antibodies specific for phospho-H3-Ser28 and 
phospho-H3-Ser10, respectively. Except the alanine replacement suppressed phosphorylation, the 
unchanged serine residues in the mutant reporters remained available for Msk-1 phosphorylation. 
The presence of smearing bands is possibly due to the antibody recognition of the proteolyzed 
fragments, in addition to the expected full-length reporter protein or mutants.       
 
 
Characterization of the Ser28 phosphorylation-specific reporter FRET response 
One interesting avenue is to search for the source of the reporter FRET specificity 
to the Ser28 phosphorylation. This can be due to the reporter geometry or can be a 
reflection of 14-3-3τ’s intrinsic preference for binding to Ser28. On the H3 peptide 
(amino acid 1-30), there are strikingly similar sequences, ARKS10TG and ARKS28AP, 
with subtle differences around both phosphorylable serine sites (underlined). Since both 
serine residues were phosphorylated by Msk-1, but they unequally contributed to the 
overall FRET response, one hypothesis was that 14-3-3τ could selectively recognize the 
phosphorylated Ser28. Yaffe et al. previously examined the substrate specificity for 14-3-
3τ binding using the phosphoserine-oriented peptide library. This method has identified 
the consensus sequences RSXXpSXP and RX(Y/F)XpSXP, where X represents any 
amino acid and pS denotes the phosphorylated serine, present in nearly all known 14-3-3τ 
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binding proteins94. Supporting this finding is a crystal structure where the phosphoserine-
containing peptide is bound to 14-3-3 in an extended conformation. For the sequence 
determinants that dictates the 14-3-3τ binding, the conserved proline residue in the pS+2 
of the peptide is critical because the corresponding alanine-replaced counterpart showed a 
5 fold weaker interaction94.  In the reporter context, only Ser28, but not Ser10, has such a 
proline in the pS+2 position. It was interesting to test whether the presence of the 
particular proline leads to the selective 14-3-3τ binding as suggested by the previous 
peptide experiment. 
Figure 2.5. a) The maximal YFP/CFP emission ratio change of the original reporter and two 
doubly substituted mutants when incubated with the Msk-1 phosphorylation conditions. b) 
Immunoblot analysis of each sample, at the end of the phosphorylation reaction in a), using 
antibodies specific to phospho-H3-Ser10 and phospho-H3-Ser28, respectively. 
 
Therefore, two reporter variants with double mutations were created. One 
construct, starting from the existing S28A mutant, was introduced with a proline to 
replace the Gly12 residue. The resultant S28A,G12P was expected to reconstitute the 14-
3-3τ binding to the phosphorylated Ser10. Alternatively, the existing S10A reporter 
mutant was further engineered to substitute its Pro30 by an alanine, to afford the 
S10A,P30G construct that should eliminate any 14-3-3τ binding upon reporter 
phosphorylation and cause no FRET change. Compared to the FRET response of the 
existing S10A mutant, S10A,P30G did not abolish its FRET signal because of the altered 
residue in the pS+2 position. S28A,G12P double mutant also did not suddenly restored 
the FRET response in comparison to the S28A mutant (Fig. 2.5a). In addition, the 
S28A,G12P mutant even failed to reveal a Ser10 phosphorylation signal by immunoblot 
analysis(Fig. 2.5b), presumably due to the altered substrate specificity for Msk-1 
phosphorylation or for anti-phospho-H3-Ser10 antibody recognition. Therefore, a simple 
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replacement of the pS+2 residue did not fully address the specificity of the reporter 
FRET. Future efforts will be required to systematically explore the sequence requirement 
that gives rise to the selective 14-3-3τ binding. 
 
Figure 2.6. In vitro characterization of the domain-transposed histone phosphorylation reporter. 
a) Domain construct and the FRET signal test of the transposed reporter. This reporter also 
responded to Msk-1 phosphorylation and displayed a FRET increase, which was reversed to the 
basal level by PP1 dephosphorylation. ATP was added at time = 0 to initiate the reporter 
phosphorylation. Leaving out either ATP or Msk-1 abolished the FRET change. b) Immunoblot 
analysis of reporter phosphorylation using anti-phospho-H3-Ser10 and anti-phospho-H3-Ser28 
antibodies (from Upstate). Both residues were phosphorylated by Msk-1, followed by a 
subsequent PP1-mediated removal of the phosphate group from the phosphorylated Ser10 and 
Ser28. c) End-point maximal emission ratio change of the transposed reporter and alanine 
mutants replacing the Ser10 (S10A) or Ser28 (S28A) residues. 
 
To test the possibility that the reporter geometry controls the specificity of the 
FRET response, another reporter identical to the original (Fig. 2.1) but with the 14-3-3τ 
and histone peptide domains transposed was constructed. This domain-transposed 
reporter was also responsive to Msk-1 phosphorylation and PP1 dephosphorylation, 
independently examined by the reporter FRET signal and the immunoblot analysis (Fig. 
2.6a and 2.6b). Results suggested that both Ser10 and Ser28 were reactive and reversibly 
modified. Interestingly, subsequent site-directed mutagenesis studies showed that 
phosphorylation of Ser10 and Ser28 both contributed to the overall reporter FRET 
response. Compared to the reporter without mutations, the S10A and S28A did not 
exhibit significantly a different magnitude of the reporter FRET (Fig. 2.6c). This result, 
in turn, suggests that the intrinsic geometrical constraint of the reporter determines the 
FRET specificity of the CFP-14-3-3τ-H3-YFP reporter in Figure 2.1. 
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Figure 2.7. Analytical ultracentrifugation analysis of the histone phosphorylation reporter. For 
sedimentation equilibrium analysis, the reporter (1-10 µM) was loaded into the six- channel 
centerpieces. Equilibrium solute distributions were obtained at the following rotor speeds: 8, 12 
and 16K r.p.m. Data obtained were analyzed with the Beckman XL-A–XL-I software based on 
Microcal Origin 6.0 using the self-association model assuming the formation of reporter 
monomer or dimer, respectively.   
 
The histone phosphorylation reporter functions as a dimer 
14-3-3τ, a 232 amino-acid protein, is known to naturally exist as a dimer. The 
dimer interface is formed by packing the helix α1 from one monomer against the helices 
α3 and α4 of the other. The presence of several conserved residues L12, A16, V62, I65, 
and Y82 provides an extensive interaction network across the dimer interface93. In the 
context of a FRET-based indicator, 14-3-3τ also causes dimerization of the reporter 
molecules27. Even truncation of the N-terminal 14-3-3τ does not prevent the dimerization 
tendency. Therefore, analytical ultracentrifugation was conducted to test whether the 
histone phosphorylation reporter, which also contained 14-3-3τ, functioned as a monomer 
or a dimer. Results from the sedimentation equilibrium analysis showed that the data fit 
better to the dimer than the monomer model, indicating the existence of reporter 
dimerization in solution. This observation led to the challenge of determining the reporter 
FRET mechanism, which could be due to true intramolecular binding upon 
phosphorylation or the change of intermolecular distance between fluorophores across the 
dimer interface. Future efforts will be required to distinguish between these possibilities.  
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Application of the histone phosphorylation reporter in cells 
The histone phosphorylation reporter was then applied to living cells. In 
particular, the reporter should display a FRET change during cell mitosis in which the 
levels of histone H3 phosphorylation are elevated3,22,76 as previously mentioned. Two 
independent assays were individually performed to assess the reporter response as a 
function of the histone phosphorylation extent at different stages of the cell cycle. One 
method compared the basal YFP/CFP emission ratios of reporters from two different cell 
populations at interphase and metaphase, respectively. The other approach focused on 
monitoring the real-time reporter FRET in single cells over an entire cell cycle.  
For protein expression in mammalian cells, the histone phosphorylation reporter 
gene in the existing pRSETB plasmid was cut and plated into the pcDNA3’ plasmid25. 
This construct was introduced to HeLa cells using lipofection. One population of cells 
expressing the original reporter was treated with nocodazole, a reversible inhibitor of 
microtubule polymerization that arrests cells in M phase. Nocodazole-synchronized cells 
display higher levels of histone H3 serine 28 phosphorylation than untreated cells22. After 
16 hr of nocodazole treatment (0.75 µg/mL), HeLa cells transfected with the reporter 
exhibited a rounded morphology, indicating that the cells were arrested in M phase (Fig. 
2.8a). Subsequently, nocodazole was withdrawn and the cells were allowed to recover for 
11 hours. The YFP/CFP emission ratios of the reporters were recorded and compared, 
before and after nocodazole removal. Results showed that cells treated with nocodazole 
display higher levels of FRET, consistent with an elevated level of the histone H3 serine 
28 phosphorylation (Fig. 2.8a).  
In addition, reporter YFP/CFP emission ratios were collected from two distinct 
pools of cells with or without nocodazole treatment. Data based on the ratios from 71 
nocodazole-treated cells and 131 untreated cells were subjected to a statistical analysis.  
On average, nocodazole-treated cells displayed higher emission ratios (n = 71, µ = 0.945, 
σ = 0.0511) than untreated cells (n = 131, µ = 0.919, σ = 0.0535) (σpooled = 0.0526, p < 
0.05) (Fig. 2.8b). For a negative control, the experiment was repeated on cells expressing 
the S28A reporter mutant under otherwise identical conditions. No significant difference 
of the reporter YFP/CFP emission ratios was observed between nocodazole-treated cells 
(n = 26, µ = 0.885, σ = 0.0685) and untreated cells (n = 62, µ = 0.8779, σ = 0.0562). 
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Figure 2.8. a) HeLa cells expressing the histone phosphorylation reporter were arrested in 
metaphase by nocodazole. The YFP/CFP emission of the reporter from individual cells, in the 
presence or after removal of nocodazole treatment, was recorded and pseudocolored according to 
the scale bar. b) Histogram showing the normalized distribution of YFP/CFP emission ratios for 
71 nocodazole-treated cells (blue) and 131 untreated cells (purple). The mean value of the ratios 
from the nocodazole-treated cells is significantly higher than that of the untreated population. 
Data were analyzed by the Student’s t test comparing two independent sample pools (σpooled = 
0.0526, p <0.05). c) Immunoblot analysis on the Ser28 phosphorylation levels of the histone 
phosphorylation reporter and the endogenous histone H3. Cells transfected with the reporter gene 
were either untreated or treated with nocodazole for the indicated time, followed by cell lysis. 
Histones were obtained by an acid extraction, and the reporter proteins were immunoprecipitated 
by anti-GFP antibody. Both proteins were then analyzed, by immunoblot using anti-phospho-H3-
Ser28 antibody, to show their correlation in phosphorylation.   
 
 
The association between the reporter FRET signal and the underlying 
phosphorylation levels inside cells was confirmed by immunoblot. When cells were 
treated with nocodazole, causing an increase of the reporter FRET, the corresponding 
levels of the reporter phosphorylation should also be elevated. Therefore, both reporter 
proteins and the endogenous histones were extracted from cells after they had been 
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incubated with nocodazole for different periods of time. There was an increased 
phosphorylation of endogenous histones when cells were exposed to nocodazole for a 
longer duration. Similarly, the reporter in cells was also more efficiently phosphorylated 
after 19 hr of the nocodazole treatment (Fig. 2.8c).  
Collectively, these results indicated that the reporter was a fair mimic of the 
endogenous histone substrates. Although no further detailed characterization was 
performed to quantitatively compare the kinetics of the reporter and the histone H3 as 
substrates for endogenous histone kinases, current data showed that the enhancement of 
reporter YFP/CFP emission ratio at metaphase was consistent with increased histone H3 
serine 28 phosphorylation levels upon nocodazole treatment.  
In addition, a real-time imaging of cells expressing reporters should reveal the 
dynamic variation of histone phosphorylation alongside the cell cycle. To localize the 
reporter inside cell nuclei, where the histone phosphorylation takes place, an organelle-
specific nuclear localization sequence (PKKKRK) was appended to the C-terminus of the 
~85 kD original reporter. The resultant plasmid was then introduced into HeLa cells via 
lipofection. Reporter proteins were readily expressed and localized in the nucleus after 
~12 hr. As discussed, the histone H3 serine 28 phosphorylation levels transiently increase 
during the mitotic (M) phase of the cell cycle22. Therefore, the subsequent imaging 
experiment monitoring the reporter FRET in transfected cells was performed with a 
period in which cells could undergo an entire cell cycle.  
However, initial attempts at cell imaging failed and encountered difficulties 
associated with transient transfection of the reporter gene. One challenge was the low 
transfection efficiency, providing limited numbers of target cells for imaging. In addition, 
within the long data acquisition period (3~16 hr) expected to observe a cell mitosis event, 
most transiently transfected cells either exhibited a loss of reporter fluorescence or 
underwent apoptosis. Both problems posed fundamental challenges to the imaging 
experiment. One solution was to establish a stable cell line that could constantly express 
the reporter proteins from one generation to another, without affecting the cell viability. 
Therefore, HeLa cells were similarly introduced with the reporter gene using lipofection, 
followed by neomycin treatment to select the transfected individuals. After three weeks 
following the manufacturer’s protocol, reporter-gene transfected cells were enriched 
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because of their neomycin resistance. More than 90 % of the cells were transfected, and 
only a minor fraction of the survived population remained either untransfected or did not 
produce the fluorescent reporter proteins.  
 
 
 
Figure 2.9. a) HeLa cells stably expressing the histone phosphorylation reporter were monitored 
over the course of cell division. The reporter YFP/CFP emission ratio was pseudocolored 
according to the scale bar. Each snapshot was taken at the indicated time with respect to the 
reference time point t = 0, defined as the moment of nuclear membrane breakdown when 
reporters diffused over an entire cell. b) (Left panel) Time-course of the reporter YFP/CFP 
emission ratios from two cells during cell division. The reporter exhibited a rapid increase of the 
emission ratio 5-15 min prior to the nuclear membrane breakdown, reached the peak value at 
metaphase, and gradually decreased over hours to the basal level. A negative control using S28A 
mutant did not show a significant FRET change at any stage. (Right panel) The YFP intensity of 
the reporter and the mutant in separate cells was recorded as a measure of the reporter expression 
level. Sudden changes of the YFP intensity due to the reporter diffusion (because of the nuclear 
membrane breakdown) and relocalization (because of the membrane reform), respectively, were 
indicated. Both the reporter and the mutant showed the same characteristic profile. 
 
Once the stable cell line had been established, the FRET level of the reporter 
readily expressed in HeLa cells was monitored over 26 hr in which multiple cells had 
undergone division. Results from the time-lapse multi-channel fluorescent imaging 
showed that the reporter exhibited a rapid increase of the YFP/CFP emission ratio when 
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cells entered mitosis (Fig. 2.9a). Over the course of recording, six cells with total eight 
mitotic events (two cells divided twice) were monitored. The average emission ratio 
change of the phosphorylation reporter in these cells during mitosis was ~20 %. The 15-
25 % YFP/CFP emission ratio change in cells was similar to the magnitude of the FRET 
response measured in vitro. Furthermore, the surge of the reporter FRET in eight cells 
consistently occurred 5-15 minutes preceding the nuclear membrane breakdown (as 
measured by reporter distribution in the cell). This high FRET signal sustained for hours 
and gradually decreased to the basal level after cytokinesis, when the cytoplasm from the 
parental cell was distributed into daughter cells (Fig. 2.9b). As a negative control, an 
experiment was repeated using the S28A reporter mutant under otherwise identical 
conditions. Because no FRET change of this mutant was observed during cell division, 
this result demonstrated that the response of the original reporter is not an artifact 
associated with the cellular environment, including changes in reporter concentration or 
cellular pH over the course of cell division.  
 
Targeting the histone phosphorylation reporter to chromosomes 
Currently, diffusion of the reporter during nuclear membrane breakdown limits 
the spatial resolution of histone phosphorylation detection. Only the information of global 
histone phosphorylation can be collected via monitoring the diffused reporters. One 
possible solution for the improvement is to anchor the reporter to chromatin, where the 
histone phosphorylation takes place. The chimeric histone H3 construct with a GFP fused 
to a full-length H3 (H3-GFP) was shown to be similar to endogenous histone H3 
proteins, in their kinetics of being incorporated into nucleosomes103. Therefore, the 
current histone phosphorylation reporter (HPR) was genetically fused to the C-terminus 
of full-length H3 for targeting to the histone cores. 
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Figure 2.10. a) Domain construct of the full-length H3 fused histone phosphorylation reporter 
(H3-HPR). b) The putative model of integrating the full-length histone H3-fused reporters into 
nucleosomes, based on the hierarchical levels of DNA-histone interaction. Assuming that the 
incorporated reporter can still undergo conformational change, one possibility is the anticipated 
occurrence of the histone phosphorylation-dependent intramolecular FRET. In addition, the two 
histone core moieties, in the condensed state, are proximal to each other by 11 nm. This 
separation is within the range that FRET can take place between two adjacent reporters 
intermolecularly regardless the protein phosphorylation.     
 
 
The resultant construct, H3-HPR (Fig. 2.10a), was then tested inside HeLa cells.  
Unlike the previous reporter tagged with the nuclear localization signal, this full-length 
histone H3-fused phosphorylation reporter exhibited a basal YFP/CFP emission ratio in 
the range of 2.2-2.4. The FRET level was insensitive to cell division, different from what 
was expected (Fig. 2.11). This level of basal FRET was higher than that observed in the 
reporters tested in vitro or the NLS-tagged reporter in cells, suggesting that incorporation 
of the H3-tagged reporter into chromosomes possibly changed the reporter geometry. As 
a result, the reporters were prevented from indicating any FRET change during mitosis. 
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Another possibility is that the reporters integrated in nucleosomes are densely packed, 
and any histone phosphorylation-induced intramolecular FRET signal is overwhelmed by 
the intermolecular phosphorylatioin-independent FRET between two proximal reporters 
(Fig. 2.10b). Nonetheless, transfected cells could still undergo division as normal and the 
reporters were indeed localized on the chromosome during cell division (Fig. 2.11b). 
These results showed that, at least, introduction of the new construct to histone cores did 
not fundamentally disable the cell viability.  
 
 
Figure 2.11. a) HeLa cells expressing the reporter variant H3-HPR can successfully undergo cell 
divisions. The YFP fluorescence of the reporter was pseudo-colored in green and superimposed 
with the corresponding DIC image. Three mitosis events were observed from cells numbered in 
red. Unlike the previous reporter, which was tagged with a nuclear localization sequence and 
diffused over the entire cell due to the nuclear membrane breakdown, this H3-fusion reporter 
variant was incorporated into chromosomes and localized in the cell center during cell division.   
b) The time-course emission ratio profile of the H3-HPR in cell no.1. Because of the large 
fluctuation of the signal over time, H3-HPR is not considered to exhibit a histone phosphorylation 
dependent FRET increase during mitosis.   
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Test the cellular reporter response upon extracellular stimulation by phorbol ester     
In addition to mitosis, histone H3 phosphorylation at Ser28 could also be 
transiently induced in response to extracellular stimulation. For example, the C3H 10T1/2 
fibroblasts were tested against the addition of phorbol ester TPA (12-O-tetradecanoyl-
phorbol-13-acetate). In response to the TPA-activated signaling cascade, these fibroblasts 
exhibited the elevated histone phosphorylation that lasted for 1.5 hr before returning to 
the basal level104. To examine whether the reporter can detect the pharmacologically 
induced histone phosphorylation, HeLa cells stably transfected with the NLS-tagged 
phosphorylation reporter gene were tested in response to TPA addition. Results were 
shown in Figure 2.12. In contrast to the expected elevation of histone phosphorylation 
within 20-30 min after TPA treatment, no FRET change of the reporter was observed 
through the monitoring duration. To exclude the possibility that cells stably transfected 
with the reporter construct has intrinsically lost the histone phosphorylation response, the 
same experiment was repeated on HeLa cells that were transiently transfected with the 
reporter gene. However, the result also showed no FRET change of the reporter in 
response to TPA treatment. Since no further experiments were performed to address the 
absence of reporter FRET change, it was unclear whether the reported transient elevation 
of histone phosphorylation was cell-line specific and took place only in the C3H 10T1/2 
fibroblasts. Another possibility is that the TPA-mediated histone phosphorylation does 
not efficiently translate to the phosphorylation of the reporter, and confirmation of this 
claim requires identification of the histone kinases in this particular case as well as the 
detailed understanding of kinetic aspects of the reporter as the substrate for kinases and 
phosphatases.     
 
 
 
 
 
 
 
 47
 
Figure 2.12. Test of the histone phosphorylation reporter in response to extracelluar stimulation 
with phorbol ester TPA. HeLa cells stably transfected with the NLS-tagged histone 
phosphorylation reporter (used in Fig. 2.9) were selected for imaging. The time-course 
fluorescent intensity of the reporter (from the cell labeled with a red asterisk) was acquired with 
different settings (“YFP” (EX: 495 ± 10 nm, EM: 530 ± 30 nm), “FRET” (EX: 420 ± 20 nm, EM: 
530 ± 30 nm), and “CFP” (EX: 420 ± 20 nm, EM: 475 ± 40 nm)) from the cell labeled with an 
asterisk. The YFP/CFP emission ratio was calculated by dividing the “FRET” intensity by “CFP” 
intensity. The black arrow indicates the time of TPA (400 ng/mL) addition.  
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Discussion 
Current understanding of histone phosphorylation is at the stage of identification 
of kinases, phosphatases, and how they coordinate in cells, thereby affecting the 
downstream biological outcomes. The most studied system is the elevation of histone 
phosphorylation during mitosis, particularly at the Ser10 and Ser28 residues of histone 
H374,91. Phosphorylation is carried out by kinases such as Msk-1 and Aurora B, but a 
complete set of underlying enzymes may include more than these existing ones that have 
been identified thus far. The existing approaches for studying histone phosphorylation 
primarily depended on the antibody-based immunofluorescence staining and 
immunoprecipitation of the target proteins in cells. These methods provide the readout of 
histone phosphorylation with the spatial resolution in the scale of the entire chromosome 
(~1 µm, Fig. 2.10b) and the temporal resolution over the course of cell division (~1 hr). 
For instance, Ser10 phosphorylation was found to start at the pericentromeric 
heterochromatin during the late G2 phase, and it became widespread over the entire 
chromosomes and sustained through prophase to telophase91. Alternatively, Ser28 
phosphorylation is relatively transient occurring at the condensing chromosomes from 
prophase to anaphase92. The difference in phosphorylation of these two serines is 
suggested as a reflection of how the activities of kinases (such as Aurora B) and 
phosphatases (such as PP1) are coordinated differently to modify these two residues (Fig. 
2.13).    
 
Figure 2.13. Schematic representation of the mechanism by which Aurora B kinase and protein 
phosphatase 1 (PP1) regulate the cell-cycle dependent histone H3 phosphorylation at Ser10 and 
Ser28. A) Only Ser10, but not Ser28, phosphorylation is readily detected in the late G2 phase. It 
is because that PP1 selectively dephosphorylates the modified Ser28, while Aurora B efficiently 
phosphorylates both residues. B) Through prophase to metaphase, both Ser10 and Ser28 
phosphorylation are observed, due to the fact that Aurora B phosphorylation overrides the 
dephosphorylation by PP1, which is presumably downregulated by the cell-cycle dependent Cdc2 
kinase. This model is constructed based on 1) immunofluorescence detection of the Aurora B 
localization and 2) modulation of PP1 activity by the inhibitor calyculin A92.   
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In addition to mitosis, histone phosphorylation can also be induced by 
extracellular stimuli such as EGF or TPA. Both reagents elicit the mitogen-activated 
protein kinase cascades and enhance the activity of downstream kinase Msk-190, which 
results in the elevation of histone H3 phosphorylation at Ser10 and Ser28. Compared with 
the mitosis-mediated histone phosphorylation, this induced response is relatively short-
lived lasting for only 20-30 min. In addition, it occurs at a small subset of the histone H3 
rather than the global population of histones during mitosis.   
To monitor the histone phosphorylation in single living cells, a FRET-based 
genetically encoded reporter has been developed. This reporter gene was cloned into two 
different plasmids: pRSETB, which was for expression and characterization of the 
reporter protein in vitro, and pcDNA3, which was for expression of reporter in 
mammalian cells. In vitro experiments demonstrate that the reporter exhibited a 
reversible FRET response as a result of Msk-1 phosphorylation and PP1 
dephosphorylation. With this preliminary information in hand, a parallel avenue was to 
test the reporter in cells in order to reveal the global histone phosphorylation during cell 
division. Without a recognition element reported a priori to bind the phosphorylated 
histone sequence, the 14-3-3τ domain was chosen because of its known interaction with 
phosphoserine/threonine. In fact, the consensus sequence27 for 14-3-3τ binding is 
significantly different from neighboring residues flanking the Ser28 on the histone H3 
tail. Either 14-3-3τ possesses an unprecedented binding promiscuity in a context-
dependent manner, or the intramolecular linkage connecting 14-3-3τ to the phosphoserine 
peptide effectively enhances the binding affinity.  
The reporter exhibited an unexpected specific FRET response to Ser28 
phosphorylation, although Ser10 and Ser28 of the reporter could both be enzymatically 
modified. Most likely, the specificity stemmed from the determined geometry of the 
reporter, depending on how individual modules were assembled into the final molecule. 
Swapping 14-3-3τ and the H3 peptide in the domain-transposed variant resulted in the 
unexpected reporter FRET response to both Ser10 and Ser28 phosphorylation.  
To better understand the performance of the reporter in vitro, detailed kinetic 
characterization of reporter phosphorylation and dephosphorylation is critical but remains 
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to be further elaborated. The Msk-1 kinase used for reporter phosphorylation was first 
cloned and preliminarily characterized by New et al. in 1999105.  No further kinetic study 
has been reported ever since. Assuming that the time-course emission ratio change of the 
reporter linearly reflects the extent of reporter phosphorylation in Figure 2.2a, 2.3b, and 
2.6a, the time required to reach half of the maximal phosphorylation (1-5 µM of the 
reporter) lies in the range of 1-2 hr (with 0.8-4 µM Msk-1). In contrast to the fact that the 
kinase such as PKA can efficiently phosphorylate the Kemptide substrate (kcat = 4.2 s-1)106 
in a typical reaction, this result suggests that Msk-1 is not an efficient enzyme in 
phosphorylating the histone phosphorylation reporter. An additional factor associated 
with the low enzyme efficiency is perhaps due to the heterologous expression of the 
human Msk-1 in E. coli., which results in the intrinsic reduction of the optimal enzyme 
activity. Future studies of this kinase will be required to understand the detailed 
mechanism and to obtain the Michalis-Menten constants.  
For dephosphorylation of the modified reporter, a typical assay used 0.06 µM PP1 
for the reaction with 5 µM reporter. Based on the reported Michalis-Menten constants of 
the λ bacteriophage protein phosphatase (kcat ~ 500 s-1, KM = 10.3 mM, using p-
nitrophenyl phosphate as the substrate)107, which is highly homologous to the commercial 
enzyme, a maximal Vinitial = 0.011 µM s-1 is expected in the reaction condition assuming 
all the reporter molecules were phosphorylated prior to dephosphorylation. The 
calculated completion time of dephosphorylation should be within several minutes 
([reporter] / Vinitial ~ 8 min). However, this expected duration is much shorter than the 
currently observed reporter dephoshorylation that lasts over several hours. This 
discrepancy possibly reflected the overestimated extent of the reporter phosphorylation, 
which is an important aspect that remains to be further investigated in the future.  
Nonetheless, the FRET-based reporter provided an opportunity to monitor the 
onset and disappearance of the histone H3 Ser28 phosphorylation in single living HeLa 
cells upon division. The novel observation of a rapid increase in levels of histone 
phosphorylation (in the order of 5 min, compared to the entire mitosis that lasts ~1 hr), 
which preceded the nuclear membrane breakdown by 5-15 min, suggested an 
unprecedented link between histone modification and cell morphological change when 
preparing the entry for mitosis. As an additional demonstration of the elevated histone 
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phosphorylation during mitosis, the basal levels of the reporter FRET were compared in 
HeLa cells treated with nocodazole, which arrested cells at the metaphase, as well as in 
the untreated cells at the interphase with a basal level of phosphorylation. Assuming that 
the scale bar is linearly proportional to the reporter phosphorylation in cells (Fig. 2.8), the 
YFP/CFP emission ratio of the reporters in the nocodazole-treated cells (µ = 0.945, 
corresponding to 49.0 % of phosphorylation) was, on average, higher than that in the 
untreated cells (µ = 0.919, corresponding to 43.8 % of phosphorylation) by 5.2 %. The 
nocodazole-induced elevation of histone phosphorylation was previously assayed by 
immunoblot, using the antibody specific for the phosphorylated Ser28 of histone H322. 
Only mitotic cells, but not the cells at interphase, gave rise to the signal. In contrast to the 
large dynamic range of immunoblot sampling a huge cells population (typically 106-108 
cells, collected by a combination of nocodazole treatment and the subsequent mechanical 
shake off22), the reporter approach collecting only ~200 cells by the imaging method 
revealed a small magnitude of difference in histone phosphorylation with or without the 
nocodazole treatment. To fairly compare these two different methods, future efforts will 
be required to examine whether the cells obtained via these approaches represent the 
same cell state.   
Another concern regarding the small yet statistically significant difference of 
reporter FRET between two populations is the choice of cells for data acquisition. Unlike 
the continuous cell imaging of the histone phosphorylation reporters, which can reflect 
the maximal reporter phosphorylation at one specific time point, the basal emission ratio 
approach only takes snapshots of cell at a particular moment in an uncontrolled manner. 
The rounded cell morphology, caused by the nocodazole treatment, was used as the 
signature of the cells that were arrested in mitosis. However, the nocodazole treatment 
may not synchronize all the rounded cells at the stage where the maximal reporter FRET 
takes place. Therefore, it was not surprising that the selected rounded cells for basal 
FRET measurement revealed a smaller phosphorylation difference than expected.    
To enhance the spatial resolution of the histone phosphorylation reporter, the H3-
HPR construct was designed for targeting the reporter to the histone cores. Although no 
FRET response of the reporter was observed during mitosis, the recombinant construct 
was indeed incorporated into nucleosomes. Currently, the cloning strategy fused the 
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reporter to the C-terminus of the full-length histone H3 for targeting to the histone cores. 
This was based on the previous success of H3-GFP, which replaced the reporter by GFP 
with the otherwise identical construct103. However, it was unclear how these C-terminal 
full-length histone H3 fusion recombinant proteins were integrated into histone cores. In 
contrast, an alternative N-terminal fusion that presumably would place the reporter in the 
outmost accessible histone tails seemed to be a more rational choice from a design 
viewpoint.  
The reporter production and the kinetics of incorporating the reporters into 
histone cores are also important considerations. Unlike the endogenous histone proteins, 
whose production is coupled to DNA synthesis and occurs at the S-phase, the unregulated 
expression of H3-GFP is constant through the entire cell cycle due to transfection. Owing 
to the bulky tag size, the H3-GFP is not capable of being inserted into densely packed 
heterochromatin. During the late S-phase when DNA synthesis remodels nucleosome and 
permits more access, the H3-GFP construct is then stably integrated into euchromatin 
with little exchange thereafter. Alternatively, fusion GFP to histone H2B results in a 
recombinant protein that is more dynamically shuttling between the histone core and the 
bulk environment in the cell nucleus. A significant fraction (~40 %) of the H2B-GFP 
incorporates into chromatin exchange in hours (t1/2 = 130 min), and there is also a small 
pool (~3 %) that more rapidly exchanges within minutes103. These GFP-tagged chimeric 
constructs represented 4-10 % of the total histone proteins, and the actually number of 
molecules expressed in one cell was estimated to be ~107. Conceivably, stable cell lines 
tolerated this expression level of the fusion constructs and their competition with 
endogenous histones. One future avenue is to explore other fusion strategies targeting the 
histone phosphorylation reporter to other histone subunits (for instance H2B and H4).  
Fusion of the reporter to the N-terminus of histone H3 as mentioned should also be an 
interesting attempt in the future. 
The histone phosphorylation reporter also possesses disadvantages and 
limitations. From a rational design viewpoint, the choice of a binding module from the 
existing natural protein domains to recognize the phosphorylated histone peptide is 
critical. However, it can also be the rate-limiting step for building a successful reporter. 
Not included in current work, other phosphoserine/threonine binding domains may be 
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considered for future histone phosphorylation sensor design and FRET signal 
optimization. These candidates include the characterized domains such as WW95, 
WD4096, FHA97,98, and survivin108,109 that associates with a kinase complex during 
mitosis. As previously illustrated, the reversibility of the reporter emission ratio change 
was relatively predictable, depending on the binding affinity between the recognition 
module and the phosphorylated substrate peptide. For instance, the FHA2-based FRET 
reporter for the kinase PKC activity exhibited a faster response to dephosphorylation in 
living cells, whereas the 14-3-3τ-based reporter for the PKA activity was shown as a poor 
substrate for phosphatases and had nearly irreversible FRET change. Presumably, the 14-
3-3τ binds more tightly to the phosphorylated peptide and prevents it from the subsequent 
dephosphorylation27,40. In fact, the dissociation constants of FHA2 for it optimal peptides 
is 10 µM98, whereas 14-3-3 binds its optimal peptide with a dissociation constant of 56 
nM98.  
However, it is difficult to rationally engineer the existing natural phosphoserine 
recognition modules with the desired binding affinity and specificity. These factors are 
coupled to other parameters such as the linker length and reporter geometry. Therefore, 
the de novo reporter design will also require the empirical optimization of the reporter 
performance, using the screening or evolutionary approach. To facilitate the technical 
work, the pRSETB plasmid where the reporter gene is incorporated provides a 
convenient platform for engineering the reporter proteins. Both CFP and YFP, two 
invariant moieties of the reporters, are integrated in the plasmid as part of the vector 
backbone, which easily accepts the inserts to complete the reporter gene via one-step 
ligation. As for the source of the insert, it can be a library containing mutants of the 
phosphoserine recognition module. This library can also incorporate a series of linkers 
with varied lengths, connecting the binding domain to the histone H3 peptide. The 
resultant plasmids can then be individually expressed to afford the proteins of the reporter 
variants, followed by assaying the reporter properties in a high-throughput screening 
manner. In addition, the library of reporter variants’ genes can also be cloned into the 
pcDNA3’vector for the subsequent cellular work. An imaging-aided screening of the 
reporter performance can then be conducted in the cells transfected with these reporter 
genes.          
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 The complex cellular environment is anticipated to pose many challenges to the 
reporter approach. One of them is the control of the expression level of the reporter 
molecules inside cells. Currently, the CMV (cytomegalovirus) promoter in the pcDNA3’ 
plasmid upstream the reporter gene affords the constitutively high level of the reporter 
expression. Although not demonstrated in current experiments, the yield of protein 
expression mediated by the CMV promoter could reach as high as 0.1~1 mg/L in COS 
cells110. Even under the control of such a strong promoter, the transfected cells showed a 
large variation in the protein expression level. One common observation in the imaging 
experiment was that an extremely high level of protein expression, judged by the reporter 
fluorescence, also raised the cell toxicity. Therefore, imaging was performed, on an 
empirical basis, in the selected cells with an expression level that sufficed data 
acquisition but not saturated the cell machinery. One potential solution to modulate the 
amount of reporters in cells is to introduce a new construct with an inducible promoter 
that can influence the downstream reporter expression by a chemical means. The Tet-On 
system is an example that permits the regulation of the protein expression levels by 
treating the cells with different concentrations of doxycycline53.  
   Another foreseeable limit is the spatial resolution of histone phosphorylation that 
the reporters can provide in cells. It is unlikely that the reporter can be directed to 
particular loci on the chromosome to fetch the information of gene-specific histone 
phosphorylation. Nonetheless, reporters can be fused to proteins that are known to 
constitute or associate with histones, as partly mentioned, for targeting to chromatin. In 
addition to histone subunits, other protein such as HP1α (heterochromatin protein 1) and 
HP1β that are known to bind the histone tails are other candidates for protein fusion. 
More extensive knowledge will be required to address the dynamic interactions between 
these proteins and histones in order to evaluate the result, if any, from the reporter 
approach.  
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Experimental 
 
The sequences of all primers for construction of the histone phosphorylation reporters 
and site-directed mutagenesis are listed in Table 2.1.  
 
Experiments of DNA cloning, expression of reporter, protein purification, and 
immunoblot were based on the general protocols listed in the Appendix unless otherwise 
mentioned. The sequences of all the constructs were confirmed by the MWG Biotech 
sequencing service.   
 
Histone phosphorylation reporter (CFP-14-3-3τ-H3-YFP): gene construction, 
expression, and protein purification 
 The primers, 14-3-3τ.F and 14-3-3τ.R, were used to amplify the 14-3-3τ gene (a 
gift from Jin Zhang, Johns Hopkins University). This introduced the SphI site upstream 
the 14-3-3 τ domain and incorporated the linker and part of the histone H3 sequence. The 
amplified product was used as the template for the subsequent PCR, which included the 
remaining H3 sequence and the SacI site with primers: H3.RR and 14-3-3τ.F. The PCR 
product was digested with SphI and SacI enzymes and ligated into the pRSETB vector, 
which was derived from the similarly cut EGFR reporter plasmid25 containing a (His)6 
epitope upstream the reporter gene for protein purification. The resultant plasmid was 
confirmed by DNA sequencing.  
 To express the reporter proteins, the plasmids were introduced into the bacterial 
strain BL21(DE3) (Stratagene) by heat-shock transformation. The cells were grown in 
Luria Broth supplemented with ampicillin (100 µg/mL) at 37 ºC until OD600 0.5. IPTG 
was then added to a final concentration of 0.4 mM to induce protein expression. The cells 
were grown for an additional 3 h at 30 ºC and then harvested by centrifugation. Cells 
were lysed by sonication at 4 ºC (six 30-sec pulses at half-maximal power with 1 min in 
between each pulse) in lysis buffer (50 mM Tris pH 7.8, 300 mM NaCl, 4 mM PMSF, 
and ¼ EDTA-free protease inhibitor cocktail tablet (Roche, Indianapolis, IN) per 10 mL 
of lysis buffer). The His6-tagged protein was purified from the lysate using a Ni-NTA 
agarose (Qiagen) column. Fractions containing the proteins were consolidated and 
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transferred into TBS (140 mM NaCl, 3 mM KCl, 25 mM Tris pH 7.4) by two rounds of 
dialysis. The purity and quantity of the protein were examined by SDS-PAGE, and the 
typical yields were 0.5-1 mg of protein per 0.5 L culture. Proteins were then stored in 
aliquots at -80 ºC. 
 
Histone phosphorylation reporter (CFP-14-3-3τ-H3-YFP) mutants: gene construction, 
expression, and protein purification 
  To construct the reporter mutants, QuikChange (Stratagene) reactions were 
individually performed using the histone phosphorylation reporter gene as the template 
and the following primer pairs: S10A.F and its reverse complement for the S10A mutant; 
S28A-1.F and its reverse complement for the S28A mutant; K49E.F and its reverse 
complement for the K49E mutant. The PCR program used was as follows:  
  Step 1:  95 ºC 30 sec. 
  Step 2:  95 ºC  30 sec. 
  Step 3:  50 ºC  15 sec; increase 0.8 ºC per cycle. 
  Step 4:  68 ºC 20 min. 
  Setp 5:  Repeat step 2-4 for 24 more times. 
  Step 6:  68 ºC 10 min. 
  Step 7:  10 ºC  forever. 
To construct the S10A,S28A double mutation variant, the PCR used the S10A plasmid as 
the template and primers: S28A.F and its reverse complement. For construction of the 
S10A,P30G mutant, the PCR used the S10A plasmid as the template and primers: 
P30G.F and its reverse complement. To create the S28A,G12P mutant, the PCR used the 
S28A plasmid as the template and primers: G12P.F and its reverse complement. All the 
mutant plasmids were confirmed by DNA sequencing, followed by protein expression in 
BL21(DE3) and Ni-NTA purification. The purity and quantity of the proteins were 
examined by SDS-PAGE, and the typical yields were 0.5-1 mg of protein per 0.5 L 
culture. Proteins were then stored in aliquots at -80 ºC. 
 
Domain transposed histone phosphorylation reporter (CFP-H3-14-3-3τ-YFP) and 
mutants: gene construction, expression, and protein purification 
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  The following primers were used to amplify the 14-3-3 τ gene: H3-14.F and H3-
14-SacI.R. This introduced the SacI site at the 3’ of 14-3-3 τ as well as incorporated the 
linker and part of the histone H3 upstream 14-3-3 τ. The product was used as the template 
in the second PCR, which completed the H3 sequence with an SphI site using primers: 
H3-14.FF and H3-14-SacI.R. The PCR product was digested with SphI and SacI enzymes 
and ligated into the pRSETB vector (derived from the similarly cut EGFR reporter 
plasmid25).  
 For construction of the alanine mutants, QuikChange reactions were individually 
performed with the domain-transposed reporter gene as the common template. Primes 
S10A.F and its reverse complement were used to create the S10A mutant. Primers 
H314_S28A.F and its reverse complement were used for construing the S28A mutant.  
All resultant plasmid were confirmed by DNA sequencing, followed by protein 
expression in BL21(DE3) and Ni-NTA purification. The purity and quantity of the 
proteins were examined by SDS-PAGE, and the typical yields were 0.5-1 mg of protein 
per 0.5 L culture. Proteins were then stored in aliquots at -80 ºC. 
 
Histone phosphorylation reporter gene tagging with a nuclear localization signal 
 To amplify the YFP gene with its C-terminus appended to the nuclear localization 
signal, the following primers were used in the PCR: YFP-Start.F and NLS reverse primer. 
The PCR product was digested with EcoRI and SacI to afford the fragment No. 1.  The 
CFP–14-3-3τ–H3–YFP (pRSETB) construct was digested with BamHI and SacI to 
generate the fragment No. 2. Both digested fragments were incubated together with the 
pcDNA3 vector, prepared from BamHI and EcoRI digested EGFR reporter25, for 
performing a three-part ligation to yield the final plasmid. To create the S28A mutant (in 
pcDNA3) tagged with the nuclear localization signal, the corresponding S28A mutant 
reporter gene (in pRSETB) was first digested with EcoRI and SacI to yield one fragment, 
followed by otherwise identical three-part ligation procedure to generate the final 
plasmid. The resultant plasmid was confirmed by DNA sequencing.  
 
Construction of the histone phosphorylation reporter variants fused to the full-length H3 
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 The following primers were used to amplify the entire histone phosphorylation 
reporter gene: BOS-H3-N-HPR.F and BOS-H3-N-HPR.R. After digestion with BamHI 
and NotI enzymes, this fragment was ligated into the vector derived from the similarly 
cut BOS-H3-GFP plasmid103 (a gift from Hiroshi Kimura, Kyoto University, Japan). The 
S28A mutant was constructed by amplifying the corresponding mutant reporter sequence, 
digestion with the same enzyme pairs, and ligation into the same vector. The resultant 
plasmid was confirmed by DNA sequencing.  
 
Phosphorylation and dephosphorylation of reporters in vitro 
  Reaction conditions for the in vitro phosphorylation assays were as follows: 1-5 
µM reporter, 0.6 mM ATP, 20 mM HEPES pH 7.7, 10 mM MgCl2, 0.1 mM EGTA, 0.5 
mM DTT, and 4 µM of Msk-1. The His6-tagged Msk-1 plasmid105 (a gift from Jiahuai 
Han, The Scripps Research Institute) was expressed and purified using the same protocol 
as mentioned above, and the concentration was determined by the BCA kit (bicinchoninic 
acid , Pierce, Rockford, IL). Reactions were incubated at 30 °C for the indicated times.  
  To dephosphorylate the modified reporter, the following reagents were added to 
the phosphorylation mixture: 0.06 µM PP1 (New England Biolabs, Ipswich, MA), 62.5 
mM HEPES pH 7.0, 0.125 mM EDTA, 0.1 mM EGTA, 6.25 mM DTT, 0.03 % Tween-
20, and 1.25 mM MnCl2. Reactions were incubated at 30 °C for the indicated times.  
  The phosphorylation state of the reporter from the in vitro assays was analyzed by 
immunoblot using 12 % SDS-PAGE gel, anti-phospho-H3-serine 10 antibody (Cell 
Signaling Technology, Beverly, MA) or anti-phospho-H3-serine 28 antibody (Upstate 
Biotechnology, Charlottesville, VA) (both at 1/1000 dilution for 3 h at 25 °C), and goat 
anti-rabbit-HRP conjugate or goat anti-mouse-HRP conjugate (1:1000 dilution for 2 hr at 
25 °C) (Bio-Rad, Hercules, CA). The HRP was visualized by chemiluminescence 
(Supersignal West Pico, Pierce, Rockford, IL). 
 
In vitro FRET measurement of histone phosphorylation reporter 
  The Safire plate reader operated with the XFluor software (Tecan, Medford, MA) 
was used to measure multiple samples of the histone phosphorylation reporter in vitro. 
Each sample solution (35 µL) incubated under a different assay condition was pipetted 
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into the 384-well plate (Greiner Bio-One, Longwood, FL). The plate was then monitored 
with the following settings: Z-position, calculated; integration time, 40 µs; gain, 100. The 
emission spectra were obtained by an excitation at 433 nm, with slit widths 2.5 nm for the 
excitation and 2.5 nm for the emission. YFP emission (527 nm) to CFP emission (476 
nm) ratios were calculated from the peak intensity at the corresponding wavelengths.  
 
Imaging of the histone phosphorylation reporter in cells 
  For expression of the histone phosphorylation reporter in cells, HeLa cells were 
transfected with the pcDNA3 plasmids containing the reporter gene, using the lipofection 
reagent Fugene 6 (Roche). To a 1.5 mL eppendorf tube containing 100 µL DMEM 
(Dulbecco’s Modified Eagle’s Medium, Invitrogen, Carlsbad, CA) add 3 µL of the 
reagent and 1 µg of the reporter DNA, followed by 30 min incubation at room 
temperature. Add this solution to cells in 2 mL culture media in a dropwise manner. After 
8-24 hr, images were collected on a Zeiss Axiovert 200M inverted epifluorescence 
microscope with differential interference contrast (DIC). To maintain the cell health 
during imaging, cells were accommodated in the following conditions: 10 % fetal bovine 
serum in phenol red-free DMEM (Invitrogen), 37 °C, 5 % CO2. For providing such 
conditions, an environmental control system (Solent Scientific, Portsmouth, UK) housed 
the microscope stage. For each data acquisition, four images were collected in rapid 
succession (automated, using OpenLab software (Improvision, Lexington, MA): a CFP 
image (420DF20 excitation, 450DRLP dichroic, 475DF40 emission), a FRET image 
(420DF20 excitation, 450DRLP dichroic, 530DF30 emission), a YFP image (495DF10 
excitation, 515DRLP dichroic, 530DF30 emission), and a DIC image (775DF50 
emission). These images were acquired by using the corresponding filter sets (from 
Omega Optical, Brattleboro, VT) as individually listed. Fluorescence images were 
background corrected. Acquisition times ranged from 100 to 800 ms. To calculate the 
emission ratios, the intensity of each pixel in the FRET image was divided by the 
intensity of the corresponding pixel in the CFP image. These calculated ratios were each 
assigned with a color according to the scale bar and presented in the emission ratio 
image. The data shown in Figure 2.9a are a merge between the pseudo-colored emission 
ratio image and the DIC image. To plot the time-course of fluorescence intensity and the 
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emission ratio, a region of interest was selected to overlap with and monitor the cell 
nucleus. From this region, individual values of the CFP, YFP, FRET intensity, and the 
emission ratio were recorded and plotted as a function of time.   
 
Acid-extraction of histone proteins from HeLa cells 
  This session was modified from the protocol kindly provided by Cynthia Barber 
(David Allis’ laboratory, Rockefeller University). HeLa cells, untreated or treated with 
nocodazole (1.5 µg/mL) for different time, were lysed for 1 hr at 4 °C in NP40 buffer 
containing 1 mM PMSF, 5 mg/mL NaF, and protease inhibitor cocktail solution 
(Calbiochem, San Diego, CA; containing 500 µM 4-(2-Aminoethyl) benzenesulfonyl-
fluoride, 150 nM aprotinin, 1 µM E-64, and 1 µM leupeptin hemisulfate) at a cell density 
of 107 cells mL-1. Subsequently, 0.4 M H2SO4 was use to precipitate the unwanted 
proteins from the lysate for 2 hr at 4 °C.  It was followed by adding the supernatant with 
25 % trichloroacetic acid to sediment the histone proteins for 1 hr at 4°C. After washing 
with acetone containing 1 % HCl, the histone proteins were dried and resuspended into 
H2O with a concentration 1 mg/mL. A typical yield is 0.6 mg protein from 107 HeLa 
cells.   
 
Immunoprecipitation of histone phosphorylation reporter expressed in HeLa cells 
  The Protein A beads (500 µL, Calbiochem) was washed with TBS-T buffer (700 
µL, containing 50 mM Tris, 150 mM NaCl, and 0.1 % (v/v) Tween 20; pH 7.5) three 
times and resuspended in TBS-T solution (600 µL), incubated with 1mg/mL BSA and 3 
µL anti-GFP antibody (Clontech, Mountain View) for 3 hr. Samples collected from the 
lysed cells (200 µL), previously untreated or treated with nocodazole for various lengths 
of time, were loaded to the above slurry (100 µL) and incubated for 3 hr at 4 °C. After 
washing with TBS-T, the samples were boiled and loaded to the 12 % SDS-PAGE for a 
subsequent immunoblot analysis. The reporter protein mixture was then transferred to the 
nitrocellulose and blocked with 3 % BSA for 45 min at room temperature. After 1hr 
incubation with the anti-phospho-H3-Ser28 antibody (1:2000 dilution, Upstate) and 2 hr 
staining with the secondary anti-rabbit antibody (1:2000 dilution, Bio-Rad) at room 
temperature, the signals were detected by the chemiluminescence.  
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Table 2.1. List of the primers for cloning the histone phosphorylation reporters 
Primer name Primer sequence Restriction 
site 
included 
corresponding 
protein 
mutation site 
Application 
14-3-3τ.F 5´-ACCGCCGCCCGCATGCATATGGAGAA 
GACTGAGCTGATC 
SphI  Phosphorylation 
reporter 
14-3-3τ.R 5´-AGACTTGCGAGCTGTCTGCTTCGTCC 
GGGCGAGGCTGCCGCCGGTGCCGCCTGC
AGAGTCTGATGTCCAAAGTGT 
  Linker sequence 
underlined 
H3.RR 5’-CCATGAGCTCTGGAGCGCTTTTGCGC 
GCTGCCTTGGTGGCCAGCTGCTTCCGCG
GTGCCTTGCCGCCGGTAGACTTGCGAGC
TGTCTG 
SacI  Include the H3 
sequence of the 
phosphorylation 
reporter 
S10A.F 5’-CAGACAGCTCGCAAGGCCACCGGCG 
GCAAGGCACC 
 S10A S10A mutation 
of H3 
Reverse 
Complement 
5’-GGTGCCTTGCCGCCGGTGGCCTTGCG 
AGCTGTCTG 
 S10A S10A mutation 
of H3 
S28A-1.F 5’-GCCACCAAGGCAGCGCGCAAAGCCG 
CTCCAGAGC 
 S28A S28A mutation 
of H3 
Reverse 
Complement 
5’-GCTCTGGAGCGGCTTTGCGCGCTGCC 
TTGGTGGC 
 S28A S28A mutation 
of H3 
K49E.F 5’-CTCTCCGTGGCCTACGAAAACGTGGT 
CGGGGGCCG 
 K49E K49E mutation 
of 14-3-3τ 
Reverse 
Complement 
5’- CGGCCCCCGACCACGTTTTCGTAGGC 
CACGGAGAG 
 K49E K49E mutation 
of 14-3-3τ 
P30G.F 5’-GCGCGCAAAAGCGCTGGCGAGCTCA 
TGGTGAGCAAGG 
 P30G P30G mutation 
of H3 
Reverse 
Complement 
CCTTGCTCACCATGAGCTCGCCAGCGCT
TTTGCGCGC 
 P30G P30G mutation 
of H3 
G12P.F 5’-CAGCTCGCAAGTCTACCCCAGGCAA 
GGCACCGCGG 
 G12P G12P mutation 
of H3 
Reverse 
Complement 
5’-CCGCGGTGCCTTGCCTGGGGTAGACT 
TGCGAGCTG 
 G12P G12P mutation 
of H3 
H3-14.F 5’-CGGCAAGGCACCGCGGAAGCAGCTG 
GCCACCAAGGCAGCGCGCAAAAGCGCT
CCAGCAGGCGGCACCGGCGGCAGCCTC
ATGGAGAAGAC 
  Domain 
swapped 
phosphorylation 
reporter; Linker 
sequence 
underlined 
H3-14-
SacI.R 
5’-CATGAGCTCAGAGTCTGATGTCCAAA 
GTGTTAGG 
SacI  Domain 
swapped 
reporter 
 
 
H3-14.FF 5’-GTTCGTGACCGCCGCCCGCATGCATG SphI  Include the H3 
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CCCGGACGAAGCAGACAGCTCGCAAGT 
CTACCGGCGGCAAGGCACCG 
sequence of the 
domain 
swapped 
reporter 
H314_S28A.
F 
5’-CAAGGCAGCGCGCAAAGCCGCTCCA 
GCAGGCGG 
 S28A S28A mutation 
of H3 
Reverse 
Complement 
5’-CAAGGCAGCGCGCAAAGCCGCTCCA 
GCAGGCGG 
 S28A S28A mutation 
of H3 
YFP-Start.F 5’-GCGCTCCAGAGCTCATGGTGAGCAA 
GGG 
  Introduce the 
nuclear 
localization 
sequence (NLS) 
NLS reverse 
primer 
5’-CCGGAATTCTTAAGCGTCTTCCACCTT 
TCTCTTCTTTTTTGGCTTGTACAGCTCG 
  NLS underlined 
BOS-H3-N-
HPR.F 
5’-CCGGATCCCGCCACCATGGTGAGCAA 
GGGCGAG 
BamHI  Full-length H3 
fusion 
BOS-H3-N-
HPR.R 
5’-GGCTGCGGCCGCTTCAAGCTTCGAAT 
TC 
NotI  Full-length H3 
fusion 
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Chapter 3  
Histone methylation reporters 
 
A significant portion of the work described in this chapter has been published in:  
Lin, C.-W., Jao, C. Y., and Ting, A. Y. Genetically encoded fluorescent reporters of 
histone methylation in living Cells. J. Am. Chem. Soc., 126, 5982-5983 (2004) 
 
Introduction 
Histone methylation was first discovered more than 40 years ago111. Unlike 
phosphorylation and acetylation, which are reversible and dynamically regulated, until 
recently this modification has been considered stable and even permanent. Methylation 
takes place on lysines and arginines, and multiple modifications on the same residues are 
common. For instance, lysines can be mono-, di-, trimethylated. In addition to mono-
methylation, arginines can be symmetrically or asymmetrically dimethylated112,112,113 by 
different classes of methyltransferases (Fig. 3.1). Furthermore, because lysines are 
reaction centers for both methylation and acetylation, the presence of dual modifications 
at histone H3 K9 in vivo has also been reported114.  
Histone methylation at different lysine residues can mediate significant, and 
sometime opposing, responses. A large body of the literature has focused on histone H3 
K9 methylation since the discovery of the first underlying metyltransferase– Suv39h1115. 
Instead of being ubiquitously present, K9 methylation appears at particular regions where 
the associated genes are selectively repressed. Therefore, K9 methylation represents a 
marker of heterochromatin116 (or condensed chromatin) in which most gene activities are 
silent. This modification on histone is believed to create a binding site for the recruitment 
of the HP1 proteins17, a family of heterochromatic adaptor molecules, causing the 
changes of the supra-nucleosomal chromatin structure and gene expression. Enrichment 
of the methylated K9 was also observed in the inactivated female X-chromosome117 and 
at the silenced loci in cancer cells118-120. In addition, K27 methylation of histone H3 is 
also another transcriptionally repressive marker, and it is important for recruiting the 
Polycomb (Pc) group18. Pc proteins are responsible for maintaining the silent state of the 
HOX genes, which are essential for fly and vertebrate limb development. In mammals, Pc 
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proteins are also implicated in X chromosome inactivation, B-cell development, and cell 
proliferation121. Mutations of the Pc proteins are associated with cancers in immune 
system and prostate122. In contrast, methylation of K4 at histone H3 is a conserved signal 
for gene activation from Tetrahymena to yeast and human123-125. In fact, different 
numbers of methyl groups deposited on the lysine could correspond to different signals 
for gene regulation. Studies in Saccharomyces cerevisiae suggested that trimethylation of 
K4 potentiated activation of gene transcription in euchromatin, whereas K4 dimethylation 
occurred at both active and inactive genes15. Although less is known about arginine 
methylation compared to lysine methylation, growing evidence suggest that this 
modification also plays a role in gene regulation. One example can be found in histone 
H3 R17, whose methylation reflects on the activation of the receptor regulated 
promoter126. 
New evidence indicates that histone methylation is enzymatically reversible. 
Histone methyltransferases (HMT) catalyze methyl group transfer from S-adenosyl 
methionine (SAM) to lysine and arginine, and this can also be removed by histone 
demethylases. A series of histone lysine methyltransferases have been identified and with 
their specificities characterized. Most of these enzymes contain a catalytic SET (Su(var), 
Enhancer of Zeste, Trithorax) domain. The reaction specificity and numbers of methyl 
groups that can be added to single lysines are controlled by two factors: the nature of the 
enzyme and its association with additional cofactor proteins. For instance, HMTases 
G9a127 and Suv39h1115 can individually di- and trimethylate histone H3 at K9 without 
any auxiliary protein. On the other hand, Ezh2 requires association with two auxiliary 
proteins, Suz12 (suppressor of zeste-12) and Eed (embryonic ectoderm development), to 
perform the trimethylation of hitsone H3 at K27128. Interestingly, the ESET (ERG-
associated protein with SET domain) enzyme alone dimethylates K9, but it performs 
trimethylation upon association with mAM (mouse-activating transcription-factor-
associated modulator). Previously, methylated histones modified by metabolic 
incorporation of the radiolabeled methyl groups exhibited a half-life indistinguishable 
from the turnover of histones themselves5,129,130. This stability and the lack of enzymatic 
demethylation led to a model where the observed “demethylation” of chromatin was 
attributed to replacing the permanently methylated histone by unmodified histones130. 
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However, recent discoveries of demethylases have shown that enzymatic removal of the 
methylation marker is indeed possible. 
 
Figure 3.1. Histone methylation on lysine and arginine residues. The reactive lysines can be 
mono-, di-, and trimethylated by histone methyltransferases (HMTs). Arginines can be mono- and 
dimethylated.  The asymmetric and symmetric arginine demethylation is catalyzed by type I and 
type II arginine methyltransferases, respectively.  
 
Among the growing list of these enzymes (Fig. 3.2), lysine-specific demethylase 1 
(LSD1) can demethylate the mono- and dimethylated K4 of histone H3131. Demethylation 
occurs via a FAD-dependent oxidative reaction, generating formaldehyde and unmodified 
lysine. Because this reaction was postulated to proceed via two-electron oxidative 
chemistry requiring the free electron pair on the nitrogen, LSD-1 is unable to demethylate 
the trimethyllysine. Alternatively, JHDM1 (JmjC domain-containing histone demethylase 
1) can specifically demethylate mono- and dimethylated lysine 36 of histone H3 in the 
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presence of FeII and α-ketoglutarate132.  The most recently discovered JMJD2 was shown 
to reduce the trimethylated K36 and K9 to their dimethylated, but not mono- or 
unmethylated, counterparts133 in a similar FeII- and α-ketoglutarate-dependent manner. 
There is also an enzyme that can counteract arginine methylation. Two studies showed 
that PAD4 (peptidylarginine deiminase 4) performed deimination to generate citrulline 
from the methylated arginine134,135 previously modified by the CARM1 (coactivator-
associated arginine methyltransferase-1) methyltransferase. 
Figure 3.2. The proposed mechanisms of histone methyllysine demethylation and methylarginine 
demethylation. JHDM uses Fe2+ and α-ketoglutarate to demethylate mono- and dimethylated K36 
of histone H3132, and LSD-1 uses FAD to demethylate mono- and dimethylated K4131. PAD4  
deiminates the methylarginine and converts it to citrulline134. 
 
 Because of the versatility and dynamic nature of histone methylation, the ultimate 
goal in this field is to monitor such an event in real time alongside the underlying 
biological processes. One example is the inactivation of X-chromosome. To compensate 
the larger numbers (n ≥ 2) of the X-chromosomes present in female cells than in male 
cells (n = 1), all except one of the chromosomes will be entirely shut down during the 
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early stages of the mouse embryo development. Alongside the X-chromosome 
inactivation there are different time-course profiles of the concomitant histone H3 K27 
di/trimethylation and K9 dimethylation136. The embryo undergoes several rounds of 
cleavage, and it exponentially generates a cluster of cells encompassed by the same outer 
membrane with the total size equal to the original zygote (Fig. 3.3). These cells readily 
diversify themselves into two distinct populations with the outer pools becoming the 
trophectoderm (TE) and the inner pool becoming the inner cell mass (ICM). The K27 
methylation emerges at the 16-cell stage, whereas the K9 methylation appears at the later 
32-cell stage. Methylation of both residues transiently peaks at the TE stage, and the 
methylation is reversed later when the ICM is formed. It would be of great interest to 
continuously image the levels of K9 and K27 histone methylation during each step of the 
developmental process, with a finer temporal resolution. This is the long-term goal of the 
collaboration project with Professor Jeannie Lee’s group (Harvard medical school), and 
currently it is at the infancy stage. Another interesting biological system is the 
asymmetric cell division, a characteristic behavior by which the adult stem cells maintain 
their limited numbers in the body137. The parent cell unevenly divides into two daughter 
progenies with one of them that can undergo a subsequent division while the other one 
stops dividing further. One proposed mechanism of this behavior is that these two 
daughters unevenly inherit the genetic determinants from their parent137. Compared to X-
chromosome inactivation, little is known about this phenomenon. However, it is unlikely 
that the commitment of the daughter cells to divide or not after their birth is due to a 
series of random decisions. The origin and the execution of this division asymmetry are 
postulated to associate with epigenetic regulations such as histone methylation138. In 
collaboration with Professor James Sherley at M.I.T., a model cell line, which mimics the 
stem cells but is more amenable for maintenance and imaging, was used to address this 
hypothesis. 
 
 
 
 
 68
 
Figure 3.3. Histone methylation and X-chromosome inactivation in the mouse embryo during 
development. a) Schematic representation of the developmental stages of the mouse embryo. The 
zygote splits into two and four cells before the 8-cell stage (not shown) and becomes two distinct 
populations at the 16-cell stage. The inner cells form the ICM (inner cell mass) and the outer cells 
constitute the TE (trophectoderm) in the blastocyst. b) Immunofluorescence detection of the 
histone H3 K9 and K27 methylation, respectively, at different stages of the embryo development. 
Polll exclusion measures the global transcriptional activity and represents the extent of 
chromosome inactivation. The imprinted inactivation of the parental X chromosome (inherited 
from the father) begins by coating the chromosome with the RNA of the Xist gene at the 4-cell 
stage. Re-activation of the parental chromosome was accompanied by the loss of Xist RNA 
coating at the ICM stage. Histone H3 methylation at K9 and K27 parallels their inactivation trend 
but subtly differs in their temporal patterns between each other. K9 methylation transiently 
appears at the 32-cell stage, peaks at TE, and disappears at ICM. K27 appears earlier at the 16-
cell stage, peaks at TE, and returns to the residual but still detectable extent at ICM. The figures 
are modified from the source136.  
 
 In this chapter, I describe the development of FRET reporters for detecting histone 
methylation in living cells. As a proof of principles, the initial efforts focused on 
monitoring K9 and K27 methylation because of their established roles in gene silencing 
that is supported by a wealth of literature. The adaptor proteins such as HP1 and Pc 
described above that selectively recognize the methylated histone tails play important 
roles in inducing the downstream biological effects. These adaptor proteins contain the 
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conserved motifs, called chromodomains, for binding the methylated histone tails 
selectively. Therefore, the FRET reporters include the histone H3 peptide sequence as the 
surrogate substrate and the chromodomain as the sensing module for reporter 
methylation. The reporters were first tested in vitro to exhibit their FRET change in 
response to methylation mediated by histone methyltransferases. Subsequently, the 
reporter was used in two cell lines to reveal their difference in the basal levels of global 
K9 histone methylation. Preliminary data on characterization of the model cells line that 
can asymmetrically divide were also presented. They provide a platform for studying 
how histone methylation plays a role in regulating the particular behavior of cell division. 
The reporters also exhibited a promiscuous FRET change in the case where a long 
substrate sequence was included, due to the cross over binding of the chromodomain to 
more than one expected methylated residue. This binding promiscuity reflected the 
limitation of the uncontrollable specificity of the chosen binding domains for the reporter 
design, particularly when the binding domain and the modified substrate peptide were 
linked in the same reporter molecule.     
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Results 
 
General design of the histone methylation reporters 
The general reporter design is shown in Figure 3.4a. Similar to the design of the 
phosphorylation reporter described in Chapter 2, these indicators are also four-part 
chimeric proteins. A peptide substrate, whose sequence corresponds to the N-terminal 
tails of histone H3 and contains the methylation site of interest, is joined via a flexible 
linker to a methyllysine binding domain known as a chromodomain. Recently discovered, 
chromodomains are small (~55 amino acids), monomeric domains found in a variety of 
nuclear signaling proteins that bind with 1-200 µM Kd to lysine-methylated peptides, but 
not to their unmethylated counterparts139. Flanking this fusion construct is a pair of CFP 
and YFP fluorophores that can undergo FRET. Upon enzymatic methylation of the 
histone-derived peptide, the resultant methyllysine side chain recruits the nearby 
chromodomain to fold and form an intramolecular complex. This reaction-dependent 
conformational change of the reporter then alters the spatial separation between the 
flanking CFP and YFP, which is reflected by a change in the FRET level.  
 
Figure 3.4. a) Schematic representation of the histone methylation reporter. b) Domain constructs 
of two reporters. The K9 reporter (top) contains a substrate peptide, corresponding to amino acids 
1-13 of histone H3, with the fourth lysine (italicized) residue replaced by an alanine. The 
heterochromatin protein 1 (HP1) chromodomain is used for recognition of the methylated K9. 
The K27 reporter (bottom) uses the polycomb (Pc) chromodomain to bind the methylated K27 
from histone H3. 
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FRET reporters for sensing histone H3 K9 and K27methylation 
Histone H3 methylation on two lysines, K9 and K27, are known to play important 
roles in transcriptional repression,140 X-inactivation141, and cellular differentation142. 
Therefore, they are interesting targets for construction of histone methylation reporters. 
Two crystal structures in which the chromodomain binds to the methyllysine peptide of 
histone H3 are helpful in guiding the reporter design. The HP1 chromodomain recognizes 
the methylated lysine 9 (PDB code: 1KNA), and the Pc chromodomain binds he 
methylated lysine 27 (PDB code: 1PDQ) (Fig. 3.5). Detailed characterizations of binding 
affinities between the chromodomains and methyllysine peptides with different 
modification states are shown in Table 3.1143.  
 
Table 3.1. Affinities of the HP1 and Pc chromodomains binding to histone H3 
peptides143. 
Kd (µM) MeK9 Me2K9 Me3K9 MeK27 Me2K27 Me3K27 
Pc >1000 >1000 125 ± 28 20 ± 3 28 ± 4 5 ± 1 
HP1 46 ± 9 7 ± 2 4 ± 1 N/A N/A 64 ± 7 
 
Standard cloning methods were carried out for assembly of these two reporter 
genes, containing four-part chimeric constructs and a N-terminal (His)6 tag similar to 
those of the histone phosphorylation reporter. The corresponding domain constructs were 
shown in Figure 3.4b. The K9 reporter (GenBank accession no. AY422822) uses the 
HP1 chromodomain (contains 55 amino acids from residue no. 21 to 76) to recognize 
lysine 9 methylation in the context of residues 1-13 of histone H39,144, while the K27 
reporter (GenBank accession no. AY422823) uses the Pc chromodomain (residues 21-78) 
to recognize lysine 27 methylation in the context of residues 24-35 of histone H319,143. 
These choices of chromodomains covered all of the residues shown in the structures 
binding to the corresponding methyllysines. Compared to the H3 peptide covering 
residues 1-30 in the case of the histone phosphorylation reporter, only a single lysine that 
could be methylated was included in the peptide region of both reporters. The major 
purpose of using the shorter substrates was for the anticipated chromodomain binding to 
occur upon residue-specific methylation, giving rise to the reporter FRET change that 
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could be definitively interpreted.  Retrospectively, it was also to prevent the crossover 
binding in which the chromodomain recognized more than one methylated lysine when 
the H3 peptide of the reporters included residues 1-30 (described later in the session of 
the promiscuous reporter FRET). Crystallographic data9,143,144 and peptide modification 
experiments145 suggest that these shorter sequences are still specific substrates for histone 
methyltransferase enzymes and retain binding affinity for chromodomains. To design a 
linker for the histone methylation reporter, a reasonable estimation of the linker length is 
to measure the distance between the last residue of the chromodomain and the first 
residue of the histone H3 peptide shown in the structure. Therefore, linkers with a 15- 
and 21-residue length for the K9 and K27 reporters, respectively, were chosen based on 
their corresponding chromodomain binding structures (Fig. 3.5a)143,144. They should be 
sufficiently long and suffice binding between the joined chromodomains and 
methyllysine peptides.   
 
FRET responses of the histone methylation reporters upon methylation in vitro 
Both reporter proteins were expressed in E. coli., followed by nickel affinity 
chromatography purification and SDS-PAGE analysis to check the protein quality. 
Reporters exhibit dual emission peaks at 476 nm (CFP emission) and 527 nm (YFP 
emission) when excited at 433 nm (CFP excitation), indicating the protein integrity and 
the presence of FRET (Fig. 3.6b). To further test the reporter function in response to 
enzymatic methylation, proteins were incubated with the methyl donor, SAM, and a 
histone methyltransferase. Initial attempts using Suv39h1115,  Suv39h2115, and Dim-5146 
that were known to methylate K9 did not succeed, and neither reporter showed a 
substantial FRET change when incubated with these enzymes. Most likely the failure was 
because of the unoptimized preparation of these GST (glutathione-S-transferase)- tagged 
enzymes that were expressed in E. coli. and purified using the glutathione column. The 
protein yield was generally low, as seen in the SDS-PAGE (Fig. 3.7), and the enzyme 
activity was not further measured. Future efforts will be required to overcome the issue of 
enzyme preparation by optimizing the protein expression conditions as well as using 
other purification system such as the (His)6 epitope. Fortunately, both reporters respond 
to methylation by vSET, a (His)6-tagged histone H3 methyltransferase from Paramecium 
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bursaria chlorella virus145 and prepared by following similar protocol for obtaining the 
FRET reporters. Thus, only vSET was used to carry out the methylation of both K9 and 
K27 reporters in the following experiments. 
 
 
 
Figure 3.5. a) Two crystal structures showing chromodomains binding to the methyllysines of 
the histone H3 peptide. The HP1 chromodomain recognizes methylated K9 (PDB code: 
1KNA)144, and the Pc chromodomain recognizes methylated K27 (PDB code: 1PDQ)143. b) Three 
aromatic residues in the binding pockets of HP1 and Pc chromodomains form superimposable 
cages around the trimethylated K9 and trimethylated K27, respectively. c) Superposition of the 
HP1 and Pc chromodomains binding to trimethylated K9 and trimethylated K27, respectively. 
These two proteins share a 54 % homology in their peptide sequences.  
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Figure 3.6. a) The FRET change of both reporters in response to vSET methylation. The K9 
reporter displayed a ~60 % increase of the YFP/CFP emission ratio, while the K27 reporter 
showed an elevated (~30 %) emission ratio change. Negative controls leaving out either vSET or 
SAM suppressed the reporter responses. b) Emission spectra of the K9 and K27 reporters at the 
onset (t = 0 hr) and the end (t = 10 hr) of the methylation reaction. Excitation: 433 nm. 
 
 
Over the course of methylation, both K9 and K27 reporters exhibited an increase 
in the YFP/CFP emission ratio (I527 nm/I476 nm) with magnitudes 60 % (K9) and 28 % 
(K27), respectively. The anti-correlation of emission changes, in which the increased 
YFP intensity was accompanied by a reduction of the CFP emission over time, is the 
hallmark of the reporter FRET signal. This FRET change is reaction-dependent, requiring 
the presence of both enzyme and SAM. Negative controls, omitting either vSET or SAM, 
abolished the reaction and, therefore, the FRET change of these reporters (Fig. 3.6a). In 
order to further understand how the reactive lysines were modified during methylation, 
which reflects methyltransferase specificity, reporters at the end of the methylation 
reaction were analyzed by mass spectrometry. Samples incubated under different reaction 
conditions for 10 hr were digested toward completion with the endopeptidase Glu-C, and 
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the resultant fragments were subjected to MALDI-TOF analysis (Fig. 3.8). Results 
showed that the K9 reporter from the +vSET/+SAM reaction produced only the 
trimethylated K9 peptide, with no mono- or dimethylation detected. As a control, the 
sample leaving out SAM generated only the unmodified peptide counterpart. On the other 
hand, the K27 reporter from the +vSET/+SAM reaction produced fragments containing 
both di- and trimethylated lysines, while the negative control omitting SAM generated a 
fragment corresponding to the unmodified peptide. It is consistent with the known 
chromodomain binding specificity, where HP1 chromodomain recognizes methylated K9 
and Pc chromodomain recognizes methylated K27, giving rise to the reporter FRET 
increase during methylation.  
 
Figure 3.7. SDS-PAGE analysis of the purified histone methyltransferases. a) The GST-tagged 
histone methyltransferase plasmids (Dim5, Suv39h1 and Suv39h2) were expressed in E. coli. 
(BL21(DE3)), followed by purification using the glutathione column. Fractions from the flow-
through, washing, and elution were collected and analyzed on the SDS-PAGE (bacteria culture 
size = 0.4 L; after cell lysis, 10 µL out of 3 mL of the supernatant in each sample was loaded onto 
the gel). Note that the enzymes present in the elution fractions were nearly invisible. b) The 
concentrated Suv39h1 was analyzed by SDS-PAGE again (loading: 5 µg protein mixture). 
Compared to the large amount of unidentified impurities (below 37 kD), only a marginal yield of 
the full-length Suv39h1 was obtained (calculated M.W. 61.5 kD, indicated by the asterisk).  
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Figure 3.8. MALDI-TOF analysis of the methylation states of the K9 and K27 reporters. After 
vSET-mediated methylation, both reporters were treated with endopeptidase Glu-C. Samples of 
digested fragments were mixed with alpha-cyano-4-hydroxycinnamic acid as the matrix and    
subjected to MALDI-TOF analysis (positive mode). The identified peptide fragments, 
GSARTAAARK(Me)2,3SAPATGGVE, indicated that the K27 was both di- and trimethylated 
(calculated m/z : 1757.93 (unmodified), 1785.95 (dimethylated), and 1799.97 (trimethylated)), 
whereas the peptide GSARTAQTARK(Me)3STGGE contained the trimethylated K9 (calculated 
m/z : 1577.80 (unmodified), 1619.85 (trimethylated)). 
 
Site-directed mutagenesis studies of the K9 and K27methylation reporters in vitro 
Site-directed mutagenesis was performed to examine the mechanism of the K9 
and K27 reporter FRET responses (Fig. 3.9a). Compared to the original K9 reporter, 
mutation of lysine 9 to a methylation-incompetent leucine (K9L) abolished the FRET 
response to vSET methylation. Immunoblot In the case of the K27 reporter, a similar 
substitution of the K27 with leucine (K27L) also eliminated the reporter FRET signal. 
Additional negative controls are from reporter mutants whose chromodomains are 
incapable of binding to methyllysines. Since both HP1 and Pc chromodomains contain 
three aromatic residues caging their cognate methyllysines, one of the triad in each 
reporter was also modified to eliminate affinity for the methylated lysine peptide 
(W45A144 for the K9 reporter, and Y26K143 for the K27 reporter). Both chromodomain 
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mutants become insensitive to the methylation-driven emission ratio change, consistent 
with the expected mechanism whereby the increase in reporter FRET stems from the 
formation of the intramolecular complex by folding the chromodomain to the methylated 
lysine residue.   
 
Figure 3.9. YFP/CFP emission ratio changes of the mutants and reporters. The original K9 and 
K27 reporters displays a ~60 % and ~30 % increase of the emission ratio, respectively, in 
response to vSET methylation. Mutants replacing the methylation sites, K9 and K27, with 
leucines abolished the FRET increase. Alteration of the conversed aromatic residues W45 and 
Y26, respectively, in the chromodomain binding pocket also suppressed the reporter FRET 
response.  
 
Testing the reversibility of the K9 reporter FRET response 
In light of the reversible FRET response of the histone phosphorylation reporter, 
testing whether the methylation reporter also exhibits a reversible FRET change is of a 
great interest. David Allis has proposed a “binary switch” mechanism in which the 
coexistence of two different modification markers, phosphorylation and methylation, at 
two adjacent residues can synergistically affect the binding to their corresponding 
effector proteins147. For example, phosphorylation of histone H3 at S10 prevents 
chromodomain binding to the neighboring methylated K9 in vitro. At the time when 
construction of the K9 reporter was in progress with no demethylase available, this 
experimental finding suggested an indirect way to test for the reversibility of the reporter 
FRET.  
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Therefore, the following experiments were set up to address whether the 
phosphorylation of Ser10 of the K9 reporter could disrupt the interaction between the 
HP1 chromodomain and the neighboring methylated K9 residue. The K9 reporter was 
first methylated by vSET until it exhibited the maximal FRET change. Subsequently, the 
histone kinase Msk-1 and ATP were added to this mixture to phosphorylate the reporter. 
Set the FRET level after vSET methylation as the reference point, the pre-methylated K9 
reporter displayed a ~10 % decrease of YFP/CFP emission upon the subsequent Msk-1 
phosphorylation (Fig. 3.10a). Immunoblot analysis further confirmed the occurrence of 
both K9 methylation and S10 phosphorylation of the reporter. With the unmeasured 
extents of both reporter methylation and phosphorylation, one possibility was that these 
two different reactions individually took place on the distinct subsets of the reporters 
without producing molecules that were doubly modified. In this case, the observed 
YFP/CFP emission ratio change was contributed from the phosphorylation-only fraction 
of the reporters. To exclude this possibility, an additional control was performed and 
demonstrated that Msk-1 phosphorylation of the unmodified K9 methylation reporter did 
not give rise to the observed decrease of reporter FRET. Results showed that the 
unmodified K9 reporter displayed only a small (~5 %) decrease in the emission ratio 
change upon phosphorylation, compared to the 10 % change of the premethylated 
reporter (Fig. 3.10b). This finding suggested that the overall FRET decrease in 
phosphorylation of the pre-methylated reporter should be a combination of two 
consequences: S10 phosphorylation-mediated reporter FRET change and the interrupted 
interaction between HP1 chromodomain and the methylated K9.  The latter implication 
indicated that the reporter FRET response should be reversible. However, testing the 
methylated reporter with demethylases will be required to provide a more direct evidence 
for the reversibility of the reporter FRET. 
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Figure 3.10. The YFP/CFP emission ratio change of the K9 reporter in response to Msk-1 
phosphorylation. a) The K9 reporter was first methylated by vSET until reaching the state with a 
largest FRET increase, followed by Msk-1 phosphorylation. Immunoblot analysis was performed 
on each sample using antibodies specific for the methylated K9 and phosphorylated S10 of 
histone H3. b)  The K9 reporter was directly phosphorylated by Msk-1 without pre-methylation. 
    
Histone methylation reporters containing a longer H3 peptide exhibit promiscuous FRET 
On the histone H3 tail, the existence of multiple lysines each subjected to 
different extents of methylation can create a diverse combination of modification 
patterns. For instance, residues K4, K9, and K27 are known to be methylated by their 
corresponding methyltransferases. Each position can be unmodified, or modified by 
adding one, two, or three methyl groups, giving rise to theoretically 64 different 
modification states. Existing residue-selective chromodomains binding to particular 
methyllysines have been characterized in a simple context. Conclusions were usually 
drawn from experiments in vitro using an isolated peptide with only one modified lysine 
present143,144. Established relationships, such as where the HP1 chromodomain interacts 
with the methylated K9 and the Pc chromodomain recognizes the methylated K27, are 
examples. However, whether the presence of additional methylation markers alters 
chromodomain binding specificity remains unanswered.  
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In the reporter context, the presence of multiple lysines poses an additional 
complication due to the intramolecular nature, which connects the chromodomain to the 
histone peptide together in one molecule. This covalent linkage could enable 
chromodomain binding to non-cognate methyllysines, because elevated effective 
concentrations can overcome the weak binding affinity between the two.  
Initial designs of the histone methylation reporters utilized a longer substrate 
peptide, corresponding to the residues 1-30 of the N-terminal histone H3 (domain 
constructs shown in Figure 3.11a). Sandwiched by a CFP and a YFP at two flanking 
ends, this peptide was linked to the HP1 chromodomain for construction of the HP1 
reporter. The Pc chromodomain was similarly used to construct the Pc reporter (Cindy Y. 
Jao and Alice Y. Ting, unpublished data). These indicators were designed to sense their 
corresponding methyllysines, K9 and K27, respectively, as where the previously 
mentioned K9 and K27 reporters. Both HP1 and Pc reporters were expressed in E. coli., 
followed by purification using nickel affinity chromatography. The FRET responses of 
these purified reporters were then examined in vitro (Fig. 3.11b). To initiate the reaction, 
vSET was used to methylate the K27 residue of the Pc reporter. Alternatively, the HP1 
reporter was incubated with G9a, a K9 methyltransferase. As expected, the HP1 reporter 
displayed a ~20 % YFP/CFP emission ratio change upon G9a methylation, while the Pc 
reporter exhibited a ~40 % emission ratio increase over the course of vSET methylation. 
Negative controls leaving out either the enzyme or SAM abolished the FRET changes of 
both reporters, suggesting that the reporter responses were reaction-dependent. After 
methylation, both indicators were characterized by immunoblot analysis using antibodies 
that can recognize particular methylated lysines. Results confirmed that methylation of 
K9 and K27, respectively, occurred on the HP1 and Pc reporters (Fig. 3.11c).  
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Figure 3.11. a) Domain constructs and the emission ratio changes of the HP1 and Pc 
reporters. b) The HP1 reporter exhibited an increase of FRET (YFP emission / CFP 
emission) in response to the G9a-catalyzed methylation. The Pc reporter also displayed a 
FRET increase upon vSET methylation. c) After 10h of methylation, the HP1 reporter 
samples incubated with different reaction conditions were analyzed by immunoblot using 
antibody specific to dimethylated K9. Samples from the Pc reporter were analogously 
analyzed using anti-dimethyl K27 antibody.  
 
Interestingly, the Pc reporter also exhibited increased FRET upon G9a 
methylation (Fig. 3.12a). This result indicated the promiscuity of either the Pc 
chromodomain binding or the G9a specificity. One possibility is that G9a, known as a K9 
methyltransferase, modified the K9 of the Pc reporter and in turn caused the Pc 
chromodomain binding, giving rise to the reporter FRET signal. Alternatively, G9a may 
have modified the K27, in addition to the K9 residue, and then recruited the Pc 
chromodomain to fold. To differentiate between these two models, site-directed 
mutagenesis studies were performed on the HP1 and Pc reporters. No YFP/CFP emission 
ratio change was observed from reporter mutants whose critical residues for the 
chromodomain binding were changed (W45A and Y26K), consistent with the designed 
reporter FRET mechanism. Replacing the K9 with a leucine of the HP1 reporter also 
suppressed the chromodomain binding as expected. While the K9L mutant of the Pc 
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reporter did not exhibit a FRET change (because of no methylation occurred on the K27 
for triggering the Pc chromodomain binding), a K27L mutant showed a FRET response 
similar to the original Pc reporter. Immunoblot analysis further confirmed that K9 
residues in both reporters were indeed methylated by G9a. Therefore, the Pc 
chromodomain was indicated to promiscuously bind the methylated K9 in the reporter 
context.  
 
Figure 3.12. a) YFP/CFP emission ratio changes of the HP1 and Pc reporters in response to G9a 
methylation. Mutants with their methylatable lysines (K9, K27, or both) or the critical residue for 
chromodomain binding (W45 and Y26, see Figure 3.4b) replaced were also compared. b) Both 
reporters and their mutants were tested in response to vSET methylation. Additional mutations on 
K4 of the HP1 reporter were also included in the panel.  
 
More striking data were from characterizations of the promiscuous reporter FRET 
in response to vSET methylation (Fig. 3.12b). A systematic approach was taken to 
mutate the lysine residues of methylation step-by-step and examine the resultant effect in 
the reporter FRET change. This process was repeated with an increased number of the 
mutated lysines in the next iteration. Therefore, K9, K27, or both residues of the histone 
H3 peptide of these two reporters was replaced with leucine(s). Compared to the W45A 
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mutant that had no FRET response and served as the negative control due to the impaired 
chromodomain binding, these HP1 reporter mutants displayed a “residual” FRET 
response upon vSET methylation. Additional mutation on K4, a methylation site that can 
be modified in endogenous histone H3, also did not completely abolish the FRET change 
of the K4,9,27L reporter variant. Collectively, results from these unexpected residual 
FRET responses of the reporter mutants implied that: 1) vSET modified residues other 
than the K9 and K27 of the histone H3 peptide (based on the MALDI-TOF 
characterization of the K9 and K27 reporters), and 2) the HP1 chromodomain recognized 
not only the methylated K9 but also the modified K27 and other unidentified lysine 
residues. Since there was no further mass spectrometry providing the molecular details of 
how the HP1 reporters were methylated by vSET, it was unclear about the location of the 
putative methylation site in addition to K9 and K27.  
Compare to the original Pc reporter, the lysine mutants exhibited a largely 
reduced FRET response upon vSET methylation (the right panel, Fig. 3.12b). Although 
the magnitude of the FRET change was small, the methylation-dependent FRET 
responses of the K9L and K27L mutants were still differentiable from the background of 
the Y26K mutant. This result indicated that the Pc reporter also exhibited promiscuous 
chromodomain binding to non-cognate methyllysines. The promiscuous binding affinity 
of the Pc reporter was lower compared to the HP1 reporter, giving rise to a smaller 
emission ratio change in the leucine mutants. Schematic representations summarizing the 
cross over binding in both reporters are shown in Figure 3.13. Efforts to identify other 
residues that are also modified by vSET in addition to the K4, K9, and K27, remain to be 
further explored. Apparently, including the longer histone H3 peptide spanning multiple 
lysines in the reporters gave rise to the complicated cross over chromodomain binding. 
To prevent the complication and ambiguity of interpreting the FRET experiment in this 
case, only reporters contained single definitive lysine in their substrate peptide region 
were used thereafter.   
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Figure 3.13.  HP1 and Pc reporters containing multiple lysines in their H3 peptide exhibit 
promiscuous FRET response upon enzymatic methylation. Two possible factors, the altered 
enzyme specificity and the chromodomain binding, contribute to the promiscuity. While G9a 
modifies K9, vSET methylates K9, K27, and unidentified lysine(s).  In addition to the known 
relationships where the HP1 chromodomain binds the methylated K9 and the Pc chromodomain 
binds the methylated K27 (labeled in red), crossover binding between these chromodomains and 
two methyllysines was also observed (pink rectangles). Because the K4, 9, 27 triple mutant of the 
HP1 reporter still exhibited an increase of FRET upon vSET methylation, unidentified 
interaction(s) between the HP1 chromodomain and the unknown methyllysines should also exist 
(labeled with a question mark). The dashed arrow between the Pc chromodomain and the 
methylated K9 in the Pc reporter indicated a weak promiscuous interaction, which gave rise to a 
smaller emission ratio change upon vSET methylation.   
 
 
Application of the K9 histone methylation reporter in living cells 
To test the K9 reporter in living cells, the reporter gene was cloned into a 
pcDNA3 vector for protein expression in mammalian cells. A nuclear localization 
sequence (PKKKRK) was added to the C-terminus of the reporter gene for directing the 
cellular distribution of the reporters. The plasmid containing the reporter gene was then 
delivered to two types of cells via lipofection: wild-type mouse embryonic fibroblasts 
(MEFs) and the sister cells lacking two major K9-H3-specific methyltransferases, 
Suv39h1115 and Suv39h2148 (Suv39h -/-). Based on previous immunoblot 
characterizations, these mutant cells exhibit reduced levels of K9-H3 methylation in 
comparison to the wild-type MEFs115.  
The K9 reporter was efficiently expressed in both cell lines and localized in their 
nuclei after 12 hr. In each transfected cell, a region of interest in the nucleus was selected 
to measure the reporter YFP/CFP emission ratios. Individual basal values of the reporter 
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emission ratios from two different populations of cells were collected, followed by a 
statistical analysis using the Student’s t test. Results showed that the FRET levels of the 
K9 reporters were, on average, lower (σpooled = 0.163, p <0.001) in Suv39h -/- cells (n = 
150 cells, µ = 1.773) than in wild-type MEFs (n = 278 cells, µ = 1.867; Figure 3.12), 
suggesting that the K9 construct was capable of reflecting the global difference in basal 
histone methylation levels across different cell lines. 
Figure 3.14.  Basal YFP/CFP emission ratios of the K9 histone methylation reporter expressed in 
wild-type mouse embryonic fibroblasts (MEFs) and in the sister cells lacking the histone H3 K9 
methyltransferases Suv39h1 and Suv39h2. These ratios were pseudo-colored according to the 
scale bar one the right and superimposed with the DIC image.  
 
Toward understanding the association between adult stem cell asymmetric division and 
histone methylation 
 Reporters were further used to search for a potential association between histone 
modifications and the epigenetically regulated stem cell growth kinetics. Stem cells have 
the capability to differentiate and undergo self-renewal for multiple lineages. Their 
decision to either reproduce stem cell progenies or to commit irreversible differentiation 
into specific cell types require sophisticated controls by the long-lasting cellular memory 
in gene expression149. The patterns of histone methylation, which usually represents a 
stable heterochromatin marker linked to gene silencing, are implicated to play an 
important role in these epigenetically regulated processes136,150,151. Therefore, application 
of the histone methylation reporters in these systems will be of a great interest.  
 My experiments use a model cell line derived from the engineered MEFs, which 
mimic somatic stem cells that can undergo asymmetric cell division. Triggered by 
addition of Zn2+, which binds to the ion-sensitive promoter to initiate the transcription 
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and the transcription machinery, each of these MEFs stably transfected with the inducible 
p53 gene will exhibit an increased level of p53 expression. As a result, it downregulates 
the activity of IMPD (inosine-5-monophosphate dehydrogenase), the rate-limiting 
enzyme of guanine nucleotide biosynthesis152. Consequently, the altered purine 
ribonucleotide metabolism reflects on the suppression of cell growth and changes the 
behavior of cell proliferation from the exponential to linear expansion manner153. The 
switched kinetics of the population growth is due to the induced asymmetric division of 
individual cells. One parent cell unequally divides into two disparate daughters: transit 
and terminal cells. While the transit daughter can continuously divide, the other terminal 
cell no longer has the ability to propagate152. One mechanism suggests that these two 
progenies exhibiting an asymmetric division in response to environmental cues is due to 
their uneven inheritance of determinants from their parent cell137. Although the detailed 
explanations remain largely unknown, the epigenetic regulation by histone modifications 
has been suggested to account for the division asymmetry138.  
 To monitor possible differences in histone modifications on two chromosomes 
during asymmetric cell division, reporters were targeted to chromatin to enhance the 
spatial resolution. Analogous to the H3-HPR construct, which appended the full-length 
histone H3 to the N-terminus of the histone phosphorylation reporter (described in 
Chapter 2), both K9 and K27 reporter were also fused to the H3 protein to afford the H3-
K9 and H3-K27 reporters, respectively. Experiments were subsequently conducted to 
address the compatibility of these reporter variants with the MEF cells. These H3-fusion 
reporter genes, including H3-HPR, H3-K9, H3-K27, and the control plasmid H3-GFP 
(domain constructs shown in Figure 3.15) were introduced into two cell lines: Ind-8, 
which could undergo the Zn2+-mediated asymmetric cell division, and Con-3, which was 
insensitive to Zn2+ and served as a negative control. Although transient transfection of all 
four constructs to cells enabled the good reporter expression momentarily, a severe loss 
of fluorescent cell populations was observed after 3-5 days presumably due to 
cytotocixity.  
 Borrowed from the experience of creating a stable cell line expressing the histone 
phosphorylation reporter (described in Chapter 2), a similar solution can be applied here 
to overcome the problem associated with transient transfection. The stable cell line 
 87
should have preferentially enriched the pool of transfected cells, and expression of the 
reporter protein in which should be at a steady level and does not deteriorate from one 
generation to another when cells divide. As such, an imaging experiment that monitors 
the reporters during an entire cell cycle will be more feasible using these stable cells than 
the transiently transfected ones. Two steps were required to establish the stable cell line: 
cells were transiently transfected with the reporter genes, followed by the enrichment of 
the transfected population using blasticidin. This inhibitor to ribosomal peptide synthesis 
was used to select the transfected cells, which could produce the deaminase154 for their 
survival bycounteracting blasticidin. To determine the dose for application, untransfected 
cells were titrated with various concentrations of blasticidin. An optimal concentration, 
~5 mg/ml, was determined, in which less than 5 % of untransfected Con-3 cells could 
still residually survive after 5 days of incubation (Fig. 3.16). 
 
Figure 3.15. Domain constructs of the proteins fused to the full-length histone H3. The scale of 
each module in the recombinant proteins is proportional to the underlying number of amino acids. 
GFP, K9 reporter, and the K27 reporter are fused to the C-terminus of the full-length histone H3 
(amino acids 1-135) via a 23-amino-acid linker to afford the construct H3-GFP103, H3-K9, and 
H3-K27, respectively.    
 
   
 
Linker: LELKLRILQSTAPRARDPPVATM
GFPH3 (1-135)
Linker 2: GSTSGSGKPGSGEGS
9
H3: ARTAQTARKSTGG
CFP YFPHP1H3 (1-135)
Linker 2: KSGSTSGSGKPGSGEGSARTA
27
H3: AARKSAPATGGV
CFP YFPPcH3 (1-135)
Linker 1: LELKLRILQSTAPRARDPPVATM
Linker 1: LELKLRILQSTAPRARDPPVATM
H3-GFP:
H3-K9:
H3-K27:
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Figure 3.16. a) Test of cell survival rate under incubation with various concentrations of 
blasticidin. Cells were stained with crystal violet, and the population density was determined by 
counting the total number of colonies formed in the upper right quadrant in each plate. 
Experiments were performed in triplicate. b) Comparison of cell density in samples treated with 
different concentrations of blasticidin and incubated for different lengths of time.  
 
 
 One potential concern is that whether the stable transfection has altered the cell 
growth kinetics. To confirm that the transfected cells could still undergo asymmetric cell 
division, stable cell lines expressing H3-GFP and H3-HPR were first tested in response to 
Zn2+ addition. Only the Ind-8 cells expressing either construct exhibited an evident 
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reduction of cell population when incubated with 65 µM Zn2+, whereas the Con-3 cells 
expressing either construct did not show any altered growth kinetics regardless of the 
presence or absence of Zn2+ (Fig. 3.17). This result was consistent with previous 
observations in untransfected Ind-8 and Con-3 cells152, suggesting that expression of the 
reporters did not alter the intrinsic cell growth kinetics.   
Figure 3.17. Examination of cell growth kinetics of two cell lines in response to Zn2+ addition. 
Ind-8 and Con-3 cells, expressing either the H3-GFP or H3-HPR construct, were incubated with 
or without 65 µM Zn2+ for 21 hr, followed by a staining with crystal violet. Cell population 
density from each stained sample was recorded for comparison.    
 
 
Stable cell lines expressing H3-GFP were then imaged throughout a cell cycle 
with the constant supply of 5 % CO2 at 37 °C. Unlike the previous NLS-tagged histone 
phosphorylation reporter, which diffused over an entire cell due to the nuclear membrane 
breakdown, H3-GFP proteins were constantly localized in the nucleus even during 
mitosis (Fig. 3.18). This result indicated that the H3-fused proteins were incorporated 
into chromosomes without interfering with the normal cell division. In addition, the H3-
GFP transfected Con-3 cell underwent a typical symmetric division. The parent cell 
became rounded (18 hr 2 min) in mitosis and divided into two daughters with equal sizes 
(18 hr 47 min). Alternatively, the H3-GFP transfected Ind-8 cell (the upper one in Fig. 
3.18) showed a different cell division pattern, as seen in the GFP fluorescence that was 
unevenly distributed in daughter cells (2 hr 41 min). This result was likely due the 
consequence of the Zn2+-mediated asymmetric cell division, although the blebbing cell 
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morphology (2 hr 8 min) could also indicate another possibility that this particular cell 
was in the process of nuclear fragmentation toward apoptosis. Nonetheless, attempts to 
image both Ind-8 and Con-3 cells expressing H3-HPR has not yet been successful. 
Imaging experiments were not able to monitor the emission ratio change of the reporter 
over the entire cell cycle, since all of the observed cells underwent apoptosis before 
entering mitosis phase with an unclear reason. Future efforts will be required to overcome 
this obstacle and to permit successful imaging. Nonetheless, this is a good starting point 
for further tests of the H3-K9 and K3-K27 reporters.         
Figure 3.18. The stable a) Con-3 and b) Ind-8 cell lines expressing H3-GFP underwent cell 
mitosis in the presence of Zn2+. GFP fluorescence was colored in green and superimposed with 
the DIC image.  
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Discussion 
FRET-based histone methylation reporters have been constructed and tested both 
in vitro and in living cells. These reporters take advantage of the known binding 
partnerships between a chromodomain and its cognate methyllysine. The K9 reporter 
uses HP1 chromodomain to sense the histone H3 K9 methylation, while the K27 reporter 
contains the Pc chromodomain for binding to the methylated K27 of histone H3. Both 
reporters exhibited increased FRET in response to vSET methylation. MALDI-TOF 
analysis on the digested reporter samples after methylation showed that the K9 reporter 
was trimethylated and the K27 was both di- and trimethylated, consistent with the 
characterized chromodomain-methyllysine binding interactions and the consequent 
reporter FRET change.  
From a rational design viewpoint, one big advantage to construct the methylation 
reporter is the presence of structural information demonstrating how the chromodomains 
bind thsimilarity in protein sequence, and they both possess three aromatic residues (Fig. 
3.5b) to bind their corresponding methyllysines via the π-cation interaction. As shown in 
both structures, the peptide containing the methyllysine is in an extended conformation 
with the extensive interaction between the peptide backbone and the chromodomain 
residues. The subtle difference in the n-1 ~ n-3 region of the H3 peptide (n refers to the 
methylated lysine) is the determinant for the selective HP1 chromodomain binding. 
Alternatively, the difference in the n-4 ~ n-7 residues fitting into the extended groove of 
the Pc chromodomain is more critical for its selectivity binding143.  Conceivably, finding 
other natural binding scaffolds that can recognize other methylated lysines of the histone 
tails will be the key to build other residue-specific methylation FRET reporters. 
Candidates of these binding motifs can be other chromodomains or structurally similar 
equivalents. One supporting finding was the recent discovery in which one of the two 
chromodomains in the Chd1 protein recognized the methylated K4155, providing the 
rational basis for designing the K4 methylation reporter. Sensors for arginine methylation 
can be rationally constructed once the methylarginine binding domain is identified. 
However, only a handful numbers of the natural binding motifs currently exist for 
recognizing the methylated histone peptides. This represents the limit for designing the 
histone methylation reporters on a rational basis. In general, the major challenge to 
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construct a reporter whose FRET response is specific to the modification of a given 
residue is, again, the choice of the binding domain (described in Chapter 2). An empirical 
approach will be required in this case to generate such a binding module. For instance, a 
library of chromodomain mutants can be cloned into reporters with the identical substrate 
sequence, followed by screening the FRET change of these resultant reporters each with 
one different chromodomain in response to enzymatic methylation. As such, a reporter 
with the desired performance can be more likely produced than using the rational design 
approach. 
Although no detailed characterization of vSET has been reported, studies of other 
histone methyltransferases that also contain the catalytic SET domain, such as Suv39h1 
and G9a, can provide reasonably estimation in the methylation kinetics. These enzymes 
are generally slow with a kcat in the order of hr-1, when the histone H3 peptide (amino 
acids 1-18) or the recombinant full-length histone H3 was used as the substrate156. In 
Figure 3.6, the reactions underlying reporter methylation approximated the single-
turnover conditions with 2.5 ~ 5-fold of the reporter molecules to vSET. The time-course 
emission ratio change of the reporters exhibited a t1/2 (the reaction time required to reach 
half of the full methylation) about 1~3 hr, similar to the order of magnitude of the kcat 
values obtained from other methyltransferases. 
One intriguing yet unexplored property of these reporters is the potential 
reversibility of the FRET response. In light of recent success in identifying several 
histone demethylases, testing the enzymatic reversal of the reporter FRET is now 
possible. Good candidates that can retrieve the methyl group from specific methylated 
lysines are: 1) LSD-1, which demethylates the mono- and dimethylated K9 when 
associated with androgen receptor157, and 2) JMJD2, which demethylates the 
trimethylated K9 and K36 to their dimethylated counterparts133. Instead of removing the 
methyl groups, another mechanism that can reverse the reporter FRET is to interrupt the 
chromodomain-methyllysine interaction by phosphorylation of the serine residue adjacent 
to the methyllysine. In fact, phosphorylation at Ser10 of the K9-premethylated histone 
methylation reporter indeed decreased the YFP/CFP emission ratio (Fig. 3.10), indicating 
that the FRET change of the K9 reporter was reversible. 
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Another useful parameter for predicting the FRET reversibility of the “GFP-
sandwich” reporter is the binding affinity of the recognition domain for the modified 
substrate protein or peptide (also described in Chapter 2). One example of a FRET 
reporter using the FHA2 domain, which weakly binds to its phosphorylated ligand (Kd 
~10 µM)40, enabled the detection of the rapid oscillating PKC kinase activity due to the 
higher binding reversibility. In contrast, a similar reporter based on 14-3-3 (Kd ~56 nM 
when binding to its optimal peptide substrate94) showed a less reversible FRET response 
once the reporter had been phosphorylated. Based on the in vitro characterizations, HP1 
and Pc chromodomains bind the methylated K9 and K27, respectively, with ~ µM 
affinities. This binding strength, similar to that of the FHA2-phosphopeptide interaction, 
should permit the FRET indicators to reflect the not-yet-shown demethylase activity on 
the reporter. 
Promiscuous FRET responses emerged when a longer H3 peptide containing 
multiple lysines was used in the reporter design. Both the HP1 and Pc reporters displayed 
the unexpected FRET responses upon G9a and vSET methylation. Two possible factors 
contributed to the FRET signal promiscuity: the altered enzyme specificity and 
promiscuous chromodomain recognition, particularly in the reporter context. From the 
site-directed mutagenesis studies, the K4,9,27L triple mutant of the HP1 reporter with the 
known methylation sites deleted still displayed a surprisingly significant increase of the 
YFP/CFP emission ratio upon vSET methylation. This result suggested that vSET 
modified not only K9 and K27, two reaction centers identified in the previous 
experiments using the K9 and K27 reporters, but also other lysine residue(s) in addition 
to K4. In addition, the promiscuity of the HP1 chromodomain, which binds the 
unidentified methyllysine, gave rise to the reporter FRET change.  On the other hand, the 
Pc reporter also exhibited an unexpected FRET increase when its K9 residue was 
methylated by vSET or G9a. Compared to the HP1 reporter mutants, all the Pc mutants 
exhibited, if any, a less than 10 % “residual” emission ratio change. The weaker FRET 
signal likely reflected a lower affinity of the promiscuous Pc chromodomain binding to 
the methylated K9, whereas the HP1 chromodomain was more permissive in accepting 
the non-cognate methyllysines. In fact, data from the intermolecular binding 
characterization seemed to be consistent with this implication. The chromodomain of 
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HP1 (containing residues 17-76) binds the trimethylated K9 (Kd = 4 µM) 16 times tighter 
than the trimethylated K27 (Kd = 64 µM)143, whereas the Pc chromodomain (residue no. 
1-98) more selectively interacts with the trimethylated K27 (Kd = 5 µM) than the 
trimethylated K9 (Kd = 125 µM), with a 25 fold difference.  
 
Figure 3.19. Intra- and intermolecular binding between the chromodomain and the methylated 
lysine peptide. Kdi: intramolecular dissociation constant; Kd: intermolecular dissociation constant.  
 
 
FRET reporters possess a special geometric constraint connecting the 
chromodomain to the non-cognate methyllysine intramolecularly. This linkage between 
two binding partners elevates the effective concentration, defined as the ratio of the 
intermolecular dissociation constant (Kd) to the intramolecular dissociation constant (Kdi) 
(Fig. 3.19). In addition to binding, this concept of the effective concentration is also used 
in a chemical reaction. It refers to the ratio of the first-order rate constant of an 
intramolecular reaction involving two functional groups within the same molecular entity 
to the second-order rate constant of an analogous intermolecular elementary reaction. In 
both bases, this ratio has the dimension of concentration. Due to the elevated effective 
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concentration, the non-canonical binding interaction is more likely to take place in the 
FRET reporter than when two molecules are separated intermolecularly. The underlying 
assumption is that the linker of the reporter, as designed to be flexible, allows the 
chromodomain to freely access the methyllysine without a geometric constraint. Only 
when the non-cognate ligand is present in high concentration will the fraction of the 
chromodomain intermolecularly binding to the non-cognate methyllysine be equal to the 
fraction where two partners are unimolecularly bound in the reporter. This threshold is 
also referred as the effective concentration, which is a function of the physical separation 
between two binding partners that are held in the same molecule. Based on the worm-like 
chain model54, the effective concentrations were estimated to be 0.12 mM for the HP1 
reporter (binding to the methylated K9) and 8.31 mM for the Pc reporters (binding to the 
methylated K27; detailed calculations were described in the experimental session). 
Assuming that the indicators with a concentration of 10 µM are fully trimethylated, 96.8 
% of the K9 reporter and 99.9 % of the Pc reporter will be in the closed state. In contrast, 
only 53.7 % (HP1 chromodomain-Me3-K9) and 50 % (Pc chromodomain-Me3-K27) of 
the binding partners are intermolecularly associated when both of them are present in the 
same concentration. The difference in the bound fraction from two binding modes 
highlights the significance of intramolecular tethering. The resultant elevated effective 
concentration in turn enhances the possibility of promiscuous binding, which is less 
likely to occur when two non-cognate binding partner are present in isolation. This 
statement was based on the conceivably simple assumption that the flexibility of the 
linker allows the chromodomain and methyllysine freely to bind. More sophisticated 
considerations, for instance how the translational and rotational entropy changes upon 
binding158 and how accessible is the methyllysine to the chromodomain, remain to be 
further explored via approaches such as computational modeling .    
For a cellular demonstration of the reporter function, the K9 reporter was used to 
reveal the different basal levels of the histone H3 K9 methylation between two MEF cell 
lines. As shown in Figure 3.6b, the dynamic range of the K9 reporter in response to 
histone methylation corresponded to the YFP/CFP emission ratios varying from 1.33 (t = 
0, no methylation) to 2.14 (t = 10 hr, assuming full methylation). Based on the statistical 
results in Figure 3.14, the reporter in wild-type cells (µ = 1.867, σ / √ n-1 = 0.0098, n = 
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278) exhibited an average emission ratio corresponding to 66.3 ± 2.3 % of methylation. 
The reporter in Suv39h-/- cells (µ = 1.773, σ / √ n-1 = 0.0133, n = 150) showed an 
average emission ratio corresponding to 54.7 ± 3.1 % of methylation. There is a ~12 % 
difference in the levels of K9 methylation between these two cell lines, assuming that the 
levels of the YFP/CFP emission ratio linearly reflect the methylation extent of the 
reporter.  
Previously, Peters et al.159 reported a ~40 % histone methylation difference 
between the wild-type and knockout primary mouse embryonic fibroblasts by 
immunoblot, using a commercial antibody specific for dimethyl-histone H3-K9. A larger 
difference, ~75 %, was observed when a custom-made antibody against the multiple 
copies of methyllysine was used. These results suggested that the dynamic range of the 
ensemble measurement of histone methylation in vitro was determined by the intrinsic 
properties of the antibody. In addition, deleting both suv39h1 and suv39h2 
methyltransferase genes did not completely eliminate the histone H3 K9 methylation in 
the knockout cell line. A residual level of methylation was still detectable in cells by 
immunoblot using either antibody159, suggesting the presence of other K9 
methyltransferases whose activities were not negligible. The speculated and 
uncharacterized background methylation activity may, in part, contribute to the small 
difference (~12 %) in methylation observed by the reporters approach in living cells. One 
possibility is that the reporters in the knockout cells are still efficiently modified by these 
unidentified residual methyltransferases. Thus, the expected reporter methylation by 
Suv39h1 and Suv39h2 activities in the wild-type cells is not substantially revealed by the 
slight increase of the reporter FRET. Future work will be required to explore the precise 
nature and the significance of this putative cell-to-cell variation.   
A model cell line derived from MEF, which undergoes a Zn2+-induced 
asymmetric cell division, was chosen for further demonstration of the reporter utility. To 
refine the spatial resolution, reporters were genetically fused to the full-length histone H3 
for targeting the protein localization to core histones. Preliminary data have identified 
conditions for constructions of the stable cell lines, as well as demonstrated that 
introduction of H3-GFP and H3-HPR did not abolish the ability for the cells to 
asymmetrically divide. Most importantly, the H3-fused constructs integrated into 
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chromosome during cell divisions as expected, although no FRET change of the reporters 
was observed throughout an entire cell cycle. This result represents a starting point for 
future optimization and success.  
In addition to the association with the asymmetric cell division mimicking the 
adult stem cell growth kinetics, histone methylation also plays a role in X-chromosome 
inactivation. In particular, trimethylation of K27 at histone H3 was implicated to initiate, 
but not to sustain, the inactivation process141. Therefore, one potential application of the 
FRET reporters is to image any dnamic change of the histone methylation levels of K9 
and K27 during embryogenesis. To increase the spatial resolution of the reporter, a 
strategy similar to fusion of the full-length histone H3 can be taken to target the reporter 
to chromosomes. For the choice of the fusion protein, one candidate is the MS2 coat 
protein that is known to bind the MS2 RNA hairpin160. To anchor the RNA hairpin on the 
chromosome, the sequence of the hairpin will be incorporated into the Xist gene whose 
mRNA product is known to tightly and selectively wrap the inactivated X-chromosome. 
Future imaging experiments can be embarked once the Xist-MS2 and histone reporter-
coat protein fusion constructs are made.  
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Experimental 
 
The sequences of all primers for construction of the histone phosphorylation reporters 
and site-directed mutagenesis are listed in Table 3.2.  
 
Experiments of DNA cloning, expression of reporter, protein purification, and 
immunoblot were based on the general protocols listed in the Appendix unless otherwise 
mentioned. The sequences of all the constructs were confirmed by the MWG Biotech 
sequencing service. 
 
Construction of the K9 reporter gene  
 An insert containing the HP1 chromodomain, linker, and substrate peptide was 
constructed through two successive PCR reactions. For the first PCR, the HP1 gene (a 
gift from Sepideh Khorasanizadeh, University of Virginia) was used as the template with 
the primers HP1.F and HP1.R to incorporate the SphI site, linker and part of the substrate 
peptide. For the second PCR, the previous PCR product was used as the template with the 
primers HP1.F and H3K9.R to incorporate the rest of the substrate peptide and a SacI 
site. The product from the second PCR was digested with SphI and SacI and prepared as 
the insert, which was ligated in-frame into similarly digested EGFR reporter pRSETB 
plasmid25 (GenBank accession number AF440201). The EGFR reporter pRSETB plasmid 
contains a CFP gene immediately upstream from the unique SphI site, and a YFP gene 
immediately downstream from the unique SacI site. It also contains a (His)6 epitope 
upstream the reporter gene for protein purification. The resultant plasmid was confirmed 
by DNA sequencing. 
 
Construction of the K27 reporter gene  
 An insert containing the Pc chromodomain, linker, and substrate peptide was 
constructed through two successive PCR reactions. For the first PCR, the Pc gene (a gift 
from Yi Zhang, University of North Carolina at Chapel Hill) was used as the template 
with the primers Pc.F and Pc.R to incorporate the SphI site, linker, and part of the 
substrate peptide. For the second PCR, the first PCR product was used as the template 
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with the primers Pc.F and H3K27.R to incorporate the rest of the substrate peptide and 
the SacI site. The insert was prepared by digesting the second PCR product with SphI and 
SacI and ligated in-frame into similarly digested EGFR reporter pRSETB plasmid as used 
for construction of the K9 reporter. The resultant plasmid was confirmed by DNA 
sequencing. 
 
Construction of the K9 and K27 reporter mutant genes 
 For construction of the K9 reporter mutants, QuikChange reactions were 
individually performed with the K9 reporter gene as the common template. Primers 
CWChromo-W45A.F and its reverse complement were used to create the W45A mutant. 
Primers nHP1_K9L.F and its reverse complement were used to create the K9L mutant. 
For construction of the K27 reporter mutants, QuikChange reactions were individually 
performed with the K27 reporter gene as the common template. Primers Y26K.F and its 
reverse complement were used to create the Y26K mutant. Primers nPC_K27L.F and its 
reverse complement were used to create the K27L mutant. The resultant plasmids were 
confirmed by DNA sequencing. 
 
Construction of the HP1 reporter gene  
 This construct differs from the K9 reporter in the substrate peptide region, and a 
longer H3 (amino acids 1-30 instead of 1-13) is included. Two successive PCR reactions 
were performed to construct an insert containing the HP1 chromodomain, linker, and 
substrate peptide. For the first PCR, the HP1 gene was used as the template with primers 
HP1.F and ChromoH3.R to incorporate the SphI site, linker, and part of the substrate 
peptide. For the second PCR, the product of the first PCR reaction was used as the 
template with primers HP1.F and H3.RR (the sequence is described in Chapter 2). The 
insert was digested with SphI and SacI and ligated in-frame into similarly digested EGFR 
reporter pRSETB plasmid25 as described for construction the K9 reporter. The resultant 
plasmid was confirmed by DNA sequencing. 
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Construction of the HP1 reporter mutant genes 
  For construction of the reporter mutants, QuikChange reactions were individually 
performed with the HP1 reporter gene as the common template. Primers CWChromo-
W45A.F and its reverse complement were used to create the W45A mutant. Primers 
CWH3-K9L.F and its reverse complement were used for construing the K9L mutant. To 
construct the K9,27L double mutant, the K9L reporter mutant was used as a template 
with the primers H3-K27L.F and its reverse complement. To construct the K4,9,27L 
triple mutant (Sean Liu and Alice Y. Ting, unpublished data), the K9,27L reporter mutant 
was used as a template with the primers HP1K4L.F and its reverse complement. All 
resultant plasmids were confirmed by DNA sequencing.  
 
Construction of the Pc reporter mutant genes  
 This Pc reporter construct (formerly contributed by Cindy Jao in Alice Y. Ting’s 
lab) differs from the K27 reporter in the substrate peptide region, and a longer H3 is 
included (amino acids 1-30 instead of 24-35). QuikChange reactions were individually 
performed with the Pc reporter gene as the common template. Primers Y26KF and its 
reverse complement were used to create the Y26K mutant. Primers H3-K27LF and its 
reverse complement were used to create the K27L mutant. To construct the K9,27L 
double mutant, the K27L mutant plasmid was used as the template with primers CWH3-
K9L.F and its reverse complement. All resultant plasmids were confirmed by DNA 
sequencing. 
 
Construction of the histone methylation reporter variants fusing to the full-length H3 
  The K9 and K27 reporter plasmids (pRSETB) were digested with BamHI and 
NotI enzymes, and these fragments were ligated in-frame into the vector derived from the 
similarly cut BOS-H3-GFP plasmid103. The resultant constructs were condirmed by DNA 
sequencing. 
 
Reporter expression and purification 
 The pRSETB plasmid containing the reporter gene between BamHI and EcoRI 
sites was introduced into the bacterial strain BL21(DE3) by heat-shock transformation. 
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The cells were grown in Luria Broth supplemented with ampicillin (100 µg/mL) at 37 ºC 
until OD600 0.5. IPTG (Isopropyl-β-D-thiogalactopyranoside) was then added to a final 
concentration of 0.4 mM to induce reporter protein expression. The cells were grown for 
an additional 3 hr at 30 ºC and then harvested by centrifugation. Cells were lysed by 
sonication at 4 ºC (six 30-sec pulses at half-maximal power with 1 min in between each 
pulse) in lysis buffer (50 mM Tris pH 7.8, 300 mM NaCl, 4 mM PMSF, and ¼ EDTA-
free protease inhibitor cocktail tablet. The His6-tagged reporter was purified from the 
lysate using a Ni-NTA agarose column. Fractions containing the reporter were 
consolidated and transferred into TBS (140 mM NaCl, 3 mM KCl, 25 mM Tris pH 7.4) 
by two rounds of dialysis. The purity and quantity of the protein were examined by SDS-
PAGE, and the typical yields were 0.5-1 mg of protein per 0.5 L culture. Proteins were 
then stored in aliquots at -80 ºC. 
 
Expression and purification of vSET  
 The vSET expression plasmid (Paramecium bursaria chlorella virus SET domain 
in pET22b (Novagen, Madison, WI) was a kind gift from Ming-Ming Zhou at New York 
University) was introduced into the bacterial strain BL21(DE3) by heat-stock 
transformation. The cells were grown in Luria Broth supplemented with ampicillin (100 
µg/mL) at 37 ºC until OD600 0.5. IPTG was then added to a final concentration of 0.4 mM 
to induce enzyme expression. The cells were grown for an additional 3 hr at 30 ºC and 
then harvested by centrifugation. Cells were lysed by sonication at 4 ºC (six 30-sec pulses 
at half-maximal power with 1 min in between each pulse) in lysis buffer (50 mM Tris pH 
7.8, 300 mM NaCl, 4 mM PMSF, and ¼ EDTA-free protease inhibitor cocktail tablet per 
10 mL of lysis buffer. The His6-tagged protein was purified from the lysate using a Ni-
NTA agarose column following the manufacturer’s suggested protocol. Fractions 
containing the protein were consolidated and transferred into storage buffer (20 mM Tris 
pH 8.0, 500 mM NaCl, 500 mM urea) by two rounds of dialysis. The purity and quantity 
of the protein were examined by SDS-PAGE, and the typical yields were 0.5-1 mg of 
protein per 0.5 L culture. Proteins were then stored in aliquots at -80 ºC. 
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In vitro methylation assays 
 Reaction conditions for the in vitro methylation assays were as follows: 5 -10 µM 
reporter, 2 mM SAM, 20 mM Tris pH 8.0, 10 mM MgCl2, 20 mM KCl, 0.5 mM H2SO4, 
0.5 mM DTT, and 0.3-0.5 µg/µL vSET (prepared as described above). Reactions were 
incubated at 30 ºC for the indicated times. 
 
Endoproteinase Glu-C digestion and MALDI analysis of methylated reporters 
 The K9 and K27 reporters were enzymatically methylated as described above. 
After a reaction time of 12 hr, the reporter was digested with 1.5 µg of endoproteinase 
Glu-C enzyme (Sigma, Allentown, PA) at 37 ºC for 16 hr. No cysteine alkylation was 
performed prior to the digestion. A fraction of the reaction mixture was mixed with the 
saturated α-cyano-4-hydroxycinammic acid (in 0.1 % trifluoroacetic acid with 50 % 
acetonitrile) in 1:1 ratio and 1 µL of the above mixture was loaded onto the MALDI 
target. MALDI-time-of-flight data were collected using the MIT Department of 
Chemistry Instrumentation Facility. Data acquisition was by operated in the reflection 
and positive-ion mode, and the m/z ranged from 700 to 3000. The mass was calibrated 
using external standards (Sigma).  The list containing the individual the digested 
fragments and their correspondind masses was generated by the online Mass-Digest 
program (http://prospector.ucsf.edu/ucsfhtml4.0/msdigest.htm).   
 
Cell imaging  
  For expressing the reporters and the mutants in mammalian cells, the 
corresponding pRSETB plasmids were digested with BamHI and EcoRI and ligated in-
frame into the similarly cut pCDNA3’ vector (described in Chapter 2). The resultant K9 
reporter (pcDNA3’) was introduced into mouse embryonic fibroblasts (wild-type and 
Suv39h -/- cells are gifts from Thomas Jenuwein, Research Institute of Molecular 
Pathology, Austria) by transfection with Fugene 6 (Roche). Images were collected 12-24 
hr after transfection on a Zeiss Axiovert 200M inverted epifluorescence microscope with 
differential interference contrast (DIC). Cells were maintained in 10 % fetal bovine 
serum in phenol red-free DMEM (Invitrogen, Carlsbad, CA) at 37 ºC under 5 % CO2 
during imaging with an environmental control system that housed the microscope stage.  
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For each data acquisition, four images were collected in rapid succession (automated, 
using OpenLab software (Improvision, Lexington, MA): a CFP image (420DF20 
excitation, 450DRLP dichroic, 475DF40 emission), a FRET image (420DF20 excitation, 
450DRLP dichroic, 530DF30 emission), a YFP image (495DF10 excitation, 515DRLP 
dichroic, 530DF30 emission), and a DIC image (775DF50 emission). These images were 
acquired by using the corresponding filter sets (from Omega Optical, Brattleboro, VT) as 
individually listed. Acquisition times were in the range of 100 to 800 milliseconds. The 
emission ratio image was generated by dividing the FRET image by the CFP image. The 
images shown in Figure 3.13 are merges between the emission ratio images and the DIC 
images. 
 
Calculation of effective concentrations based on the worm-like chain model  
The effective concentrations of the HP1 and PC reporters were calculated by 
comparing the association constant Ka for the chromodomain and methylated H3 peptide 
(as shown in Table 3.1), to Kai for intramolecular binding that both partners are 
covalently joined by a linker in the reporter design. The relationship between these two 
constants is listed as follows: Kai = Ka p(d), where p(d) is a probability density function 
(Fig. 3.20). Through the modeling of the peptide linker as a flexible worm-like chain, 
Zhou has recently demonstrated that p(d) can be considered as the effective 
concentration161:  
p(d) = (3/4πlplc)3/2 exp(−3d2/4lplc) 
(1−5lp/4lc+2d2/lc2−33d4/80lplc3−79lp2/160lc2−329d2lp/120lc3+6799d4/1600lc4 
−344ld6/2800lplc5+1089d8/12800lp2lc6), 
where b = 3.8 Å is the nearest Cα–Cα distance, and lc = bL and lp = 3.04 Å are the contour 
length and persistence length, respectively, of the peptide linker. This linker contains L 
residues and has the end-to-end distance d, corresponding to the separation between the 
C-terminus of chromodomain and the N-terminal residue of the H3 methylated peptide in 
the crystal structure.  
In the HP1 reporter, the Asp76 of the chromodomain and the Ala1 on the peptide 
are connected via 15-residue linker (L = 15). These two residues are separated by 36.2 Å 
(d = 36.2 Å) in space according to the crystal structure (PDB code: 1GUW). Given the 
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known L and d, the resulting effective concentration is estimated to be 0.12 mM from the 
equation listed above. The analogous calculation for intramolecular binding to 
methylated Lys27 in the PC reporter was 8.31 mM. This modeling result is based on the 
38-residue linker in between Asn76 of the chromodomain and Arg2 of the methylated H3 
peptide, which presumably spans same end-to-end distance 24.1 Å and leaves the equal 
number of residues from the N-terminus to the methylated lysine (Leu20-Lys27; PDB 
code: 1PFB).  
 
Maintenance and growth analysis of the MEF cells that undergo asymmetric division 
The Ind-8 and Con-3 cells were obtained from James Sherley at M.I.T. They were 
maintained under 5 % CO2 at 37 ºC in DMEM, supplemented with 10 % dialyzed fetal 
bovine serum, 5 µg/mL puromycin, and 1 % penicillin/streptomycin. Cells were 
transiently transfected with the H3-fusion reporter constructs (H3-GFP, H3-HPR, H3-K9, 
and H3-K27) by Cytofectin (Genlantis, San Diego, CA), following the manufacturer’s 
protocol. Transfected cells were incubated with 5 µg/mL blasticidin (Calbiochem), 
followed by a FACS sorting (performed by Rouzbeh Taghizadeh, Sherley labaratory) to 
select the stably fluorescent cells.  The stably transfected cells were first grown to 50 % 
confluency, followed by redistribution into imaging dishes with a density of 12000 
cells/dish. After 24 hr, cells were incubated with 6.5 µM of Zn2+ to trigger the 
asymmetric cell division. Cell imaging was performed with the settings described as 
above and incubated with 5 % CO2 and 37 ºC over the course. For examination of the cell 
population growth, cells were stained with crystal violet (1:200 dilution of the saturated 
stock solution in 10 % ethanol), washed with PBS, and the numbers of stained individual 
colonies were counted. 
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Table 3.2. List of the primers for cloning the histone methylation reporters 
Primer name Primer sequence Restriction 
site 
included 
corresponding 
protein 
mutation site 
Application 
HP1.F 5´-ACCGCCGCCCGCATGCATGAGGAGG 
AGTACGCCGT 
SphI  Clone the HP1 
chromodomain 
ChromoH3.R 5´-AGACTTGCGAGCTGTCTGCTTCGTCC 
GGGCAGAACCCTCACCAGAACCCGGCTT
CCCAGATCCAGATGTAGACCCATCCTTG
CGGCTCGCCTC 
  Linker sequence 
of the HP1 
reporter 
underlined 
HP1.R 5´-GCAGAACCCTCACCAGAACCCGGCTT 
CCCAGATCCAGATGTAGACCCATCCTTG 
CGGCTCGCCTCGTAC 
  Linker sequence 
of the K9 
reporter 
underlined 
H3K9.R 5´-CCATGAGCTCGCCGCCGGTAGACTTG 
CGAGCTGTCTGGGCCGTCCGGGCAGAAC
CCTCACC 
SacI  Include the H3 
sequence of the 
K9 reporter 
Pc.F 5´-GCTGCTCGCATGCTCCCAGTCGATCT 
AGTGTAC 
SphI  Clone the PC 
chromodomain 
Pc.R 5´-GGCAGAACCCTCACCAGAACCCGGCT 
TCCCAGATCCAGATGTAGACCCGGATTT 
GTTCGTTTGTTCGTAG 
  Linker sequence 
of the Pc 
reporter 
underlined 
H3K27.R 5´-CCATGAGCTCCACCCCCCCCGTAGCT 
GGAGCGCTTTTGCGCGCTGCGGCCGTCC
GGGCAGAACCCTCACC 
SacI  Include the H3 
sequence of the 
K27 reporter 
CWChromo-
W45A.F 
5’-GAGTACTATCTGAAAGCCAAGGGCTA 
TCCCG 
 W45A W45A mutation 
of the HP1 
chromodomain 
Reverse 
Complement  
5’-CGGGATAGCCCTTGGCTTTCAGATAG 
TACTC 
 W45A W45A mutation 
of the HP1 
chromodomain 
nHP1_K9L.F 5’-CAGACAGCTCGCCTCTCTACCGGCGG 
CGAGCTC 
 K9L K9L mutation 
of H3 of the K9 
reporter 
Reverse 
Complement 
5’-GAGCTCGCCGCCGGTAGAGAGGCGA 
GCTGTCTG 
 K9L K9L mutation 
of H3 of the K9 
reporter 
Y26K.F 5’-CCCAGTCGATCTAGTGAAGGCGGCTG 
AGAAAATC 
 Y26K Y26K mutation 
of H3 of the Pc 
chromodomain 
Reverse 
Complement 
5’-GATTTTCTCAGCCGCCTTCACTAGAT 
CGACTGGG 
 Y26K Y26K mutation 
of H3 of the Pc 
chromodomain 
nPC_K27L.F 5’-CGGCCGCAGCGCGCTTAAGCGCTCCA  K27L K27L mutation 
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GCTACG of H3 of the 
K27 reporter 
Reverse 
Complement 
5’-CGTAGCTGGAGCGCTTAAGCGCGCTG 
CCGGCCG 
 K27L K27L mutation 
of H3 of the 
K27 reporter 
CWH3-
K9L.F 
5’-CAGACAGCTCGCCTCTCTACCGGCGG 
CAAGGC 
 K9L K9L mutation 
of H3 of the 
HP1 reporter 
Reverse 
Complement 
5’-GCCTTGCCGCCGGTAGAGAGGCGAGC 
TGTCTG 
 K9L K9L mutation 
of H3 of the 
HP1 reporter 
H3-K27L.F 5’-CCAAGGCAGCGCGCTTAAGCGCTCCA 
GAGCTC 
 K27L K27L mutation 
of H3 of the 
HP1 reporter 
Reverse 
Complement 
5’-GAGCTCTGGAGCGCCTTAAGCGCGCT 
GCCTTGG 
 K27L K27L mutation 
of H3 of the 
HP1 reporter 
HP1K4L.F 5’-CTGCCCGGACGCTGCAGACAGCTCGC  K4L K4L mutation 
of H3 of the 
HP1 reporter 
Reverse 
Complement 
5’-GCGAGCTGTCTGCAGCGTCCCGGGCA 
G 
 K4L K4L mutation 
of H3 of the 
HP1 reporter 
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Chapter 4  
Transglutaminase-mediated site-specific protein labeling 
 
A significant portion of the work described in this chapter has been published in:  
Lin, C.-W. and Ting, A. Y. Transglutaminase-catalyzed site-specific conjugation of 
small-molecule probes to proteins in vitro and on the surface of living cells J. Am. Chem. 
Soc., 128, 4542-4543 (2006). 
 
Introduction 
Small-molecule probes bearing diverse functionalities are suitable for studying 
proteins in living cells. These probes have many applications, including use in the 
examination of protein-protein interactions, the photo-regulation of protein functions, and 
the monitoring cellular events such as protein turnover and trafficking. For “visualizing” 
biological processes, GFP fusion is the canonical method for optical imaging. Despite the 
convenience and the robust fluorescence readout of GFP, the diffraction limit associated 
with the visible wavelengths imposes limits. Non-optical methods such as the electron 
microscopy and magnetic resonance imaging, accompanied by the use of small-molecule 
probes, have advanced molecular imaging beyond the relatively restricted fluorescence 
applications as described in Chapter 1.  
However, the major bottleneck for using these probes in cells is the shortage of 
robust methods for targeting them to specific proteins of interest. The complex cellular 
environment presents a huge number of competitors, such as endogenous proteins, 
sugars, and lipids, which can potentially interfere with the intended probe application.  
Many new methodologies for protein labeling in cells have recently been reported162-164. 
Most of these use special peptide or protein handles, which are genetically fused to the 
target protein and recruit the probe of interest via a covalent or non-covalent interaction. 
There is great variation in the strengths and weaknesses of these methods as listed in 
Table 1.1. For example, the GFP fusion method renders excellent labeling specificity and 
signal stability by stoichiometrically appending the reporter gene to the sequence 
underlying the protein of interest via a covalent linkage. However, the intrinsic 
fluorescence associated with GFP forbids other applications as mentioned, and the 
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introduction of a bulky protein tag can potentially alter the protein localization and 
function57. On the other hand, genetically fusing a protein-sized tag (such as FKBP 
(FK506 binding protein), hAGT (human O6-alkylguanine-DNA alkyltransferase) and 
PCP (peptide carrier protein)) usually permits better labeling specificity and covalent 
probe conjugation than fusing a peptide-sized epitope (such as tetracysteine biarsenicals 
and His6 tag). The recent success of using E. coli. biotin ligase for site-specific protein 
labeling61 represented an alternative approach for tackling the tag-size-specificity 
problem. In this method, a 15-amino-acid substrate peptide was fused to the target 
proteins, followed by an enzyme-mediated covalent conjugation of a biotin-like ketone 
handle. A second-step addition of a fluorophore or a photo-crosslinker was performed to 
attach the desired functionality. Although not shown in the context of living cells, Yin et 
al. have also used an 11-amino-acid ybbR substrate peptide for site-specific conjugation 
of CoA analogs via the Sfp enzymatic reaction165. Borrowing the natural specificity of an 
enzyme for its substrate peptide suggests a general method for site-specifically labeling 
proteins with a small tag.  
An ideal labeling method should include the following features: excellent labeling 
specificity, small tag size, minimal cell toxicity, speed and short operation procedure, 
stable signal over time, compatible with different cell types, and accepting probes that 
differ in their structures. However, no single method exists yet that is successful in all 
these respects. Thus, new methods are still needed to facilitate the routine use of non-
genetically encoded probes in cells. In this chapter, I describe the use of transglutaminase 
and its 6- or 7- amino-acid substrate peptides (called Q-tags) to achieve site-specific 
protein labeling, both in vitro and on the surface of living cells.   
Transglutaminases (TGases) are a large family of enzymes that naturally catalyze 
amide bond formation between a glutamine and a lysine sidechain on two different 
proteins in a calcium dependent manner (Fig. 4.1). In nine different subtypes with 
individually distinct subcellular localization and tissue expression, type II TGases are 
ubiquitously expressed and present in many cellular compartments166. In particular, their 
protein cross-linking functions are associated with many important biological processes 
such as cell migration167, apoptosis166, blood clotting168, neurite outgrowth169, 
neurodegenerative Huntington’s disease170, and Celiac Sprue169,171,172. One of the most 
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well-studied type II TGases is the guinea pig liver tissue transglutaminase (gpTGase), a 
77 kD monomeric protein expressed in the cytosol168 that has been known since 195964. 
gpTGase has unique properties which make it ideal for protein labeling applications; it 
exhibits high specificity for its glutamine-containing protein substrate, but still has wide 
tolerance for the structure of the amine-containing substrate65. Instead of lysine-
containing substrate proteins, small-molecule amines as diverse as fluorescein 
cadaverine66 and biotin cadaverine67 can be used by gpTGase. Because a protein structure 
of how gpTGase binds its substrate has not yet been available, intensive efforts were 
previously focused on comparing a series of amine substrates to map the enzyme acitive 
site. A linker length of ~7.2-7.6 Å, corresponding to a separation of five methylene 
groups, between the hydrophobic substituent and the nucleophilic nitrogen was found to 
be optimal for substrates65. This result in turn suggests the existence of a narrow crevice 
in the primary substrate binding site of gpTGase, as such a crevice can accommodate the 
linear amines better than bulky divergent structures65.  
In addition, the reactive glutamine-containing proteins can be further reduced to a 
peptide (called a Q-tag), which is still efficiently modified by gpTGase both in isolation 
and when it is fused to recombinant proteins69,173. As previously shown, gpTGase can 
label the Q-tagged proteins in vitro. For instance, interleukin-2 fused with a Q-tag was 
labeled with monodansyl cadaverine69 and a amine derivative of poly(oxyethylene)69, and 
the recombinant Glutathione S-transferase was tagged with fluorescein cadaverine173. 
Despite the long history of using TGase to label proteins by reactions with endogenous 
glutamines, the use of TGases for labeling specific Q-tagged proteins in cells or complex 
mixtures surprisingly has never been reported. 
 In this chapter, I first demonstrated that three different Q-tags, Q1 (PNPQLPF), 
Q2 (PKPQQFM), and Q3 (GQQQLG), could confer the in vitro labeling specificity 
using fluorophores and biotin probes when the tags were fused to CFP as a model protein. 
These portable sequences were then tagged to the transmembrane domain or the full-
length receptor proteins for testing site-specific labeling on cell surface. Labeling the cell 
surface Q-tagged proteins with fluorophores requires the optimization of the reaction 
conditions, which reduced the temperature to 4 °C and elevated the calcium concentration 
to ~10 mM. In addition to fluorophores and biotin cadaverine, gpTGase was also shown 
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to accept a photo-crosslinker for studying the protein-protein interaction. As a proof of 
principle, the p50 transcription factor that could undergo homodimerization was chosen 
for labeling. An elevated level of the photo-crosslinked p50 homodimer formation was 
observed when the probe-labeled p50 protein was incubated with DNA or myotrophin 
prior to the photoreaction, consistent with the reported roles of both molecules in 
promoting the p50 self-association.    
 Limitations exist for the site-specific labeling strategy with the current form of 
gpTGase. It did not exclusively label the Q-tag, and other glutamine residues were also 
modified under the labeling conditions in vitro and on the cell surface. Labeling Q-tagged 
proteins on the surface of HeLa cells with fluorophores was performed at the expense of 
a combination of the high Ca2+ concentration and low temperature. Although assays 
testing the cell morphology, growth kinetics, and the intrinsic cell response to ATP-
triggered intracellular Ca2+ oscillation did not find any apparent alteration of the HeLa 
cell behavior, these conditions may not be compatible with cells (for example, neurons) 
that are more sensitive to the temperature and Ca2+ concentration in the environment. 
Future work requires exploring other subtypes of TGase, for instance the microbial 
TGase that does not require Ca2+ for activation72 and fXIIIa73 that is known to be more 
specific than gpTGase, or engineering of the enzyme active site to overcome the current 
obstacles.   
Figure 4.1. Schematic representation of the transglutaminase-catalyzed site-specific probe 
ligation to the Q-tag-fused protein. The target protein on the cell surface presents a Q-tag 
accessible to the extracellularly added TGase, which incorporates the cadaverine-functionalized 
probes (green circle) to the Gln sidechain of the Q-tag (blue) via an amide bond formation and the 
accompanied loss of ammonia. For the choices of the Q-tag, three sequences were used: Q1 
(PNPQLPF), Q2 (PKPQQFM), and Q3 (GQQQLG). 
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Results 
 
In vitro labeling of Q-tag-CFP with fluorescein cadaverine and biotin cadaverine   
 
Three different sequences of the peptides were chosen as the Q-tag substrates of 
gpTGase, and they were genetically appended to the N-terminus of CFP. The Q1 peptide, 
PNPQLPF174, was a gift from Jeffery Keillor (Université de Montréal) and initially 
derived from the fragment of wheat protein gliadin70. The Q2 tag, PKPQQFM69,173, was 
identified from the substance P protein. The Q3 peptide, GQQQLG71, was demonstrated 
in hydrogel formation. The design principle for Q3 was based on the previous 
observations: 1) proteins containing two or more adjacent glutamines were better 
substrates for gpTGase68,175, and 2) the presence of a leucine adjacent to the glutamine 
near C-terminus of the peptides increased the substrate specificity176. These purified Q-
tagged CFP recombinant proteins were labeled by gpTGase with fluorescein cadaverine 
in a calcium-dependent manner (Fig. 4.2a, lane 2, 5, and 8). Omitting Ca2+ suppressed the 
probe conjugation (Fig. 4.2a, lane 1, 4, and 7). To demonstrate the labeling specificity, 
all three alanine mutants (sequences: Q1(Ala), PNPALPF;  Q2(Ala), PKPAAFM; Q3 
(Ala), GAAALG) were incubated with the same labeling conditions. Only background 
levels of probe incorporation into mutants were observed (Fig. 4.2a, lane 3, 6, and 9). 
The signal-to-background ratios (Q-tag protein intensity: alanine mutant intensity) of 
labeling were determined to be 3.3 ~ 16.7 (Fig. 4.2b).  
In order to further estimate the extent of modification during the in vitro reaction, 
Q1-CFP was also labeled with biotin cadaverine under otherwise identical conditions. 
The CFP-AP61 was chosen as a concentration reference of the biotinylated protein. CFP-
AP contains the 15-amino-acid acceptor peptide fused to the C-terminus of CFP, and it 
resembles Q1-CFP except the difference in the tagged eptiope. The fully biotinylated 
CFP-AP was prepared via the reaction with BirA (E. coli. biotin ligase) until completion, 
and BirA site-specifically introduced one biotin moiety onto the acceptor peptide per 
CFP-AP molecule61. The biotinylated Q1-CFP and CFP-AP together were analyzed by 
immunoblot using streptavidin-HRP, and Q1-CFP was estimated to be ~70-80 % labeled 
by gpTGase (Fig. 4.3a) 
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Figure 4.2. TGase-catalyzed labeling of Q-tagged CFP proteins in vitro with fluorescein 
cadaverine. a) Three Q-tagged proteins (6.3 µM each), Q1-CFP, Q2-CFP, and Q3-CFP, were 
incubated with 25 ng/µL gpTGase, 5 mM CaCl2, and 0.5 mM fluorescein cadaverine for 30 min 
at 4 °C (reaction volume = 10 µL). The labeling result was visualized on 12 % SDS-PAGE by 
fluorescence. Fluorescein conjugation to Q-tag-CFP proteins was observed when the reaction 
included Ca2+(lane 2, 5, and 8) but not when Ca2+ was omitted (lane 1, 4, and 7). Protein mutants 
replacing each glutamine with alanine also suppressed the labeling (lane 3, 6, and 9). Coomassie 
staining of the same gel showed an equal loading of all samples. b) The fluorescence intensity of 
Q-tag-CFP and the alanine mutants, which substituted every glutamine by alanine, was recorded 
after gpTGase reactions and quantified using ImageQuant software. The signal to background 
ratios observed were: 6.8 (Q1 to Q1(Ala)), 3.3 (Q2 to Q2(Ala)), and 16.7 (Q3 to Q3(Ala)).    
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Figure 4.3. Estimation of the labeling efficiency in vitro. a) Domain constructs of Q1-CFP and 
CFP-AP. b) Q1-CFP and its alanine mutant were labeled in vitro with biotin cadaverine either 
under conditions identical to that used for fluorescein cadaverine labeling (Figure 4.2) or c) 
under conditions identical to that used for live cell labeling. The labeled samples were loaded 
onto a 12 % SDS-PAGE and blotted with streptavidin-HRP. For comparison, fully biotinylated 
CFP-AP protein61 was run at several dilutions alongside. The intensity of each band was recorded 
and compared by ImageQuant software. For condition (b), the extent of labeling was determined 
to be 70-80 %.  For condition (c), the labeling extent was estimated to be ~80 %.    
 
Labeling of Q-tag-CFP-TM on cell surface with fluorescein cadaverine and biotin 
cadaverine 
gpTGase-mediated site-specific protein labeling was further tested in a more 
complex environment –on the surface of living cells. Three Q-tag-CFP sequences were 
fused to the N-terminus of the transmembrane domain of platelet-derived growth factor 
receptor (PDGFR), which directs the fusion proteins to the cell membrane, to afford the 
Q-tag-CFP-TM constructs. HeLa cells expressing the Q2-CFP-TM protein on the cell 
surface were labeled with Alexa 568 cadaverine directly (Fig. 4.4a), or with biotin 
cadaverine and detected with Alexa 568-conjugated streptavidin (Fig. 4.5). Both probes 
were successfully conjugated to all three Q-tags via gpTGase-mediated reaction. To 
further quantify the labeling signal, cells expressing different levels of Q2-CFP-TM or 
Q2(Ala)-CFP-TM were chosen for monitoring their corresponding levels of Alexa 568 
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incorporation (Fig. 4.4b). The 16-bit recording of the microscopy detects the intensity of 
a given pixel ranging from 0 to 65535. This number is used to indicate the relative level 
of CFP expression as well as that of the Alexa 568 labeling. Compared to the dynamic 
range of detection, the extent of Alexa 568 labeling (the numbers varied from 0 to 18000) 
only corresponded to ~30 % of the full intensity window of the microscopy instrument 
without saturating the detection capability. In addition to the expected selective labeling 
of Q2-CFP-TM, the background level of labeling was also observed in the negative 
control using Q2(Ala)-CFP-TM or omitting gpTGase. All three samples were selected 
based on their similar expression levels of CFP. Results showed a 4-5 fold signal-to-
background labeling ratio, defined as Q2-CFP-TM intensity: Q2A-CFP-TM intensity, 
upon labeling with Alexa 568 cadaverine as highlighted in the black box of Figure 4.4b.  
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Figure 4.4. TGase-catalyzed labeling of Q-tagged cell surface protein. a) The domain structure of 
Q2-CFP-TM, from N- to C-terminus, is shown. TM is the transmembrane domain of the PDGF 
receptor directing Q2-CFP to the cell surface. HeLa cells expressing Q2-CFP-TM were labeled 
with Alexa 568 cadaverine by incubating with the probe, gpTGase, and CaCl2 for 25 min at 4 °C. 
The top row shows the CFP images superimposed on the DIC images. The bottom row shows the 
Alexa 568 fluorescence. Negative controls are shown with the alanine mutant Q2(Ala)-CFP-TM 
(replacing both glutamines) and with gpTGase enzyme left out. b) Labeling of Q2-CFP-TM or 
Q2(Ala)-CFP-TM expressed on HeLa cell surface with Alexa 568 cadaverine in a) was further 
quantified according to the Alexa 568 fluorescence intensity (in the black box). Different 
expression levels of target proteins on the surface of individual cells were chosen (determined by 
CFP fluorescence) and listed in the x-axis, and their corresponding levels of labeling were plotted 
in the y-axis. Analysis of 42 cells showed the signal-to-background ratios ranging from 2.4-5.7. c) 
Labeling experiment repeated on Q2-CFP-TM with an elevated temperature at 37 °C. The 
punctuate fluorescence randomly appeared in every cell due to cell endocytosis during labeling.  
   
 
 The data were further quantified to determine how the labeling extent correlated 
to the level of Q-tag-CFP-TM protein present on the cell surface. Cells differing in a wide 
range of the protein expression level were selected, and the corresponding different 
degrees of labeling were recorded. The expression and labeling extents of the Q-tag-CFP-
TM proteins were, in general, linearly correlated with each other (under the 95 % 
confidence level): Y = (1415.00 ± 623.91) + (0.23 ± 0.12) X for Q2-CFP-TM and Y = 
(254.13 ± 124.00) + (0.10 ± 0.02) X for Q2 (Ala)-CFP-TM; Y = Alexa 568 intensity and 
X = CFP intensity, respectively (Fig. 4.4b). Further assessment based on the analysis of 
covariance (significance level = 0.05) indicated that the difference between these two 
slopes was insignificant (p = 0.63), whereas the intercepts (means) were significantly 
different (p <0.001). In addition, the slope of the Q2(Ala)-CFP-TM is clearly different 
from zero, suggesting the non-specific labeling of glutamine residues of the CFP moiety. 
However, the intercepts of these two traces do not merge at the same point at the zero 
intensity of CFP as they should. One possibility is that only limited data points were 
sampled for the analysis, and the labeled Q2-CFP-TM seemed to exist in two 
populations. In addition, the region where the CFP intensity is below 2000 represents the 
detection limit. The microscopy does not unambiguously differentiate the signal from the 
background and contribute meaningful data in this range. To precisely quantify the 
labeling result as well as to look for the correlation between the expression level of Q-tag 
proteins and the labeling extent, future work will be required to collect more sample 
points for an in-depth data analysis. Nonetheless, this successful labeling result was a 
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consequence most likely due to a combination of the reduced temperature and the 
elevated calcium concentration in the labeling reaction. Elevation of the labeling 
temperature from 4 °C to 37 °C severely disabled labeling with the fluorescent probes. 
These probes were randomly accumulated inside cells perhaps due to the dynamic 
endocytosis at the higher temperature (Fig. 4.4c). Thus, the labeling reaction was 
necessarily maintained at a reduced temperature, 4°C. A high concentration (10 mM) of 
Ca2+ was also applied to sustain the gpTGase reactivity at low reaction temperature.  
 
Figure 4.5. HeLa cells expressing either Q2-CFP-TM or the alanine mutant were enzymatically 
labeled with biotin cadaverine. a) For detection of the introduced biotin, Alexa 568-conjugated 
streptavidin was added after labeling with biotin cadaverine, gpTGase, and CaCl2 for 25 min at 4 
°C. Results were examined by fluorescent microscopy. Only cells expressing the Q2-CFP-TM 
(cyan colored in the CFP channel) were labeled (orange colored in the Alexa channel) in the 
presence of TGase reaction. Negative controls leaving out the TGase or using alanine mutant 
showed no labeling. b) Q2-CFP-TM or Q2(Ala)-CFP-TM expressing HeLa cells were similarly 
labeled with biotin cadaverine as in a), followed by cell lysis and immunoblot analysis using 
streptavidin-HRP. A parallel immunoblot was set up using the anti-myc antibody, which stained 
the myc epitope in the junction between CFP and the TM (Fig. 4.4a), as a control for equal 
loading of all samples. The red asterisk in the Coomassie stain indicates the location of Q2- and 
Q2(Ala)-CFP-TM proteins on the gel. Biotin conjugation to Q2-CFP-TM (MW 37 kD) is seen in 
lane 1 but not in lanes 2 and 3 where the alanine mutant is used, and gpTGase is omitted, 
respectively. 
 
In addition to using fluorescence microscopy to reflect labeling specificity, 
labeling of the cell surface Q-tag proteins was also independently assessed by 
immunoblot (Fig. 4.5b). HeLa expressing the Q2-CFP-TM on the cell surface were 
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similarly labeled with biotin cadaverine as shown in Figure 4.5. Subsequently, the 
labeled cells were lysed, and the lysate was run on SDS-PAGE and blotted with 
streptavidin-HRP. Only a single biotinylated band was observed at 37 kD, corresponding 
to the expected molecular weight of Q2-CFP-TM. The band disappeared when the 
alanine mutant of Q2-CFP-TM was used instead, or when gpTGase was omitted from the 
labeling reaction. To confirm that the specific biotinylation of Q2-CFP-TM was not an 
artifact of uneven loading, a parallel immunoblot was performed probing the c-myc 
epitope that both Q2-CFP-TM and Q2A-CFP-TM commonly shared. In addition, the 
Coomassie staining of all the proteins released upon cell lysis did not show a strong bias 
toward Q2-CFP-TM expression in comparison to other endogenous proteins, further 
indicating labeling specificity and sensitivity.  
Despite the difficulty in estimating the actual modification extent of the cell 
surface proteins in situ, the identical reaction conditions were applied to labeling purified 
Q-tag-CFP in vitro served as an approximation (Fig. 4.3b). Q1-CFP was incubated with 
the conditions used for labeling Q2-CFP-TM on the HeLa surfaces, and the biotinylated 
product was analyzed by immunoblot using streptavidin-HRP. Similar to quantification 
of the modification extent in Figure 4.3a with fully biotinylated CFP-AP as a reference, 
Q1-CFP was ~80 % labeled under the conditions used for cell surface protein labeling 
(Fig. 4.3b).  
To ensure that the labeling conditions did not introduce cytotoxicity, experiments 
were performed to examine the cells’ responses to low temperature and high calcium 
concentration. Compared to the untreated HeLa cells, the cells exposed to a short reaction 
time (30 min, 4 °C) and a subsequent course in the growth incubator (24 hr, 37 °C, 5 % 
CO2) exhibited the similar grow rate and cell morphology. One concern was that the 
labeling conditions created a concentration gradient of Ca2+ across the cell membrane. As 
a result, it could cause the influx of the extracellular Ca2+ into cells and alter the Ca2+ 
balance. Therefore, cells were loaded with Calcium Green-1, a fluorogenic Ca2+-sensitive 
dye, to examine the intracellular Ca2+ concentration in response to the labeling 
conditions. Results showed that there was no apparent change in the intracellular Ca2+ 
concentration during labeling, even in the presence of abundant Ca2+ in the bulk solution. 
The ATP-triggered oscillation of intracellular Ca2+ concentration was also monitored as 
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an additional test of the cell state. Under the normal physiological conditions, the 
exogenously added ATP can bind the purinoceptors on the cell surface and, in turn, 
activate the PKC kinase inside cells177. The subsequent cleavage of PIP2 (phosphatidyl-
inositol-4,5-bisphosphate) by PKC generates the IP3 (1, 4, 5-trisphos-phate), which then 
binds the IP3-gated calcium channel in the ER and releases the intracellular Ca2+ from the 
storage pool, giving rise to the Ca2+ oscillation177. Cells loaded with the calcium indicator 
and exposed to the labeling conditions were monitored over time. Results showed that the 
cells exhibited no change in the Ca2+ concentration until the moment when 1 mM ATP 
was exogenously added. There was a resultant rapid and periodic fluctuation of the probe 
fluorescence intensity, indicating the ongoing Ca2+ oscillation inside cells178 (Fig. 4.6a). 
Untreated cells as well as the cells exposed to either full labeling conditions or negative 
control conditions (omitting gpTGase) all showed a similar characteristic Ca2+ signal. 
Together, these data indicated that the labeling conditions were compatible with living 
cells and did not significantly alter the normal cell physiology.          
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Figure 4.6. Incubation with the reaction conditions for protein labeling did not affect the ATP-
triggered Ca2+ oscillation in living cells. a) HeLa cells were pre-loaded with Calcium Green-1 (5 
µM bulk concentration), incubated with the transamidation conditions for protein labeling (over 
the entire course), and followed by addition of 1 mM ATP (arrow). The resultant periodic 
fluctuation of the fluorescence intensity reflected the oscillation of the intracellular calcium 
concentration in cells (black box). b) As negative controls that were otherwise identical to a), 
cells were incubated with either incomplete (enzyme omitted) or absence (nothing added) of 
reaction conditions. Signatures of the Ca2+ oscillation were still observed in both cases.     
 
 
Labeling of Q-tag-EGFR on cell surface with biotin cadaverine 
 The gpTGase-mediated site-specific protein labeling was further demonstrated in 
the context of cell-surface epidermal growth factor receptor (EGFR), an important 
biomarker that is commonly overexpressed in many cancerous cell lines179,180.  Two 
constructs were made with Q3-tags fused to the N-terminus of the EGFR. The His6-Q3-
EGFR has the internal Q3 sequence sandwiched by a His6 epitope, while the Q3-FLAG-
EGFR exposes its Q3-tag at the flanking end of the recombinant construct. Both plasmids 
were introduced to cells via lipofection, with a cytoplasmic expression YFP plasmid as 
co-transfection marker. These Q-tags, accessible to the extracellular solution, were 
incubated with biotin cadaverine, gpTGase, and CaCl2 for 30 min at 37 °C, followed by 
staining with Alexa 568-conjugated streptavidin for detection of biotin conjugation. 
Results showed that both Q-tagged EGFR constructs expressed on the surface of the 
transfected cells, which were indicated by the cytoplasmic YFP expression, were 
enzymatically labeled with biotin cadaverine. Negative controls omitting gpTGase or 
using an alanine mutant showed no labeling, indicating that the labeling was site-specific 
(Fig. 4.7a and 4.7b).   
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Figure 4.7. TGase-catalyzed labeling of two Q3-EGFR constructs with biotin cadaverine. a) A 
Q3 tag was fused to the N-terminus of the EGFR and flanked by an outer His6 sequence. The 
resultant His6-Q3-EGFR construct, in conjunction with the cytoplasmic expression plasmid YFP 
as a cotransfection marker, was delivered to CHO-K1 cells via lipofection. The internal Q3 tag of 
the surface displayed EGFR was enzymatically labeled with biotin cadaverine by incubating with 
the probe, gpTGase, and CaCl2 for 30 min at 37 °C. Biotin incorporation was detected by staining 
with Alexa 568-conjugated streptavidin. The left column shows the YFP channel images 
superimposed on the DIC images, indicating the transfected cells. The right column shows the 
labeling result (Alexa 568 channel). Negative controls are shown with the alanine mutant or with 
gpTGase left out. b) The Q3 tag was alternatively fused to N-terminus of EGFR via a FLAG 
linker (sequence: DYKDDDDKG). The Q3-FLAG-EGFR construct was expressed on the surface 
of HEK cells and labeled under the same conditions used in (a).  
 
One concern of any labeling scheme is the potential interference with the function 
or localization of the target protein. To ensure that the gpTGase labeling did not alter the 
protein’s behavior, cells expressing the Q-tag-EGFR constructs after biotinylation were 
tested for their response to EGF stimulation. Cells were fixed and stained with anti-
phosphotyrosine antibody to reflect EGF-driven protein phosphorylation (Fig. 4.8). Cells 
co-transfected with both plasmids, Q-tag-EGFR and YFP, were identified as those 
expressing YFP over the entire cytoplasm. Compared with the unstimulated cells, the Q3-
EGFR expressing cells showed an elevated level of protein phosphorylation after labeling 
and EGF stimulation, as expected. Cells expressing Q3(Ala)-EGFR also showed a similar 
result, suggesting that the EGF response was not biased to a specific recombinant protein 
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construct. Incubation with or without transamidation prior to EGF addition did not result 
in any appreciable difference, and both conditions showed enhanced levels of protein 
phosphorylation in response to EGF. In addition, the anti-phosphotyrosine antibody 
stained primarily the surface of the EGF-treated cells, possibly due to its recognition of 
the autophosphorylated EGFR located on the membrane. Collectively, these results 
suggest that the transamidation for labeling Q-tag-EGFR did not cause any evident 
disruption in the localization and function of EGFR. 
 
 
Figure 4.8. Examination of EGF-stimulated protein phosphorylation. CHO-K1 cells were 
transfected with His6-Q3-EGFR or His6-Q3A-EGFR, using YFP as a co-transfection marker (left 
column). Cells were then incubated with the reaction conditions for protein labeling, followed by 
EGF stimulation for 10 min. After cell fixation with 4 % paraformaldehyde, the EGF-dependent 
protein phosphorylation was examined by staining with an anti-phosphotyrosine antibody (α-pY; 
right column). The control experiment without incubating the labeling reaction also showed a 
similar EGF response.      
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In vitro photo-crosslinking of Q-tag-p50 
To test the diversity of probe structure that gpTGase can accept, a series of 
benzophenone (BP)-based photo-crosslinkers, each bearing an aliphatic primary amine, 
was synthesized. To examine whether these BP probes were good substrates for 
gpTGase, a competition assay was carried out. It tested the reduction of the fluorescein 
cadaverine incorporation to Q1-CFP in vitro due to the presence of competitors. While 
the presence of BP-spermine (1) and 2 reduced the fluorescein cadaverine incorporation 
to Q1-CFP, 3 and 4 did not show any evidence of inhibition. Furthermore, immunoblot 
analysis using streptavidin-HRP confirmed that gpTGase did not incorporate 3 or 4 to 
Q1-CFP. Only BP-spermine was used in the following experiment (Fig. 4.9a).  
 
 
Figure 4.9. a) Structures of the benzophenone-based photo-crosslinkers bearing a spermine (1 
and 4) or a cadaverine (2 and 3) moiety. A biotin group was attached in 3 and 4 for affinity 
detection. b) Synthesis of benzophenone spermine. 
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BP has been previously used for probing protein-protein and protein-DNA 
interaction. The fact that gpTGase accepts BP-spermine as a substrate encourages the 
further attempt to test the BP’s crosslinking property. A protein that associates with its 
partner with the underlying interaction known and tunable should be a good candidate for 
the initial demonstration of crosslinking. Therefore, site-specifically labeling proteins 
with BP-spermine was used to investigate the homodimerization of NF-κB transcription 
factor p50. The homodimer of p50 binds to DNA as a transcriptional repressor, and p50 
plays an important role in the regulation of genes involved in immune response, 
inflammation, cell proliferation, differentiation, apoptosis, and oncogenesis181. 
Electrophoretic mobility shift assay (EMSA)182 is one commonly used method for 
determining the extent of p50 homodimerization and probing p50-DNA interaction, both 
in vitro and in cell lysate. This assay is, however, tedious and inaccurate. Dissociation of 
DNA probes from the DNA-p50 complex during electrophoresis can contribute to the 
inaccuracy of the measurement, and the input DNA per se can alter the quantity of p50 
homodimer. From a technical viewpoint, data analysis and interpretation can be difficult 
in the case when the gel-shift is marginal and the presence of a severe smearing 
background. Therefore, the photo-crosslinking approach should be an appealing 
alternative that can investigate the p50 homodimer formation directly without auxiliary 
DNA probes. 
  The Q2-tag was genetically appended to the C-terminus of the p50 protein. 
According to the crystal structure (Fig. 4.10a), the C-terminal attachment of Q-tag, but 
not the N-terminal attachment, is likely to present the photo-crosslinker to the other p50 
monomer across the dimerization interface after probe conjugation184. Therefore, the Q2 
sequence was placed immediately following the last residue (Glu350), which is part of 
the unstructured region at the flanking end as shown in the structure. To introduce the 
photo-crosslinker, p50 was incubated with benzophenone spermine, gpTGase, and Ca2+ 
for 1.5 hr at 37 °C. Excess probes were removed by nickel affinity purification. After 
irradiation with UV light, the probe-labeled p50-Q2 monomer and covalently cross-
linked homodimer were separated on SDS-PAGE and detected with anti-p50 antibody 
(Fig. 4.10b).  
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Figure 4.10. Photo-crosslinking of the BP-spermine labeled p50-Q2. a) The structure of p50 
homodimer binding to DNA (PDB code: 1NFK). The N- and C-terminus of each p50 monomer 
(residue no. 39-350), respectively, is labeled in white. The p50-Q2 protein (p50 residue no. 41-
350) used in the experiments has the Q2-tag fused at the C-terminus (not shown in the figure). b) 
The p50-Q2 protein was labeled with benzophenone spermine using gpTGase and CaCl2 for 1.5 
hr at 37 °C. After Ni-NTA affinity column to remove excess unconjugated benzophenone, the 
purified probe-labeled protein was irradiated with UV light for 7 min at 4 °C, in the presence or 
absence of DNA (0.18 µM) or myotrophin (360 µM; 90 equivalents over p50183). The products 
were separated on 10 % SDS-PAGE and blotted with anti-p50 antibody. An enhanced (p50)2 to 
p50 ratio (p50 dimer MW 78.5 kD) was observed in lanes 8-10, but not in others where the 
alanine mutant was used or when gpTGase was omitted. There was background detected at the 
(p50)2 position prior to UV crosslinking (lanes 1-4).   
 
   
  One critical factor for optimizing the photo-crosslinking efficiency is the UV 
exposure time, which is usually empirically determined according to the different nature 
of the photo-crosslinking probes. A longer exposure time may lead to the enhanced 
photo-crosslinking yield, but it may also increase the possibility of probe damage and 
generate the non-specific higher-order byproducts. For instance, the system of tris-
bipyridylruthenium (II) dication and ammonium persulfate for protein cross-linking 
required <1 sec exposure using a 150 W xenon lamp, but it lacked the labeling specificity 
of the probes and thus formed protein aggregates in addition to the expected 
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homodimer185. Photo-crosslinking proteins with the benzophenone-based unnatural 
amino acid required longer UV irradiation (5 min, 4 °C, 15 W UV lamp186). Another 
example with aryl azide also used 5 min UV exposure time, but this photoaffinity reagent 
was irreversibly self-activated upon illumination even without any reaction with 
proteins187. Photo-crosslinking of p50-Q2 with benzophenone spermine used 7 min 
exposure time, similar to the typical duration for the benzophenone-based probes. The 
shorter exposure generated a lesser extent of the expected photo-crosslinked product, 
whereas lengthening the irradiation time to 10 min did not result in the further increase of 
the protein dimer formation. There was visual variation in the lane-to-lane intensity of the 
total amount of the samples (Fig. 4.10b). For instance, the signal in lane 10 looked 
seemingly more intense than that in lane 11, even though the protein loading in both 
cases was identical. For analyzing the p50 homodimer formation under various 
conditions, the individual dimer/monomer ratio from each lane was calculated and plotted 
in Figure 4.10b. The photo-crosslinked p50 homodimer was readily observed after UV 
irradiation (lane 8), and the level of which was higher than the background detected in the 
samples without photoreaction (lane 1-4). In contrast, the negative control using the p50-
Q2(Ala) did not produce any photo-crosslinked product. The ratio of the p50 homodimer 
to p50 monomer was more pronounced in the presence of DNA (lane 9), consistent with 
previous reports that binding to DNA facilitated the p50 homodimezation188. One 
interesting observation was the effect associated with myotrophin, which was structurally 
similar to IκBα and previously shown to form the ternary complex with p50 homodimer 
and DNA189. However, adding myotrophin alone in the present study, without DNA, was 
sufficient to substantially increase the extent of p50-Q2 homodimer formation (lane 10). 
This illustrates one advantage of the photo-crosslinking assay over EMSA. Even without 
the presence of DNA, one can test the levels of the p50 homodimerization in response to 
various additives by the gpTGase labeling strategy. Future efforts will be required to 
perform quantitative analysis and obtain the Kd value of the p50 homodimerization.  
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In vitro photo-crosslinking of Q-tag-CFP 
Q1-CFP was chosen to illustrate the generality of the photo-crosslinking method. 
CFP is the color-shifted mutant of GFP, which is known to weakly homodimerize with 
the configuration as shown in Figure 4.12. Similar to labeling p50-Q2, Q1-CFP was 
incubated with benzophenone spermine, gpTGase, and Ca2+ for 16 hr at 37 °C. The 
purified probe-labeled Q1-CFP was then exposed to UV irradiation to initiate the photo-
crosslinking of CFP. Compared with the dissociation constant for the CFP self-
dimerization (100 µM190), 4.3 µM labeled protein corresponding to ~3.5 % Q1-CFP 
dimer existing in the solution was sufficient to generate the covalently photo-crosslinked 
homodimer (Fig. 4.11). Negative controls using Q1(Ala)-CFP, omitting gpTGase, or 
forgoing UV exposure showed no dimer formation, suggesting that the photo-
crosslinking of Q1-CFP was indeed due to site-specific probe conjugation.   
 
Figure 4.11. Labeling Q1-CFP with benzophenone and photoinduced cross-linking. Q1-CFP 
protein was labeled with benzophenone spermine using gpTGase and CaCl2 for 16 hr at 37 °C. 
After Ni-NTA purification to remove excess benzophenone, the protein was irradiated with UV 
light for 2 min at 4 °C. The photoreacted products were separated on 10 % SDS-PAGE and 
blotted with anti-His6 antibody. Formation of CFP homodimer (MW 64.6 kD) is seen in the 
fourth lane, but not in others where the alanine mutant was used, gpTGase was omitted, or the 
samples were not UV-irradiated. 
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Figure 4.12. Cartoon representation of the wild-type GFP dimer (PDB code: 1W7S). Two GFP 
monomers dimerize in a head-to-tail configuration. The N-terminus of the monomer is the 
attachment site of the Q1-tag in CFP, which is structurally similar to GFP.   
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Discussion 
Numerous protein labeling approaches have recently emerged, and each tackles 
the issue of specificity from a different angle. Methods that use a protein tag, including 
FKBP191 and DHFR to recruit their ligand-derivative probes are highly specific, but 
suffer from the rather bulky size of the fusion epitope (Table 1.1). Peptide tags, such as 
tetracysteine biarsenicals and His6, rely on chemoselectivity or special metal coordination 
and are generally less specific. Another concern is their potential toxicity to cells. In 
addition, covalent conjugation is better than non-covalent binding of probes, for 
preventing signal deterioration over time. In order to combine these advantages– a small 
tag, high labeling specificity, and covalent attachment of probes– enzymes have been 
used to mediate the probe-tag interaction.   
A successful example is the use of biotin ligase61,192. This method harnesses the 
orthogonal pair of the bacterial enzyme and its unique substrate peptide for labeling 
proteins site-specifically on the cell surface and in cell lysate. However, in its present 
form, biotin ligase only accepts analogs whose structures highly resemble biotin. Efforts 
in enzyme evolution are anticipated to expand the variety of acceptable probes while 
maintaining enzyme-probe specificity. 
The TGase labeling method presented here excels in the versatility of probe 
structure. Small-molecule fluorophores, biotin, and photo-crosslinkers bearing a primary 
amine derived from cadaverine or spermine, as shown here, were accepted by gpTGase. 
In fact, earlier literature comparing a series of amine substrates found that the optimal 
linker length for substrates65 was five methylene groups between the hydrophobic 
substituent and the nucleophilic nitrogen. In the absence of enzyme structure 
demonstrating how gpTGase binds the substrate, this result suggests the existence of a 
narrow crevice in the primary substrate-binding site of gpTGase. Therefore, such a 
crevice can accommodate the linear amines better than bulky and branched substrates65. 
Consistent with this observation, biotin cadaverine was shown to be more efficiently 
incorporated than a branched probe, where biotin was attached to the secondary nitrogen 
of spermine193. Therefore, the fact that probes 3 and 4 (Fig. 4.9) were not incorporated by 
gpTGase is possibly due to this same aspect in the substrate preference of the enzyme.    
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The major competition with the TGase-mediated protein labeling is the 
crosslinking of the substrate protein itself. The glutamine residue first reacts with the 
TGase and forms the covalent acyl-enzyme thioester intermediate, followed by a 
subsequent nucleophilic attack from the lysine residues of the protein or from the amine 
probe. As a result of crosslinking, formation of insoluble aggregates was observed in the 
substrate proteins containing multiple glutamine residues adjacent to each other194. 
Crosslinking could also result in a highly networked yet soluble protein polymer195, 
depending on the nature of the substrate protein. As previously shown, one signature 
indicating the formation of these intermolecularly crosslinked products was the 
emergence of the high-molecular-weight species when the reaction mixture was analyzed 
on a gel195. When gpTGase was incubated with His6-Xpress-CFP196, which had a linker 
sequence similar to the Q-tag-CFP constructs at the N-terminus upstream the Q-tag (see 
the sequence of pRSETB in Fig. A1 in the Appendix), the intramolecularly crosslinked 
product (connecting the Gln and Lys residues of the same molecule) also displayed a 
mobility shift on the protein gel. Experiments described in this chapter for labeling Q-tag-
CFP in vitro did not produce either of these crosslinked byproducts, and the only band 
that appeared on the gel corresponded to the dye-modified protein monomer. The reason 
for favoring probe ligation over protein crosslinking was, in part, attributed to the 
reaction conditions. The high concentration of biotin cadaverine used for labeling 
proteins (0.4 mM) was 40-fold higher than the reported Km (0.01 mM)193. Consistent with 
previous reports, an increase of putrecine (Km = ~0.17 mM)197 concentration from 5 mM 
to 0.01~0.02 M was shown to efficiently block formation of the protein oligomer caused 
by TGase-mediated crosslinking198. However, labeling p50-Q2 with benzophenone 
spermine did show a background level of crosslinked homodimer formation, suggesting 
that the nature of the amine substrate plays an important role in the competition between 
protein crosslinking and probe conjugation.    
Compared to the excellent labeling specificity of biotin ligase, TGase’s 
promiscuity in probe structure is accompanied by the relatively reduced specificity.  
Because all three alanine mutants of the Q-tag-CFP proteins were also weakly labeled by 
gpTGase, it suggested that the unidentified Gln residues on the CFP surface were also the 
reaction centers for labeling. Nonetheless, the presence of the Q-tag resulted in a 3.3-16.7 
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fold elevated labeling signal of the Q-tag-CFP proteins (Fig. 4.2b), with an ~80 % 
labeling extent (Fig. 4.3a). Similarly, on the cell surface, Q2-CFP-TM gave a 2.4-5.7 fold 
better signal-to-background labeling result than that from the corresponding alanine 
mutant. Apparently, the existence of the Q-tag indeed dictates the specificity of the amine 
probe incorporation. Unlike the broad tolerance of amine substrates, gpTGase recognizes 
a narrower range of the glutamine-containing substrates. Early identification of a “Q-
tag”-like sequence was from the truncation study of the extracellualr matrix protein BM-
40, done by mapping the minimal peptide containing the reactive glutamine residues. 
However, appending this sequence, APQQEAL, to an unrelated protein did not yield a 
high extent of probe incorporation68. The transferable Q-tag epitopes in the present study 
can be attached to the N- terminus, the C- terminus, as well as the interior of the target 
protein. As seen in Figure 4.7, attachment of the Q-tag that was either exposed to the 
outmost N-terminus or flanked by a His6 sequence to EGFR enabled site-specific labeling 
in both cases. Analogously, the Q2 sequence was also reported to be compatible with 
tagging to either the N- or C- terminus of glutathione S- transferase, without interfering 
with enzyme activity after probe labeling173. Not demonstrated here but based on these 
observations, the Q-tag can also be fused to the flexible loops of the target protein as long 
as it is still accessible to TGase.   
Except the Q1 tag, which has a definitive reaction center, both Q2 and Q3 contain 
multiple glutamines, and so can possibly accept more than one probe per epitope. As 
previously shown, Gln4 in the Q2 sequence (PKPQQFM, underlined) is the exclusive site 
for the reaction with fluorescein cadaverine173 or monodansyl cadaverine69. Modification 
of Gln5 also occurred, in a minor fraction, when the amine derived from 
poly(oxyethylene) was used as the substrate. The intrinsic property of the amine probe 
contributes to the control of the gpTGase labeling specificity, but the exact effect of how 
the probe structure affects the modification pattern of the Q2- and Q3- tags remains to be 
characterized.      
TGase-mediated labeling allows the direct incorporation of the fluorophores to 
cell surface proteins. In light of the dynamic nature of cell membranes and endocytosis, 
hydrophobic fluorescent probes can be non-specifically absorbed on the surface or 
imported into subcellular compartments, giving rise to high background (Fig. 4.4c). This 
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observation led to the later optimization of cell-surface protein labeling: reducing the 
endocytotic activity by simply lowering the temperature199. As examined by cell 
morphology and growth kinetics after recovery from the cold treatment, 25-30 min 
exposure to the reduced temperature at 4 °C did not introduce any phenotypic difference 
compared to cells labeled at 37 °C. To address how the endocytosis plays a role in 
influencing the conditions for cell surface labeling, one can use the selective actin 
inhibitor, latrunculin A for instance, to block the endocytic pathway. The detailed 
characterization remains to be carried out in the future. 
Two main formidable challenges prevent the extension of the TGase-based 
method for intracellular protein labeling: 1) Many endogenous TGase substrates exist 
insides cells, and 2) the low concentration of Ca2+ (~10-7 M)193 under physiological 
conditions is insufficient for TGase activation. Also, despite TGase’s long known history, 
no single crystal structure of TGase present in its active form has been reported. The 
structural interpretation of how Ca2+ precisely activates the enzyme activity remains 
unclear at this moment. Nonetheless, there are Ca2+-bound structures of the human type II 
TGase and fXIII (factor XIII), another TGase. These structures in their inactive forms 
provide insight into the possible roles of Ca2+. Ca2+ Binding triggers a conformational 
change, which releases the barrel from blocking the active site where the catalytic triad 
(Cys, His, and Asp) are located200.  Another possibility is that one Ca2+-binding helix 
allosterically interacts with the other across the enzyme dimerization interface201. As 
previously shown, activation of the circulating fXIII zymogen in the blood requires 
thrombin cleavage and 1.5 mM Ca2+ 201. Such a high concentration of Ca2+ can be reached 
by releasing ions from the ER or mitochondria when the cell status is largely deviated 
from the physiological state202, leading to protein crosslinking during cell apoptosis or 
blood clotting. The requirement of 1 mM Ca2+ for gpTGase activity was also reported203. 
Although the high calcium concentration (up to 10 mM) used for labeling proteins on the 
surface of HeLa cells did not evidently alter cell physiology (Fig. 4.6), applications of the 
TGase method may exclude cells that utilize Ca2+ as an important extracellular messenger 
(for instance, neurons). To exercise the TGase-based labeling method in cell lines 
different than HeLa, the potential interference or cytotoxicity due to the high 
concentration of Ca2+ must be carefully examined.  
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The TGase-mediated site-specific incorporation of the photoaffinity probes is 
useful for investigating the protein-protein interactions. As demonstrated here, the NF-κB 
p50 protein was tagged with the Q2 sequence and labeled with benzophenone spermine. 
Upon photoactivation, formation of p50 homodimer was readily detectable by 
immunoblot analysis. Adding either DNA or myotrophin was shown to efficiently 
promote p50 homodimerization. This assay largely contrasts the existing popular EMSA 
method, which relies on detection of the radiolabeled DNA probe that is either free or 
bound to proteins, for an indirect estimation of the extent of p50 association. In addition, 
previous characterization of p50 self-association by methods other than EMSA produced 
ambiguous results. For instance, Sengchanthalangsy et al. reported two different 
approaches for measuring the Kd of p50 homodimerization and obtained two different 
values: 16.01 µM (from analytical ultracentrifugation (AUC)) and <0.66 µM (from 
chemical crosslinking followed by densitometry analysis204). On the other hand, de 
Lumley et al. showed a drastically different Kd ~5.9 nM, based on measuring the 
fluorescence polarization of the probe-labeled p50 protein188. The large discrepancy 
between these results reported by two groups possibly stems from the different natures of 
the underlying assays. Both the crosslinked products and the samples for the polarization 
measurement included additional unexpected byproducts that could interfere with data 
analysis. For instance, the chemical crosslinking method generated oligomers whose 
presence complicated the analysis assuming a pure p50 monomer-dimer transition. 
Alternatively, the fluorescence anisotropy measurement used fluorophore-conjugated p50 
but the extent and specificity of labeling were not clearly characterized. Therefore, one 
future direction is to use the photo-crosslinking assay to resolve this discrepancy. 
Although it is not fully demonstrated in present experiments, the TGase-mediated site-
specific incorporation of photoaffinity probes should be able to generate the probe-
labeled p50 with known labeling efficiency. A series of the labeled p50-Q2 samples at 
different dilutions can be subjected to the same photo-crosslinking reaction, and the 
resultant ratios of the p50-Q2 homodimer to monomer at different input p50-Q2 
concentrations can constitute a titration curve whereby the Kd of p50 homodimerization 
can be calculated.   
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In general, different results of the binding affinity measurement can be obtained 
depending on the acquisition methods. In the context of testing the DNA-protein 
interaction, different results were reported from two approaches: EMSA, which is based 
on the reversible binding, and photo-crosslinking, which is based on the irreversible 
reactions. For instance, DPC107 protein binding to MT3 DNA was only detected by 
photo-crosslinking but not by EMSA205. EMSA measures the DNA-protein complex 
formed under the true equilibrium conditions, whereas the photo-crosslinking irreversibly 
“freezes” the complex during photoreaction. The amount of the photo-crosslinked 
product is assumed to be proportional to the total amount of the DNA-protein complex 
present prior to photo-activation. Due the short time scale of the photoreaction, the photo-
crosslinking approach is capable of sensing the weak and transient protein-protein or 
protein-DNA interaction that is difficult for EMSA to detect. However, due to the nature 
of the irreversible reaction and lack of targeting specificity, photo-crosslinking can also 
shift the equilibrium and form the high-order crosslinked byproducts. 
Previous characterization of myotrophin focused on its interaction with p50 and 
the consequent influence in the DNA binding affinity, which was considered as a novel 
mechanism in regulating the gene transcription. The underlying EMSA method identified 
the formation of DNA-myotrophin-p50 homodimer ternary complex. Except the 
structural analysis of myotrophin, which possesses the ankyrin repeats similar to IκBα 
that is know to interact with p50, no further evidence has been provided for the direct 
association between p50 and myotrophin. Therefore, the result from photo-crosslinking 
of p50-Q2 with myotrophin suggests the existence of the direct yet unexplored protein-
protein interaction. However, a huge excess amount of myotrophin (360 µM) with respect 
to the benzophenone-labeled p50-Q2 (1 µM) was added in the current assay condition. 
Future work will require titration of different amounts of myotrophin against p50-Q2 to 
confirm their binding stoichiometry. For a comparison with EMSA, photo-crosslinking 
experiments will be repeated with conditions where duplex DNA, myotrophin, and p50-
Q2 are all present.  
However, the photoaffinity approach based on TGas-mediated labeling in its 
current form has yet to be improved for providing further quantitative information. One 
concern is the use of the benzophenone moiety for photo-crosslinking proteins. Currently, 
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the extent of photo-crosslinking is not only a function of the probe-target proximity but 
also of probe nature, attachment site, and photochemical reaction condition206. While the 
apparent yield 10-40 % of the photo-crosslinked p50-Q2 homodimer formation was 
observed (based on the relative density of protein bands in Fig. 4.10b) in response to 
incubation under various conditions, only less than 5 % of the Q1-CFP was photo-
crosslinked (Fig. 4.11). One possibility is that the difference in protein crosslinking can 
be interpreted as the readout for the varied affinity of the protein-protein interaction. 
However, tagging the photoaffinity probe to specific residues on the Q-tag, which is 
fused to the proteins at either the N- or C-terminus that is usually unstructured with 
conformational flexibility, may not directly target the protein-protein interaction interface 
to afford the maximal extent of the photo-crosslink formation. As another example, an 
attempt was made to site-specifically label the N-terminally Q-tag-fused EGFR with 
photoaffinity probes, followed by photo-crosslinking the EGFR dimer (or oligomer) that 
was formed as a response to the EGF stimulation. The failure was possibly due to a 
combination of factors that were difficult to deconvolute: low labeling efficiency, 
uncertain geometry of probe attachment, and the uncharacterized extent of crosslinking. 
The flexibility of the spermine linker and the Q-tag might also add another parameter, 
forming the intramolecularly photo-crosslinked byproduct. In contrast, an alternative 
powerful approach is to genetically incorporate the unnatural amino acid, p-benzoyl-L-
phenylalanine (pBpa) for example207, at various positions along the contact surface for 
the interacting protein. The extent of photo-crosslinking between pBpa-containing Grb2 
and EGFR depends on how close the pBpa is placed to the EGFR protein207, reflecting a 
nice spatial correlation. This approach will be more streamlined once more photoaffinity 
amino acid analogs have been identified for incorporation into mammalian proteins. To 
expand the current TGase-mediated photoaffinity probe ligation strategy, efforts can be 
made to search for more TGase substrates and to explore the tolerable sites for Q-tag 
insertion. For future improvement of the TGase-mediated labeling specificity, one might 
try other enzyme candidates such as fXIIIa, which was previously shown to exhibit 
higher sequence specificity than gpTGase73.  
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Experimental 
 
The sequences of all primers for construction of the histone phosphorylation reporters 
and site-directed mutagenesis are listed in Table 4.1.  
 
Experiments of DNA cloning, expression of reporter, protein purification, and 
immunoblot were based on the general protocols listed in the Appendix unless otherwise 
mentioned. The sequences of all constructs were confirmed using the Invitrogen 
sequencing service.   
 
Q-tag-CFP gene construction, expression, and protein purification  
 The following primers were used to amplify the CFP gene: Q1-CFP.F and Q-tag 
CFP. R. These introduced the Q1 tag (amino acid sequence PNPQLPF) in-frame onto the 
C-terminus of CFP. To introduce the Q2 tag (amino acid sequence PKPQQFM), the 
primers were used: Q2-CFP.F and Q-tag CFP.R. To introduce the Q3 tag (amino acid 
sequence GQQQLG), the following primers were used: Q3-CFP.F and Q-tag CFP.R. 
These PCR product was digested with BamHI and EcoRI enzymes and ligated into the 
similarly cut pRSETB vector, which contained a (His)6 epitope upstream the reporter 
gene for protein purification and was also used for constructing the K9 histone 
methylation reporter as described in Chapter 3. All plasmids were confirmed by DNA 
sequencing. For protein expression, the plasmids were introduced into the bacterial strain 
BL21(DE3) by heat-shock transformation. The cells were grown in Luria Broth 
supplemented with ampicillin (100 µg/mL) at 37 ºC until OD600 0.5. IPTG was then 
added to a final concentration of 0.4 mM to induce protein expression. The cells were 
grown for an additional 3 hr at 30 ºC and then harvested by centrifugation. Cells were 
lysed by sonication at 4 ºC (six 30-second pulses at half-maximal power with 1 minute in 
between each pulse) in lysis buffer (50 mM Tris pH 7.8, 300 mM NaCl, 4 mM PMSF, 
and ¼ EDTA-free protease inhibitor cocktail tablet per 10 mL of lysis buffer). The His6-
tagged protein was purified from the lysate using a Ni-NTA agarose column following 
the manufacturer’s instructions. Fractions containing the proteins were consolidated and 
transferred into TBS (140 mM NaCl, 3 mM KCl, 25 mM Tris pH 7.4) by two rounds of 
dialysis for storage in aliquots at -80 ºC. Typical yields were 0.5-1 mg of protein per 0.5 
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L culture. Alanine mutants were constructed by the same cloning procedure described 
above, using the following forward primers: for Q1(Ala)-CFP.F for Q1(Ala)-CFP, 
Q2(Ala)-CFP.F for Q2(Ala)-CFP, and Q3(Ala)-CFP.F for Q3(Ala)-CFP. The common 
reverse primer Q-tag CFP.R is used for cloning all three constructs.  
 
Construction of the Q-tag-CFP-TM genes  
 The CFP gene was PCR-amplified using the following primers: Q1-CFP-TM.F 
and Q-tag CFP.R for Q1-CFP-TM; Q2-CFP-TM.F and Q-tag CFP.R for Q2-CFP-TM; 
and Q3-CFP-TM.F and Q-tag CFP.R for Q3-CFP-TM. These PCR products were 
digested with XmaI and SacII and ligated into the pDisplay vector (Invitrogen). To 
construct the alanine mutant of Q1-CFP-TM, QuikChange reaction was performed using 
the primer Q1(Ala)-CFP-TM.F and its reverse complement. Q2(Ala)-CFP-TM was 
constructed via PCR of CFP with the primers Q2(Ala)-CFP-TM.F and Q-tag CFP.R, 
followed by digestion and ligation into pDisplay. Q3(Ala)-CFP-TM was constructed via 
PCR of CFP with the primers Q3(Ala)-CFP-TM.F and Q-tag CFP.R, followed by 
digestion and ligation into pDisplay. All these resultant plasmids were confirmed by 
DNA sequencing.  
 
Construction of the Q3-EGFR gene 
 PCR was performed with the AP-EGFR pcDNA3 plasmid61 as template with the 
primers T7 (5’-TAATACGACTCACTATAGGG) and a Q3-EGFR.R. The PCR product 
was digested with XhoI and NheI and ligated into similarly cut AP-EGFR pcDNA3. The 
alanine mutant was constructed by PCR amplification of the EGFR gene with the T7 
primer and Q3(Ala)-EGFR.R, followed by digestion and ligation into similarly cut AP-
EGFR pcDNA3. These plasmids were confirmed by DNA sequencing. 
 
Labeling of Q-tag-CFP in vitro 
 Reaction conditions were as follows: 6.3 µM Q-tag-CFP, 20 mM HEPES pH 8.2, 
10 mM MgCl2, 0.1 mM EGTA, 5 mM CaCl2, 0.5 mM fluorescein cadaverine (Molecular 
Probes), and 25 ng/µL guinea pig liver transglutaminase (gpTGase, Sigma) with the 10 
µL reaction volume. To quantify labeling specificity, we used ImageQuant software 
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(Amersham Biosciences) to determine the background-corrected fluorescence intensity 
for each band in the gel. The signal to background ratio was determined by dividing the 
intensity of the Q-tag CFP band by the intensity of its corresponding alanine mutant 
band. Analyses were performed on three independent labeling experiments. To estimate 
the extent of labeling, Q1-CFP was incubated with biotin cadaverine under conditions 
otherwise identical to those given above. In a separated reaction, CFP-AP was 
enzymatically biotinylated by biotin ligase61. Under the reaction conditions, the modified 
CFP-AP was assumed to be fully biotinylated and used as a reference standard. The 
modified Q-tag CFP samples were run on 12 % SDS-PAGE and then blotted with horse 
radish peroxidase (HRP)-conjugated streptavidin (1: 4000 dilution; Bio-Rad.) The 
detailed protocol is listed in the Appendix. A standard curve for CFP-AP was generated 
using ImageQuant software (Amersham Biosciences). Analyses were performed on three 
independent labeling experiments. 
 
Labeling of cell surface Q-tag-CFP-TM with Alexa 568 cadaverine  
 HeLa cells maintained in 10 % fetal bovine serum in DMEM at 37 ºC under 5 % 
CO2 were transfected with the Q-tag-CFP-TM plasmids using Lipofectamine 2000 
(Invitrogen). After 12-24 hr, the cells were cooled for 10 min in 4 ºC DPBS, then labeled 
for 25 min at 4 ºC with 0.4 mM Alexa 568 cadaverine (Molecular Probes), 12 mM CaCl2, 
1 mg/mL BSA, and 50 ng/µL gpTGase in DMEM with the 100 µL reaction volume. The 
cells were rinsed three times with 4 ºC DPBS, then imaged on a Zeiss Axiovert 200M 
inverted epifluorescence microscope with CFP (420DF20 excitation, 450DRLP dichroic, 
475DF40 emission), Alexa 568 (560DF20 excitation, 585DRLP dichroic, 605DF30 
emission), and DIC (775DF50 emission) filter sets. Images were acquired for 0.5-0.9 sec 
using OpenLab software. To quantify labeling specificity, regions of interest (ROIs) were 
selected on 42 cells expressing either Q2-CFP-TM or Q2(Ala)-CFP-TM, using OpenLab 
software (Improvision, Lexington, MA). ROIs were selected to overlap with cell 
membranes, and to exclude non-membrane space. For each ROI, both the Alexa 568 and 
CFP mean intensities were recorded and graphed against each other. Given a fixed CFP 
intensity, the signal to background ratio was calculated by dividing Alexa 568 intensity 
for a Q2-CFP-TM ROI by that for a Q2(Ala)-CFP-TM ROI. 
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Labeling of cell surface Q3-EGFR with biotin cadaverine 
HEK293 cells maintained in 10 % fetal bovine serum under 5 % CO2 were co-
transfected with Q3-EGFR and YFP-pcDNA3 plasmids in a 10:1 ratio using 
Lipofectamine 2000. Cells were labeled with 0.5 mM biotin cadaverine, 12 mM CaCl2, 
and 25 ng/µL gpTGase in DMEM at 37 ºC for 30 min. The biotin was then detected with 
Alexa 568-conjugated streptavidin (1:200 dilution, Molecular Probes) in DPBS for 22 
min at room temperature. Cells were imaged as described above. 
 
Immunofluorescence detection of Q-tag EGFR localization and EGF-stimulated protein 
tyrosine phosphorylation  
CHO-K1 that lack of endogenous EGFR expression208 were cotransfected with Q-
tag-EGFR and a YFP marker plasmid (in a 10:1 ratio), and the cells were incubated under 
5 % CO2 at 37 ºC and grown up to ~90 % confluence. The alanine mutant plasmid was 
introduced to cells with otherwise identical conditions. Cells were then treated with the 
following reaction conditions: 1 mM biotin cadaverine, 10 mM CaCl2, 0.017 mg/mL 
gpTGase in DMEM at room temperature for 30 min. Human recombinant EGF (83 
ng/mL, Sigma) was then added to the cells to trigger the signaling cascade for 10 min at 
37 ºC, and immediately followed by 4 % paraformaldehyde fixation for 12 min at room 
temperature. Permeablized cells were then treated with anti-phosphotyrosine antibody 
(2.5 µg/ml, BD Transduction Laboratories) for 30 min at room temperature and 
subsequently probed against Alexa 568-conjugated anti-mouse antibody (1:200 dilution) 
for 30 min at room temperature. A YFP image (495DF10 excitation, 515DRLP dichroic, 
530DF30 emission), Alexa image, and a DIC image from the microscope were taken and 
the results were shown in Figure 4.8.  
 
Calcium Green 1 assay testing intracellular Ca2+ oscillation  
HeLa were incubated with 5 µM Calcium Green 1-AM (Invitrogen) in DPBS for 
30 min at 37 ºC, followed by two washes with DPBS to introduce the Ca2+ sensor into 
cells. The probed-loaded cells were incubated with either the labeling reaction (10 mM 
CaCl2, 0.4 mM biotin cadaverine, 25 ng/µL gpTGase), or control conditions with 
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gpTGase absent or with both gpTGase and biotin cadaverine absent in DPBS for  20 min 
at room temperature. To trigger the intracellular Ca2+ oscillation, 0.9 mM ATP was added 
to the above solutions. The time-lapse fluorescence images (495DF10 excitation, 
515DRLP dichroic, 530DF30 emission) were captured by Cascade II 512B camera in a 
30 s interval. The post-acquisition data analysis was performed by using SlideBook 
(Intelligent Imaging Innovations, Denver, CO) software.  
 
Synthesis of benzophenone spermine 
To a stirred solution of spermine (1.26 g, 6 mmol, 9.8 equiv) in ethanol (5 mL), 
benzophenone N-hydroxysuccinimide (NHS) ester (prepared as reported,209 205 mg, 0.63 
mmol, 1 equiv) in CH2Cl2 (3 ml) was added. The reaction was allowed to proceed 
overnight at room temperature. The mixture was then concentrated in vacuo and purified 
by silica chromatography using 1:1 methanol-CH2Cl2, then 2:2:0.5 methanol-CH2Cl2-
NH4OH, then 2:2:1.5 methanol-CH2Cl2-NH4OH, to yield benzophenone spermine (13 
mg, 5 %). TLC: Rf = 0.22 (2:2:1.5 methanol-CH2Cl2-NH4OH). 
1H-NMR (400 MHz, 
D2O): δ 7.88 (s, 4H), 7.82 (d, 2H, J = 7.6), 7.74 (t, 1H, J = 6.8), 7.59 (t, 2H, J = 7.2), 3.43 
(t, 2H, J = 6.4), 3.00 (m, 10H), 1.95 (m, 4H), 1.69 (m, 4H). ESI-MS m/z: (pos) 411.2 
[M+H]+ (calculated: 411.3). The 1H NMR spectrum and the result of mass spectrometry 
are shown in the Appendix. 
 
Synthesis of benzophenone cadaverine 
 To a stirred solution of cadaverine (300 µL, 2.8 mmol, 21.5 equiv) in ethanol (5 
mL), benzophenone NHS ester (described above, 42 mg, 0.13 mmol, 1 equiv) in CH2Cl2 
(3 ml) was added. The reaction proceeded for 24 hr at room temperature. The reaction 
mixture was separated by TLC using 4:4:1 methanol-CH2Cl2-NH4OH, and the product 
was recovered from the plate to yield benzophenone cadaverine (3 mg, 8 %). TLC: Rf = 
0.57. ESI-MS m/z: (pos) 311.0 [M+H]+ (calculated: 311.2). The starting material 
cadaverine (calculated [M+H]+ = 103.1) that could interfere with the subsequent TGase 
reaction was not detected.     
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Figure 4.13. The precursor (5) for the synthesis of benzophenone biotin cadaverine and 
benzophenone biotin spermine 
 
 
Synthesis of benzophenone biotin cadaverine  
To a stirred solution of cadaverine (300 µL, 2.8 mmol, 23 equiv) in ethanol (5 
mL), compound 5 (Fig. 4.12, previously synthesized by Eric McNeil in Alice Ting’s 
laboratory, 60 mg, 0.12 mmol, 1 equiv) was added. The reaction was refluxed for 24 hr at 
80 ºC, followed by an additional 12 hr at 90 ºC. The mixture was then concentrated in 
vacuo, followed by addition of 2 mL CH2Cl2. The crude product was extracted with 2.5 
M H2SO4, followed by neutralization with NaOH. The final product (compound 3, Fig. 9) 
was extracted from the mixture using CH2Cl2, and dried. Yield: 10 mg, 15 %.  ESI-MS 
m/z: (pos) 580.4 [M+H]+ (calculated: 580.3) and 290.7 [M+2H]2+ (calculated: 291.2). The 
starting material cadaverine (calculated [M+H]+ = 103.1) that could interfere with the 
subsequent TGase reaction was not detected. 
 
Synthesis of benzophenone biotin spermine 
To a stirred solution of spermine (0.3 g, 1.5 mmol, 25 equiv) in ethanol (6 mL), 
compound 5 (Fig. 4.12, 30 mg, 0.06 mmol, 1 equiv) was added. The reaction was 
refluxed at 85 ºC for 21.5 hr. The reaction mixture was separated by HPLC using a C18 
column with a gradient elution (varying H2O:CH3CN from 90:10 to 60:40 over 25 min), 
monitoring the absorbance at 280 nm. The peak with a retention time of 19 min was 
collected and lyophilized to afford benzophenone biotin spermine (compound 4, 5 mg, 13 
%, Fig. 4.9). ESI-MS m/z: (pos) 680.2 [M+H]+ (calculated: 680.4), 340.6 [M+2H]2+ 
(calculated: 340.7), and 227.0 [M+3H]3+ (calculated: 227.5). The starting material 
spermine (calculated [M+H]+ = 216.2) that could interfere with the subsequent TGase 
reaction was not detected. 
O
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p50-Q2 gene construction, expression, and protein purification 
  The p50 gene (murine, a gift from Gourisankar Ghosh, UCSD) was PCR-
amplified (from amino acid 41 to 350) with the primers: 5´-CCCATATGGATTACAA 
AGACGATGATGACAAGGGCGCTAGCGGCCCATACCTTC (FLAG-p50.F) and 5´-
GGGGATCCCTACATGAATTGTTGTGGTTTTGGTTCAGGGTAGTAGAGAAAGG
G. The PCR product was digested with NdeI and BamHI and ligated into similarly cut 
pET-15b vector (Novagen). The alanine mutant (p50-Q2(Ala)) was constructed similarly, 
by using the primers FLAG-p50.F and 5´-GGGGATCCCTACATGAAGGCGGC 
TGGTTTTGGTTCAGGGTAGTAGAGAAAGGG. For protein expression, the plasmids 
were introduced into the bacterial strain BL21(DE3) by heat-shock transformation. The 
cells were grown in Luria Broth supplemented with ampicillin (100 µg/mL) at 37 ºC until 
OD600 0.3. IPTG was then added to a final concentration of 0.4 mM to induce protein 
expression. The cells were grown for an additional 15 h at room temperature and then 
harvested by centrifugation. Cells were lysed by sonication at 4 ºC (six 30-second pulses 
at half-maximal power with 1 minute in between each pulse) in lysis buffer (50 mM Tris 
pH 7.8, 300 mM NaCl, 4 mM PMSF, and ¼ EDTA-free protease inhibitor cocktail tablet 
per 10 mL of lysis buffer). The His6-tagged protein was purified from the lysate using a 
Ni-NTA agarose column following the manufacturer’s instructions. Fractions containing 
the recombinant proteins were consolidated and transferred into TBS by two rounds of 
dialysis (each round 6~8 hr) for storage in aliquots at -80 ºC. Typical yields were 5-10 
mg of protein per 0.5 L culture.  
 
Photo-crosslinking assay for p50-Q2 
  Proteins were labeled in vitro with benzophenone spermine as follows: 20 µM 
p50-Q2 or p50-Q2(Ala), 10 mM CaCl2, 1 mM benzophenone spermine, 100 ng/µL 
gpTGase, and 50 mM DTT in PBS pH 7.4 for 1.5 h at 37 ºC. The proteins were then re-
purified to remove excess benzophenone using Ni-NTA agarose, with a wash buffer 
consisting of 50 mM Tris pH 7.8, 300 mM NaCl, and 30 mM imidazole, and an elution 
buffer consisting of 50 mM Tris pH 7.8, 300 mM NaCl, and 100 mM imidazole. The 
proteins were re-concentrated with YM-10 centricon filters (Millipore). For cross-linking 
 142
reactions, 1 µM benzophenone-labeled protein was irradiated for 7 min at 4 ºC (800 W 
lamp from Hanovia). To promote p50-Q2 dimerization, 0.18 µM duplex DNA (pre-
formed by annealing κB#SeqB.F: 5´-GTAGGGGGCCTCCCCGGCTCGAGATCCTAT 
G and κB#SeqB.R: 5´-CATAGGATCTCGAGCCGGGGAGGCCCCCTAC)210 or 360 
µM myotrophin183 was added and incubated with the sample for 20 min at room 
temperature before UV exposure. The samples were separated on a 10 % SDS-PAGE and 
blotted with anti-p50 antibody (1:1000 dilution, Biomeda, Forster City, CA), followed by 
incubation with HRP-conjugated anti-rabbit antibody (1:1000 dilution, Bio-Rad). The 
HRP signal was generated by Supersignal West Pico (Pierce), and the 
chemiluminescence was detected by gel imager. 
 
Photo-crosslinking assay for Q1-CFP 
  Proteins were labeled in vitro with benzophenone spermine as follows: 14 µM 
Q1-CFP or Q1(Ala)-CFP, 10 mM CaCl2, 1.5 mM benzophenone spermine, 33 ng/µL 
gpTGase in MOPS/MES pH 8.0 for 16h at 37 ºC. After Ni-NTA purification (wash 
buffer: 50 mM Tris pH 7.8, 300 mM NaCl, and 30 mM imidazole, and elution buffer: 
consisting of 50 mM Tris pH 7.8, 300 mM NaCl, and 100 mM imidazole) removing the 
excess probe, 8 µM of the labeled protein was irradiated for 2 min at 4 ºC (800 W lamp 
from Hanovia). The photo-crosslinked products were separated on a 10 % SDS-PAGE 
and blotted with anti-histidine tagged protein antibody (1:333 dilution, CalBiochem, San 
Diego, CA), followed by incubation with HRP-conjugated anti-mouse antibody (1:1000 
dilution, Bio-Rad). The HRP signal was visualized by Supersignal West Pico. 
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Table 4.1. List of the primers for cloning the Q-tag constructs 
Primer name Primer sequence Restriction 
site 
included 
corresponding 
protein 
mutation site 
Application 
Q1-CFP.F 5´-CCGGATCCGCCCGGGCCAAACCCAC 
AACTACCATTCGAGTCCTCCGGCGGCAT
GG 
BamHI 
and    
XmaI 
 Q1 (PNPQLPF) 
sequence 
underlined 
Q-tag CFP.R 5´-GGGGAATTCTTACCGCGGCTTGTACA 
GCTCGTC 
EcoRI 
and 
SacII  
 Clone Q-tag-
CFP proteins 
Q2-CFP.F 5´-CCGGATCCGCCCGGGCCAAAACCACA 
ACAATTCATGGAGTCCTCCGGCGGCATG
G 
BamHI 
and    
XmaI 
 Q2  
(PKPQQFM) 
sequence 
underlined 
Q3-CFP.F 5´-CCGGATCCGCCCGGGGGCCAACAAC 
AACTAGGCGAGTCCTCCGGCGGCATGG 
BamHI 
and    
XmaI 
 Q3 (GQQQLG) 
sequence 
underlined 
Q1(Ala)-
CFP.F 
5´-CCGGATCCGCCCGGGCCAAACCCAG 
CCCTACCATTCGAGTCCTCC 
BamHI 
and    
XmaI 
Ala Ala mutation in 
Q1 underlined 
Q2(Ala)-
CFP.F 
5´-CCGGATCCGCCCGGGCCAAAACCAG 
CCGCCTTCATGGAGTCCTCC 
BamHI 
and    
XmaI 
(Ala)2 Ala mutations 
in Q2 
underlined 
Q3(Ala)-
CFP.F 
5´-CCGGATCCGCCCGGGGGCGCCGCCG 
CCCTAGGCGAGTCCTCCG 
BamHI 
and    
XmaI 
(Ala)3 Ala mutations 
in Q3 
underlined 
Q1-CFP-
TM.F 
5´-GGCCCGGGCCAAACCCACAACTACC 
ATTCGAGTCCTCCGGCGGCATGG 
XmaI  Q1-CFP-TM; 
Q1 sequence  
Q2-CFP-
TM.F 
5´-GGCCCGGGCCAAAACCACAACAATTC 
ATGGAGTCCTCCGGCGGCATGG 
XmaI  Q2-CFP-TM; 
Q2 sequence  
Q3-CFP-
TM.F 
5´-GGCCCGGGGGCCAACAACAACTAGG 
CGAGTCCTCCGGCGGCATGG 
XmaI  Q3-CFP-TM; 
Q3 sequence  
Q1(Ala)-
CFP-TM.F 
5´-CCAAACCCAGCCCTACCATTCGAG  Ala Ala mutation in 
Q1 underlined 
Reverse 
Complement 
5´-CTCGAATGGTAGGGCTGGGTTTGG  Ala Ala mutation in 
Q1 underlined 
Q2(Ala)-
CFP-TM.F 
5´-GGCCCGGGCCAAAACCAGCAGCATTC 
ATGGAGTCC 
XmaI (Ala)2 Ala mutations 
in Q2 
underlined 
Q3(Ala)-
CFP-TM.F 
5´-GATCTCCCGGGGGCGCAGCAGCACTA 
GGCGAGTCCTC 
XmaI (Ala)3 Ala mutations 
in Q3 
underlined 
Q1-EGFR.R 5’-GGGCTAGCGAATGGTAGTTGTGGGTT 
TGGCATATGATGATGATGATGATGAGCC
CGACTAGC 
NheI  Q1 and (His)6 
sequences 
underlined 
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Q2-EGFR.R 5’-GGGCTAGCCATGAATTGTTGTGGTTTT 
GGCATATGATGATGATGATGATGAGCCC
GACTAGC 
NheI  Q2 and (His)6 
sequences 
underlined 
Q3-EGFR.R 5´-GGGCTAGCGCCTAGTTGTTGTTGGCC 
CATATGATGATGATGATGATGAGCCCGA
CTAGC 
NheI  Q3 and (His)6 
sequences 
underlined 
Q1(Ala)-
EGFR.R 
5’-GGGCTAGCGAATGGTAGGGCTGGGTT 
TGGCATATG 
 Ala Ala mutation in 
Q1 underlined 
Reverse 
Complement 
5’-CATATGCCAAACCCAGCCCTACCATT 
CGCTAGCCC 
 Ala Ala mutation in 
Q1 underlined 
Q2(Ala)-
EGFR.R 
5’-GGGCTAGCCATGAAGGCGGCTGGTTT 
TGGCATATG 
NheI (Ala)2 Ala mutation in 
Q2 underlined 
Q3(Ala)-
EGFR.R 
5’-GGGCTAGCGCCTAGGGCGGCGGCGCC 
CATATG 
NheI (Ala)3 Ala mutation in 
Q3 underlined 
Q1-
EGFR(Ver2).
R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCGAATGGTAGTTGTG
GGTTTGGAGCCCGACTAGC 
NheI  FLAG tag 
(DYKDDDDK
G) and Q1 
sequences 
underlined 
Q2-
EGFR(Ver2).
R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCCATGAATTGTTGTG
GTTTTGGAGCCCGACTAGC 
NheI  FLAG tag and 
Q2 sequences 
underlined 
Q3-
EGFR(Ver2).
R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCGCCTAGTTGTTGTT
GGCCAGCCCGACTAGC 
NheI  FLAG tag and 
Q3 sequences 
underlined 
Q1-
EGFR(Ver2).
R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCGAATGGTAGTGCTG
GGTTTGGAGCCCGACTAGC 
NheI Ala Ala mutation in 
Q1 underlined 
Q2(Ala)-
EGFR 
(Ver2).R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCCATGAATGCTGCTG
GTTTTGGAGCCCGACTAGC 
NheI (Ala)2 Ala mutation in 
Q2 underlined 
Q3(Ala)-
EGFR 
(Ver2).R 
5’-CGGCTAGCGCCCTTGTCATCATCGTCT 
TTGTAATCGCCGCCGCCTAGTGCTGCTG
CGCCAGCCCGACTAGC 
NheI (Ala)3 Ala mutation in 
Q3 underlined 
FLAG-p50.F 5´-CCCATATGGATTACAAAGACGATGAT 
GACAAGGGCGCTAGCGGCCCATACCTTC 
NdeI     
and     
NheI 
 Clone p50-Q2 
p50-Q2.R 5´-GGGGATCCCTACATGAATTGTTGTGG 
TTTTGGTTCAGGGTAGTAGAGAAAGG 
BamHI  Q2 sequence 
underlined 
p50-Q2A.R 5’-GGGGATCCCTACATGAAGGCGGCTGG 
TTTTGGTTCAGGGTAGTAGAGAAAGGG 
BamHI (Ala)2 Ala mutation in 
Q2 underlined 
κB#SeqB.F 5´-GTAGGGGGCCTCCCCGGCTCGAGATC 
CTATG 
  Duplex DNA 
for p50 binding 
κB#SeqB.R 5´-CATAGGATCTCGAGCCGGGGAGGCCC 
CCTAC 
  Duplex DNA 
for p50 binding 
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Chapter 5 
 Future FRET Reporter Design and Site-Specific Protein Labeling Method 
 
In this chapter I describe the extended work in two main directions: developing FRET 
reporters for detecting histone acetylation and sensing dopamine, as well as developing a 
new method for site-specific protein labeling using kinases. 
 
A. Histone acetylation reporters 
 
Introduction 
Acetylation is the most studied post-translational modification of histones. There 
is strong evidence suggesting the relationship between transcriptional activation and 
histone acetylation4,211. For instance, elevated levels of histone acetylation appear in the 
euchromatin where genes are actively transcribed, whereas hypoacetylation takes place in 
the transcriptionally inactive heterochromatin12. Histone acetylation is associated with 
chromatin decondensation and permits the access to DNA by transcription factors212. 
Interestingly, the TAFII (TATA-box binding protein-associated factor) subunit of the 
transcription factor TFIID and the global transcriptional co-activators p300/CBP213,214 
(CREB-binding protein) are themselves HATs (histone acetyltransferases), which 
catalyze histone acetylation. They are recruited to the protein complex responsible for 
gene transcription. On the other hand, histone acetylation can be reversed by HDACs 
(histone deacetylases), which catalyze deacetylation of histone and regenerate the lysine 
residues. Inactivation of chromatin by HDACs-mediated histone deacetylation is linked 
to silencing of the cancer-related genes such as BRAC1215 and CDH1216. Current 
methods for detecting histone acetylation are similar to those for detection of the other 
modifications described in Chapter 2 and 3. To visualize the real-time interplay between 
histone acetylation and gene transcription in living cells, one approach is to develop 
FRET reporters for monitoring this particular histone modification.   
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Construction of FRET-based histone acetylation reporters  
Because bromodomains bind specifically to acetylated histone peptides with an 
affinity ranging from 1.4 to 900 µM Kd217,218,220 (Table 5.1), they are suitable candidates 
for designing FRET reporters for monitoring histone acetylation. A series of reporters 
each with a substrate peptide corresponding to the histone H4 tail (amino acids 1-30) 
fused to the C-terminus of a bromodomain was previously constructed in our lab. When 
these reporters were tested in vitro with HATs, unfortunately none of them exhibited a 
FRET change upon acetylation (Sean Liu and Alice Y. Ting, unpublished data). All of 
these reporters possessed a common 15-amino-acid linker for connecting the binding 
domain to the H4 peptide within the same molecule. The distance between the 
bromodomain terminus and the H4 peptide containing the acetylated lysine approximates 
40 Å. Thus, one concern was that the linker length was insufficient to properly span the 
end-to-end distance between the bromodomain and the H4 peptide, which is critical for 
bromodomain binding upon acetylation.  
 
Table 5.1. Affinity of bromodomains binding to acetylated histone H4 peptides 
 
  
 
My efforts toward redesigning a functional histone acetylation reporter focused on 
two areas: examining enzyme specificities of HATs for H4 peptide acetylation, which 
contributes to the subsequent bromodomain binding, and exploring different modular 
assemblies of the reporters. First, the tandem bromodomains (amino acids 1358-1638) or 
the second single bromodomain (amino acids 1497-1638) of the TAFII250 protein was 
Bromodomain Binding Peptide Kd (µM) PDB ID Reference 
Ac-K16 39 ± 7 
Ac-K8 and Ac-K16 5.6 ± 0.2 
Ac-K5 and Ac-K12 1.4 ± 0.3 
TAFII250 
Ac-K5, 8, 12, and 16 5.3 ± 0.2 
1EQF 217 
Ac-K8 GCN5 
Ac-K16 
900 1F68 218 
GCN5 Ac-K16 N.D. 1E6I 219 
PCAF Ac-K8 346± 54 1N72 220 
BRG1 Ac-K8 N.D. N.A. 221 
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selected as a recognition module. The choices of these residues were based on the amino 
acids shown in the crystal structure that constituted the entire bromodomains (PDB code: 
1EQF). These domains were fused to the N-terminus of H4 with a CFP and a YFP 
flanking the ends to afford reporters TAFII-H4 and TAF-B-H4, respectively. Compared to 
previous H4-based constructs, these reporters each possess a new linker derived from 
repeating the old linker sequence with a doubled length- 34 residues (Fig. 5.1). All 
histone acetylation reporters shared the same peptide sequence, the first 30 amino acids 
of the histone H4 tail. Multiple lysines in this sequence context, including K5, K8, K12, 
and K16, have been identified as primary target sites for many HATs222. Most 
importantly, different combinations of the acetylated residues would give rise to the 
varied extents of bromodomain binding.  
 
 
Figure 5.1. Domain constructs of the histone acetylation reporters. All reporters contain identical 
H4 peptide and the linker sequences. Possible lysines for acetylation in the H4 peptide are 
underlined.   
 
 
The purified TAFII-H4 and TAF-B-H4 reporters were tested in vitro in response 
to acetylation. Both the CFP and YFP fluorescence emission of reporters were monitored 
during reaction, and the YFP/CFP emission ratio was measured as a level of FRET. 
However, there was no FRET change of these reporters upon acetylation by CBP or MOF 
(males-absent on the first), two histone acetyltransferases (Fig. 5.2a and 5.2b). To 
determine whether the H4 peptide could be enzymatically modified in the reporter 
context, both TAFII-H4 and TAF-B-H4 reporters were analyzed by immunoblot after 
acetylation, using antibodies that are individually specific to one acetylated lysine residue 
of histone H4. Whereas the p300/CBP associated factor (PCAF) acetylated the reporters 
at K8 as suggested by the literature, other enzymes such as CBP and MOF exhibited 
Linker
YFPH4 Peptide
Linker
TAF double bromoCFP
Linker: GSTSGSGKPGSGEGSTGAGGAGSTSGSGKPSGEG
H4: SGRGKGGKGLGKGGAKRHRKVLRDNIQGIT
5 8 12 16
TAFII -H4
TAF-B -H4 YFPH4 Peptide
Linker
TAF 2nd bromoCFP
H4-TAF-B YFPH4 Peptide
Linker
TAF 2nd bromoCFP
TAF double bromo YFPH4 PeptideCFPH4-TAFII 
H4-PCAF YFPH4 Peptide
Linker
PCAF bromoCFP
H4-GCN5 YFPH4 Peptide
Linker
GCN5 bromoCFP
H4-BRG1 YFPH4 Peptide
Linker
BRG1 bromoCFP
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altered substrate specificity and modified the reporters at different residues other than the 
predicted lysines (Fig. 5.2c and 5.2d).  
In addition, the FRET measurements were repeated on reporters with their H4 and 
bromodomain swapped. This design was based on the previous observation that the 
domain swapped histone phosphorylation reporter (described in Chapter2) yielded a 
different FRET response upon phosphorylation due to the different reporter geometry. 
Domain swapped reporters H4-TAFII and H4-TAF-B were similarly modified by HATs 
as described above, but neither of them displayed a FRET change in response to 
enzymatic acetylation (result of the H4-TAFII reporter shown in Fig. 5.3a). 
Figure 5.2. a) Test of the TAFII-H4 reporter FRET in response to CBP acetylation. b) Test of the 
TAF-B-H4 reporter FRET in response to CBP acetylation. c) The TAFII-H4 reporter after 
acetylation by histone acetyltransferases, CBP and MOF, was analyzed by immunoblot, using 
antibodies specific for acetylated K5, K8, K12, and K16 of histone H4. d) The TAF-B-H4 
reporter after acetylation by CBP and MOF was similarly analyzed by immunoblot using the 
same set of antibodies.  
 
One explanation for the absence of a FRET change is the mismatch between the 
residues that were actually acetylated and those required for TAF bromodomain binding. 
The presence of two acetylated lysines at K5 and K12, or at K8 and K16, is essential for 
tandem TAFII250 double-bromodomain recognition with a ~µM Kd affinity. By contrast, 
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the singly acetylated K16 showed the significantly reduced binding affinity to the TAFII 
double-bromodomain (~20 fold weaker, Table 5.1). However, there was no evidence that 
these TAF bromodomain-based reporters were either singly acetylated at K16 or doubly 
modified at residues K5/K12 or K8/K16. Either modification pattern should contribute to 
the TAF brodmodomain bidning based on the previous characterization. Due to this 
reason, an alternative strategy for constructing a histone acetylation reporter would be to 
use a recognition domain specific to singly acetylated K8 of histone H4. This residue is 
modified by nearly all HATs in my expeirments.   
 
Table 5.2.  Comparison of the substrate specificity of HATs reported from literature and from the 
observation in the context of FRET reporters.  
 
Figure 5.3. a) Test of the H4-TAFII reporter FRET in response to acetylation by CBP and MOF 
b) Test of the H4-PCAF reporter FRET in response to acetylation by CBP and MOF.  
 
Therefore, other reporters were constructed based on three bromodomains that 
were known to bind the histone H4 singly acetylated at K8. The same H4 sequence was 
fused to the N-terminus of the bromodomains from PCAF (p300/CBP-associated factor), 
GCN5, and BRG1 (brahma-related gene 1), respectively. Bromodomains from PCAF 
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(amino acids 718-832214) and GCN5 (amino acids 328-439227) were previously shown to 
bind the acetylated K8 in vitro (Table 5.1). In addition, the BRG1 bromodomain (amino 
acids 1447-1524) was also demonstrated to mediate the recruitment of the SWI/SNF 
chromatin remodeling complex to the acetylated K8 of histone H4221. The resultant H4-
PCAF, H4-GCN5, and H4-BRG1 reporters were tested in response to the enzymatic 
acetylation by CBP and/or MOF226 in vitro (result of H4-PCAF shown in Fig. 5.3b). 
Despite the fact that CBP was shown to modify K8 of the reporter (Fig. 5.2c and 5.2d), 
under no conditions did the reporter exhibit any FRET change. Suggestions to future 
reporter design include searching for other binding pairs of bromodomains and acetylated 
lysines (for instance PCAF binding domain and the H3 acetylated K14220), exploring 
different linker lengths and compositions, and to quantitatively analyze the extent of 
reporter acetylation by different HATs.   
 
 
B. FRET-based dopamine sensor 
 
Introduction 
 Neurotransmitters are a class of molecules important for signal transduction 
across the synaptic junctions between neurons. Dopamine is the predominant 
catecholamine present in the mammalian brain and is responsible for controlling emotion, 
cognition, positive reinforcement, hormone secretion, and modulation of cardiovascular 
function228. Current methods for sensing dopamine in vivo largely rely on a combination 
of several analytical tools, including microdialysis for selective sample collection, HPLC 
separation, and electrochemical detection229,230. One big advantage of these methods is 
the sensitivity of dopamine detection, higher than that of two major interferants in vivo- 
dihydroxyphenylacetic acid and ascorbate.  In addition, dopamine possesses a special 
voltammogram that is distinct from that of many other neurochemical substances231. 
However, the primary limitations of all voltammetric techniques are their chemical 
selectivity and the requirement of sophisticated instrumentation. For instance, 
norepinepherine, another important neurotransmitter, has an identical voltammetric 
signature. Electrical signals can also arise from changes in other factors, such as the pH 
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of the extracellular fluid, rather than fluctuations in dopamine concentration231-234.  
Therefore, developing a FRET reporter that permits the convenient, real-time detection of 
the extracellular dopamine would be of a great interest. 
  
Construction of a FRET-based dopamine reporter 
 To search for a protein scaffold that specifically recognizes dopamine, three major 
groups of candidates were initially considered: enzymes that utilize dopamine, dopamine 
transporters, and dopamine receptors. Enzymes, such as monoamine oxidase235, 
phenylalanine hydroxylase236, catechol-O-methyltransferase237,238 and dopamine-β-
hydroxylase239, use Fe2+ or Cu2+ cofactors for coordination of the catechol moiety of 
dopamine and thus also accept other catecholamines to different extents. In addition, 
dopamine transporters also recognizes norepinephrine240,241, another important 
neurotransmitter. Therefore, only dopamine receptors were used for the reporter design. 
 Among the large family of dopamine receptors, the D3 receptor (D3R) belonging 
to the D2-like subtype with the highest affinity for dopamine (Kd ~ 70 nM242) among all 
receptors, was chosen for dopamine sensing. Despite the lack of X-ray crystal structure, 
results from sequence alignment suggest that D3R is homologous to the seven 
transmembrane domain G protein-coupled receptors (GPCRs), with a long third 
intracellular loop and a relatively short C-terminus242. Previously constructed FRET 
reporters using the GPCRs α2A-adrenergic receptor and parathyroid hormone receptor as 
recognition domains had one fluorescent protein inserted in the third intracellular 
loop37,45. Moreover, swapping this intracellular loop of D3R with that of D2R, another 
dopamine receptor, retained D3R binding to dopamine243. Therefore, this particular loop 
was selected for an insertion of the fluorescent protein moiety. Because the recombinant 
D3R with its C-terminus tagged to CFP retained the membrane localization and binding 
affinity of wild type D3R244, the other fluorescent protein to complete the FRET pair was 
similarly appended to the C-terminus of D3R.  
 The schematic design of the FRET reporter for dopamine is shown in Figure 5.4. 
Instead of the conventional CFP and YFP used for the histone modification reporters, 
fluorescent proteins with better photophysical properties were used for the current 
application. These protein variants include the circularly-permuted Venus (cpV), a YFP 
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variant that gave rise to a significant increase in the reporter FRET signal when used in 
the context of a Ca2+ sensor32, and the monomeric Cerulan (Ceru)55, a brighter version of 
CFP. cpV was inserted into the third intracellular loop of D3R, and Ceru was tagged at 
the C-terminus of D3R. 
Figure 5.4. Examination of dopamine reporter expression in HEK cells. a) Fluorescence signals 
from the circularly permuted venus (cpV) and monomeric cerulean (Ceru), respectively, of the 
reporter were detected. Their punctate fluorescence mainly localized in the cell interior. This 
pattern differed from the anti-FLAG antibody staining, which detected the FLAG epitope at the 
N-terminus of D3R and produced a fluorescent distribution around the cell membrane. b) 
Construct 2 with the cpV inserted into the third intracellular loop of D3R exhibited a reporter 
localization on the cell surface as expected. c) Construct 3 with the Ceru tagged at the C-terminus 
of D3R exhibited the reporter localization in the perinuclear space. d) D3R-GFP244 construct with 
a longer linker sequence in the junction between D3R and CFP showed the protein localization on 
cell membrane.  
 
Problematic expression of dopamine reporters on the surface of living cells 
 The resultant construct was introduced in HEK cells via lipofection. Despite the 
successful expression of both cpV and Ceru based on the observed fluorescent signals, 
most of the reporters were retained inside cells (Fig. 5.4a), possibly in the ER or Golgi. 
cpV
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However, the antibody staining of the FLAG epitope at the N-terminus of the D3R still 
produced a fluorescent distribution around the cell edges, indicating a minor fraction of 
the reporters were present on the cell surface. This finding contradicts prior work 
showing that the D3R245 and D3R-CFP244 were primarily localized at cell surface. 
Expression of the reporters in other cells, including HeLa, COS, and CHO-K1, did not 
show any difference. To tackle this problem, other D3R constructs tagged with either 
cpV or Ceru, but not both, were expressed in cells for comparison. While construct 2 with 
only the cpV inserted in the D3R exhibited an expected surface expression pattern, 
construct 3 with its Ceru tagged to the C-terminus of D3R showed a problematic 
expression pattern (Fig. 5.4b and 5.4c). Unlike the result previously reported, tagging the 
C-terminus of D3R with a fluorescent protein in the current reporter context seemed to 
alter the expected protein distribution. A careful comparison of the current construct and 
the reported recombinant protein that exhibited nice surface expression showed a 
difference in the junction between Ceru and D3R (Fig. 5.4d). This observation suggested 
that the short linker present in the reporter construct interfered with the folding of D3R 
and, therefore, altered the reporter localization inside cells.   
 HEK cells expressing the reporter construct were monitored in response to 
dopamine addition. Although the majority of the expressed reporter did not localize on 
the membrane, the detectable levels of proteins present on the cell surface still 
encouraged tests of their ability to detect dopamine. Time-lapse imaging was performed 
to monitor the reporter FRET as described for the histone phosphorylation reporters in 
Chapter 2. Reporter fluorescence was detected every 20 sec, and 5-10 µM dopamine was 
added to the cells to trigger the reporter response. However, there was no apparent 
reporter FRET change before and after dopamine addition. A typical result is shown in 
Figure 5.5. In addition, the basal levels of the cpV/Ceru emission ratio fluctuated, 
possibly due to the selection of a narrow region on the cell membrane and monitoring 
only the minor subset of the reporters.  
 One bottleneck hampering the imaging is the low levels of dopamine reporter 
expression on cell surface. To enhance the surface localization of reporters, one solution 
is to adopt the linker identical to that of the mentioned D3R-GFP. An interesting 
observation is that the protein export from the ER represents the rate limiting step for cell 
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surface display of the human δ opioid receptor, another GPCR246. In light of this result, 
strategies that can facilitate the exit of protein from ER should be able to enhance the 
levels of surface localization of the dopamine reporters. Some signaling sequences have 
been identified, such as FXXFXXF247 (isolated from the C-terminus of D1R, X 
represents any amino acid) and FCYENE248  (isolated from the inward-rectifying K+ 
channel), and they are capable of promoting the protein export from ER. Current efforts 
testing the efficacy of these sequences in elevating the levels of reporter expression on 
the cell surface are in progress.  
 
 
Figure 5.5. Imaging of the dopamine reporter expressed in HEK cells in response to dopamine 
addition. The cpV/Ceru emission ratio was monitored as a measure of the reporter FRET, and the 
cpV emission intensity represented the reporter quantity. A region of interest on the cell surface 
containing the subpopulation of reporters was selected for FRET analysis (pointed by the red 
arrow and labeled in “0”). Dopamine (9.1 µM) was added to the cells at the time indicated by the 
grey bar. Data were collected every 20 sec. 
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C. Kinase-mediated site-specific protein labeling 
 
Introduction 
As described in Chapter 4, a general strategy for labeling proteins site-specifically 
is to use enzymes to mediate the probe-tag ligation. While TGase exhibits wide tolerance 
of probe structure, predicting the ligation efficiency of any given substrate is difficult. To 
systematically expand probe versatility, the labeling reaction can be performed in two 
steps: initial introduction of a common reactive handle, followed by subsequent covalent 
attachment of the diverse probes via a chemoselective reaction. This two-step labeling 
scheme has been explained in the biotin ligase labeling method, which site-specifically 
incorporates a ketone analog of biotin for the subsequent conjugation to hydrazide 
probes. Demonstrated below in this session is a similar two-step protocol for labeling 
proteins using kinases.  
Figure 5.6. Schematic representation of the two-step kinase-mediated protein labeling method. A 
kinase transfers the thiophosphate group from adenosine 5’-O-(thiotriphosphate) (ATPγS) to the 
substrate peptide fused to the protein of interest, and this chemical handle can react with the 
subsequently loaded probe (green circle) to form a covalent bond. To avoid the competition for 
the probe by endogenous cysteines, the reaction proceeds at a reduced pH where the thiols remain 
protonated and are less reactive.    
 
          
The scheme of the kinase-mediated protein labeling is shown in Figure 5.6. A 
consensus substrate peptide for the kinase is genetically fused to the protein of interest 
and expressed either in E. coli. or on the surface of mammalian cells. A kinase transfers 
the γ-thiophosphate from ATPγS to the reactive serine within the peptide, which also 
serves as a chemical handle that can be further conjugated to iodoacetyl or maleimide 
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probes. To avoid non-specific labeling from endogenous cysteine sidechains, the pH of 
the second reaction is maintained at 6-7 where the thiol groups remain protonated and are 
thus less reactive than the thiophosphate. This selective labeling method was previously 
demonstrated using casein kinase 1 (CK1) to thiophosphorylate a substrate peptide and 
conjugate the iodoacetyl probe at pH 3.5249. Demonstrating the specific labeling of 
proteins as close to physiological pH is important and necessary for compatibility with 
live cell labeling.   
 
Initial attempts using Msk-1 to site-specifically label the histone H3-tagged protein  
 The overall labeling specificity of the two-step procedure is determined by a 
combination of two factors: specificity of the enzymatic incorporation of the reactive 
handle and chemoselectivity of the subsequent loading of the probe. Therefore, the initial 
focus was to identify an orthogonal kinase-substrate peptide pair. Ideally, the kinase 
should thiophosphorylate as efficiently as it would phosphorylate the substrate peptide, 
and it also would not cross react with other endogenous proteins. The kinase Msk-1 
(described in Chapter 2) could be such a specific enzyme, since no other physiological 
substrates other than histone and CREB for kinase Msk-1 have been reported23. Because 
the histone H3 Ser10 is a known Msk-1 modification site, the pilot experiment thus 
utilized Msk-1 and histone H3 peptide as a pair for site-specific labeling.     
 Msk-1 was first examined for its ability to thiophosphorylate Ser10 of the histone 
H3 sequence. The peptide corresponding to the histone H3 tail (amino acids 1-15) was 
fused to the C-terminus of CFP, and a solvent-accessible cysteine was introduced on the 
protein surface by replacing Gln 204250. The purpose was to fairly test whether the 
enzymatically incorporated thiophosphate in the subsequent step could compete with the 
introduced cysteine in probe labeling. The resultant CFPQ204C-H3 construct was 
expressed in E. coli. and purified by Ni-NTA affinity column. The protein integrity was 
examined by the SDS-PAGE analysis. Subsequently, CFPQ204C-H3 was incubated with 
Msk-1 and ATPγS for in vitro thiophosphorylation. For comparison, CFPQ204C-H3 was 
incubated with ATP instead of ATPγS in a separate phosphorylation reaction. 
Immunoblot analysis using the anti-phospho-H3-Ser10 antibody showed that CFPQ204C-
H3 could be phosphorylated as well as thiophosphorylated (Fig. 5.7a). Compared to 
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phosphorylation, thiophosphorylation took place significantly slower and gave rise to a 
weaker signal even after 28 hr. This result reflected a lesser extent of modification on 
Ser10 and/or the intrinsic compromised antibody recognition of the thiophosphorylated 
serine. Although the levels of thiophosphorylation were not measured, a sufficient extent 
of the reaction was reasoned to enable site-specific alkylation in the subsequent step. 
Therefore, CFPQ204C-H3 after enzymatic reaction was incubated with either OGM 
(Oregon Green 488 maleimide) or IAB ((+)-Biotinyl-iodoacetamidyl-3,6-dioxaoctane-
diamine). An expected pattern of labeling CFPQ204C-H3 is as follows: only the 
thiophosphorylated residue (Ser10 at the H3 peptide region) is labeled at low pH, 
whereas the endogenous thiols (most likely, Cys204 on the CFP surface) and the 
thiophosphorylated residues are both modified at high pH. Results showed that reaction 
with OGM did not produce any expected pattern of labeling, and all samples were 
modified in a thiophosphorylation-independent manner. One possibility of the failure in 
site-specifically labeling CFPQ204C-H3 was due to the presence of residual ATPγS, which 
could consume the thiol-specific probes and make them unavailable to the 
thiophosphorylated protein. Therefore, the reaction mixture was filtered after enzymatic 
thiophosphorylation to remove excess ATPγS, using a commercial spin column. 
Comparing two CFPQ204C-H3 samples, with or without spin column purification, after 
they have been thiophosphorylated in the first step, the subsequent alkylaion did not 
produce any difference in the labeling pattern. This result, in turn, possibly reflects a low 
level of Msk-1 thiophosphorylation in the first step (Fig. 5.7c). On the other hand, 
labeling CFPQ204C-H3 with IAB produced a modification pattern roughly as expected. 
The thiophosphorylated CFPQ204C-H3 exhibited a higher extent of IAB labeling than 
negative controls, where the protein was phosphorylated or incubated without Msk-1 
(Fig. 5.7d). However, the probe-dependent labeling selectivity was marginal, also 
implying the low efficiency of Msk-1 thiophosphorylation. This result, therefore, 
prompted the further effort in identifying another kinase-peptide substrate pair for more 
robust labeling.   
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Figure 5.7. a) Comparison of CFPQ204C-H3 phosphorylation and thiophosphorylation at different 
times by immunoblot using anti-phospho-H3-Ser10 antibody. b) Structures of two probes utilized 
in the alkylation reaction: OGM (Oregon Green 488 maleimide) and IAB ((+)-Biotinyl-
iodoacetamidyl-3,6-dioxaoctanediamine). c) Labeling of thiophosphorylated (lanes 5 and 10) 
CFPQ204C-H3 with OGM at pH 6.0. After the first-step thiophosphorylation, the excess ATPγS 
was removed from the enzymatic reaction mixture using spin columns. Fractions with (lane 10) 
and without (lane 5) column purification, respectively, were labeled with OGM for comparison. 
As negative controls, CFPQ204C-H3 was either phosphorylated (lanes 4 and 9) or incubated with 
conditions where Msk-1 and/or the ATPγS were omitted before the subsequent alkylation (lanes 
1-3 and 6-8). One sample was labeled at pH 9.6 to show the accessibility of endogenous thiols 
(lane 11). Labeling result was visualized by monitoring the probe fluorescence using Storm 
system (excitation at 450 nm). d) Labeling of thiophosphorylated (lane 2) CFPQ204C-H3 with IAB 
at pH 6.5. Immunoblot staining with steptavidin-HRP detected the probe incorporation. Negative 
controls were also included: using ATP instead for phosphorylation (lane 1) or with Msk-1 
omitted in the first-step enzymatic reaction (lane 3), followed by IAB alkylation at pH 6.5. The 
extent of protein labeling was not measured in all cases. 
 
 
 
 
 
 
IAB
Thiophosphorylation
Phosphorylation
-
++
+ + +
+
- -
- - - -
-
anti-phospho-H3-Ser 10 antibody
1 hr 2 hr 28 hr
+
--
+
+
+
- -ATP
ATPγS
Msk-1
-
-
-
- +
- + +
-
+
+
+
- --
-
-
- +
-
-
+
-
-
-
No spin column purification
Reaction pH 6.0
spin column purified
Reaction pH 6.0
Reaction   
pH 9.6
-
-+
+ -+
- -
Excitation: 450 nm, Emission: 520 nm Long-Pass filter Streptavidin-HRP
ATP
Msk-1 + + - -
Reaction pH 6.5
Reaction 
pH 9.6
a)
c) d)
OGM
b)
1     2     3     4      5     6      7      8     9    10    11
1          2            3          4
ATPγS
 159
PKA-mediated site-specific protein labeling in vitro by tuning pH 
The cAMP-dependent protein kinase (PKA) is known to utilize ATPγS  and 
thiophosphorylate the rabbit muscle phosphorylase kinase251. A synthetic peptide, 
LRRASL (reactive serine underlined), named the Kemptide252 was also shown to be an 
efficient substrate for thiophosphorylation by PKA. By varying the pH of the reaction 
conditions, Kemptide was selectively labeled with a caged compound253  or a biotin 
moiety254.  These observations established the groundwork for using PKA and Kemptide 
for kinase-mediated protein labeling.   
The Kemptide sequence was fused to the C-terminus of CFP to afford the CFP-
Kemp construct. The resultant plasmid was expressed in E. coli., followed by protein 
purification using Ni-NTA affinity chromatography. For in vitro thiophosphorylation, the 
purified CFP-Kemp was incubated with ATPγS and PKA. The enzyme used in this 
experiment has only the catalytic domain and is constitutively active. For comparison, 
CFP-Kemp was also phosphorylated. Immunoblot analysis using anti-phospho-PKA 
substrate antibody showed that CFP-Kemp could be thiophosphorylated as well as 
phosphorylated, and omitting either ATPγS or PKA abolished the reaction, as expected 
(Fig. 5.8a).  
The overall labeling specificity was examined as a function of the reaction pH of 
the second step. In addition to OGM and IAB, two probes bearing a maleimide group 
were used: AXM (Alexa Fluor 568 C5-maleimide) and BTM (Nα-(3-maleimidyl-
propionyl) biocytin). Following thiophosphorylation CFP-Kemp was incubated with 
these probes individually at different pHs. The alanine mutant CFP-Kemp(Ala), with the 
reactive serine of the Kemptide replaced, was also reacted under otherwise identical 
conditions. Results showed that the thiophosphorylated CFP-Kemp was selectively 
labeled by OGM at pH 5.5~7.1 (Fig. 5.8c), whereas CFP-Kemp(Ala) incubated under the 
same thiophosphorylation conditions was not labeled. Phosphorylation of CFP-Kemp or 
omission of PKA omitted in the first step both suppressed labeling. CFP-Kemp(Ala) 
incubated under the thiophosphorylation condition was also not labeled, indicating the 
substrate specificity of PKA to Kemptide. The labeling specificity decreased reciprocally 
when the reaction pH increased. Background levels of labeling became increasingly 
noticeable in the alanine mutant and in the phosphorylated CFP-Kemp at pH 7.1, and a 
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complete loss of labeling specificity occurred at pH 8.2. As additional evidence for the 
labeling specificity disappearing at a high reaction pH, additional bands above CFP-
Kemp were also observed in the gel. To confirm that this labeling specificity was not due 
to the inaccessibility of the endogenous cysteines to probes, a separate alkylation was set 
up at pH 9.6, resulting in intense protein labeling.  
The labeling specificity was also demonstrated using AXM (Fig. 5.8d). 
Analogous to labeling protein with OGM as mentioned, only the thiophosphorylated 
CFP-Kemp was labeled at pH 5.5~7.1. Reaction at pH 8.2 showed no labeling specificity, 
and proteins incubated under different conditions for the first step were all intensively 
labeled. In addition to fluorophores, CFP-Kemp was also labeled with BTM for affinity 
detection (Fig. 5.8e). BTM appeared to be a more reactive probe because it modified not 
only thiophosphorylated CFP-Kemp but also PKA. A significant level of non-specific 
labeling was observed on CFP-Kemp(Ala) mutant and on phosphorylated CFP-Kemp 
even at pH 6.2, and raising reaction pH beyond 7.1 completely abolished the labeling 
specificity. Lastly, IAB was used to site-specifically label CFP-Kemp and resulted in a 
surprising modification pattern. In all reaction pH ranging from 5.5-8.2, only the 
thiophosphorylated CFP-Kemp was modified. Non-specific protein modification did not 
occur even at pH 9.6. This exceptional labeling specificity could be, in part, due to the 
intrinsic probe inaccessibility to the reactive cysteines on the target protein. Experiments 
repeated using CFPQ204C-Kemp, which introduced a surface accessible cysteine, showed 
the same labeling pattern across different pHs. Another possibility for the absence of IAB 
labeling at alkaline pH could be probe hydrolysis, which was not examined further.     
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Figure 5.8. a) Immunoblot analysis of CFP-Kemp phosphorylation and thiophosphorylation by 
PKA, using anti-phospho-PKA substrate antibody. The additional band above CFP-Kemp 
corresponded to PKA itself. b) Structures of AXM (Alexa Fluor 568 C5-maleimide) and BTM 
(Nα-(3-maleimidylpropionyl) biocytin). c) Selective labeling of CFP-Kemp using OGM. CFP-
Kemp were incubated with thiophosphorylation (labeled with “T”) or phosphorylation (labeled 
with “P”), and CFP-Kemp(Ala) was incubated with the thiophosphorylation condition (labeled 
with “M”). The negative control containing CFP-Kemp but no PKA was also included. In the 
second step of the reaction, these samples were incubated with the probe at the indicated pHs. An 
additional reaction of CFP-Kemp was incubated at pH 9.6 for non-specific labeling. Labeling was 
visualized by fluorescence detection using the Storm system. d) Selective labeling of CFP-Kemp 
using AXM. Results were observed by fluorescence detection. e) Selective labeling of CFP-Kemp 
using BTM. Results were analyzed by immunoblot using HRP-conjugated streptavidin, followed 
by detection of the chemiluminescence signal. f) Selective labeling of CFP-Kemp using IAB. 
Results were analyzed by immunoblot using HRP-conjugated streptavidin.  
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Challenges in site-specifically labeling proteins on the surface of living cells 
Having established labeling specificity in vitro, the next challenge was to 
demonstrate specific labeling of proteins on the surface of living cells. The model protein 
Kemp-CFP-TM was constructed analogously to the Q-tag-CFP-TM construct used for 
gpTGase labeling (described in Chapter 4), by fusing the Kemptide sequence to CFP that 
was also fused to the N-terminus of the transmembrane domain of PDGFR. The resultant 
Kemp-CFP-TM construct was introduced to HeLa cells via lipofection, and the 
corresponding proteins expressed well on the cell surface after ~12 hr. To initiate the first 
step of the two-stage protein labeling protocol, the reaction was carried out by incubating 
cells with exogenously added PKA and ATPγS for 3 hr at 37 °C at pH 7.4 (Fig. 5.9). 
Subsequently, OGM was added to label the thiophosphorylated cells. For comparison, 
cells were also directly alkylated by OGM without the first enzymatic reaction. 
Unfortunately, results showed that both labeling procedures exhibited a non-specific 
labeling pattern. The untransfected cells were also labeled along with the Kemp-CFP-TM 
expressing cells, whether or not the thiophosphorylation occurred prior to reaction with 
OGM. In fact, no fluorescence was detected when the OGM concentration was below 20 
µM during alkylation, whereas severe cytotoxicity and high background arising from 
probe accumulation inside cells were observed when the concentration exceeded 100 µM. 
The diffusive staining pattern throughout the entire cell was possibly due to penetration 
of OGM across the membrane. 
Because AXM enabled the most specific modification of CFP-Kemp in vitro at 
pH 6.2 (Fig. 5.8d), it was used instead of OGM for the labeling reaction. To prevent cell 
endocytosis that could cause the probe accumulation inside cells, alkylation was 
performed at 4 °C. Results showed that there was also no labeling specificity (Fig. 5.10). 
Both Kemp-CFP-TM expressing cells and untransfected cells were labeled along their 
edges in a thiophosphorylation-independent manner. Apparently, using AXM did not 
alleviate the problem of non-specific background staining. Therefore, an alternative 
attempt was to use affinity probes, which did not result in visible background, instead of 
fluorophores for alkylation.  
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Figure 5.9. Labeling of Kemp-CFP-TM on HeLa cell surface with OGM. HeLa cells expressing 
Kemp-CFP-TM were directly labeled with OGM for 20 min at room temperature (top row) or 
sequentially labeled, first by enzymatic thiophosphorylation (3 hr, 37 °C, pH 7.4) and then 
followed by reaction with 20 µM OGM at pH 6 (20 min, room temperature).  
 
Figure 5.10. Labeling of Kemp-CFP-TM on HeLa cell surface with AXM. HeLa cells expressing 
the Kemp-CFP-TM construct were incubated with ATPγS and PKA for 30 min at 37 °C, followed 
by alkylation with 50 µM AXM at pH 6.1 (20 min, 4 °C). Negative controls omitting PKA or 
ATPγS in the first step were incubated under the identical alkylation conditions. 
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Preliminary results using IAB for cell surface protein labeling seemed 
encouraging but required further examination and optimization. HeLa cells expressing 
Kemp-CFP-TM were first thiophosphorylated (details were included in the Experimental 
session) for 1 hr at 37 °C, followed by a reaction with 1 mM IAB (pH 6.0) for 25 min at 
room temperature. Labeling was visualized by immunofluorescent staining using Alexa 
568 conjugated-streptavidin. A heterogeneous extent of labeling with varied signal-to-
noise ratios among different cells was observed. While transfected cells exhibited a nice 
labeling pattern around the cell edges, untransfected cells were also modified in different 
degrees (compare the first and second row of Figure 5.11). Nonetheless, cells that were 
phosphorylated prior to IAB alkylation did not result in labeling, suggesting that the 
probe incorporation was indeed thiophosphorylation-dependent.   
Figure 5.11. Labeling of Kemp-CFP-TM on HeLa cell surface with IAB. HeLa cells expressing 
the Kemp-CFP-TM construct were incubated with ATPγS and PKA for 1 hr at 37 °C, followed 
by alkylation with 1 mM IAB at pH 6 (25 min, room temperature). Labeling was detected by 
staining with Alexa 568 conjugated- streptavidin for 15 min at room temperature. Two different 
regions were selected to monitor the labeling result (top two rows). As a negative control, cells 
were phosphorylated in the first step and incubated with the identical alkylation condition. 
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Immunofluorescent staining with anti-phospho-PKA substrate antibody was 
carried out to estimate the extent of the cell surface proteins modified by PKA. As shown 
in Figure 5.12, Kemp-CFP-TM expressing cells either phosphorylated or 
thiophosphorylated by PKA both gave rise to the expected staining. However, incubation 
with PKA, but not ATPγS, alone also produced a pattern selectively staining only the 
transfected cells. The underlying reason for this unexpected result remains unclear at 
present. Some possibilities are: 1) the antibody recognizes PKA itself, 2) the PKA was 
co-purified with ATP, and 3) the exogenously added PKA preferentially associates with 
the unidentified protein on the surface of transfected cells.   
 
Figure 5.12. Immunofluorescent staining for PKA-mediated thiophosphorylation and 
phosphorylation of Kemp-CFP-TM using anti-phospho-PKA substrate antibody. Transfected 
HeLa cells were phosphorylated, thiophosphorylated, or treated with conditions where either 
PKA or ATPγS was left out. After staining with the primary antibody, the signal was visualized 
by incubation with the Texas Red conjugated-anti-rabbit antibody.   
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There remain multiple challenges that currently prevent the kinase-mediated 
labeling method from being broadly applicable. Systematic troubleshooting the problems 
of labeling on living cells is particularly difficult, due to the intrinsic heterogeneity 
among individual cells. One concern is the availability of Kemp-CFP-TM to exogenously 
added PKA for thiophosphorlyation. Phosphorylation of Kemp-CFP-TM by endogenous 
kinases prior to the labeling experiment is unlikely. Although literature precedent 
suggested the presence of Ecto-kinase on the HeLa cell surface possessing the capability 
to modify Kemptide255, immunoblot analysis (Fig. 5.12, third row) using anti-phospho-
PKA substrate antibody did not show any evidence for such innate kinase activity. Other 
factors that can influence the labeling result are the intrinsic specificity between kinase 
and its substrate peptide, as well as different amounts of the substrate proteins presented 
on the cell surface in different cell lines.  
 
Figure 5.13. HeLa cells expressing Kemp-CFP-TM were labeled with different concentrations of 
ThioGlo1 for 15 min at 4 °C. The transfected cells in the CFP image were indicated by the 
asterisks, and the background in the untransfected cells was due to bleed-through from the 
ThioGlo1 fluorescence.  
 
Because application of fluorescent probes, including OGM and AXM, above a 
concentration greater than 50 µM exhibited a significant level of background labeling 
(Fig. 5.9 and 5.10), one strategy to achieve labeling specificity might be to reduce the 
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probe concentration while lengthening the reaction time. However, prolonging the 
reaction time of a reduced pH ~6 may not be compatible with the health of cells. In 
particular, cells incubated at pH 5 in DPBS for 1 hr were found to significantly change 
the morphology and perhaps undergo apoptosis.  
As alternative reagents to fluorophores, thiol-selective, membrane impermeable 
fluorogenic probes may be used to reduce the background labeling. In principle, 
unreacted fluorogenic probes non-specifically absorbed onto cell membrane would not 
give rise to background fluorescence. The membrane impermeability of probes is 
essential since reaction with the intracellular glutathione can largely contribute to the 
background, as observed in the experiment where 50-250 nM of the probe ThioGlo1 was 
used (Fig. 5.13). Only one fluorogenic probe, Thiolyte MQ (Fig. 5.13a), matching the 
above criteria is currently available from commercial sources. Application of this probe, 
which has an emission overlapped with the CFP fluorescence wavelength, required the 
monomeric red fluorescent protein (mRFP) instead of CFP as a model protein (Christian 
Schubert, unpublished data). Unfortunately, the problematic expression and aggregation 
of Kemp-mRFP-TM on the cell surface prevented the conclusive judgment on whether or 
not the Thiolyte MQ was suitable for site-specific protein labeling. Future synthetic 
efforts will be required to expand the availability of fluorogenic probes with wider 
spectroscopic properties.   
 
In vitro applictaion of the kinase-mediated labeling method in progress 
The kinase-based labeling method could be applied to study the dynamic protein 
conformational change. As a proof of principle, the E. coli. maltose binding protein 
(MBP) that undergoes a large conformational change upon ligand binding was chosen for 
demonstration of the labeling method. Previously, MBP was singly labeled with 
environment-sensitive probes via attachment to an engineered cysteine residue256. The 
resultant fluorescence intensity change of the dye-labeled MBP was accompanied by 
maltose binding, and this result was used to calculate the ligand binding affinity and to 
investigate the allostery in different regions of the protein. However, multiplexing the 
signal readout, by introducing more than one probe to MBP with controlled labeling 
specificity, is important yet challenging. Smith et al. reported an orthogonal, dual 
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modification of MBP by thiol protection mechanisms257. In this case, an MBP construct 
was created bearing a cysteine residue and a truncated zinc finger domain containing two 
proximal sulfhydryls that could undergo reversible disulfide formation to control the 
reactivity. A strict sequence must be followed to perform the double labeling:  protecting 
the zinc finger domain, adding the first probe to the free thiol, and liberating the two 
thiols in the protected zinc finger for addition of the second probe. Despite the 
observation of the doubly labeled MBP exhibiting FRET efficiency change upon binding 
maltose, the 2:1 stoichiometry of both probes could complicate the actual FRET analysis. 
This complexity perhaps also accounted for the unexpected decrease of FRET efficiency 
upon ligand binding, which was assumed to shorten the probe-to-probe distance and 
cause an increase in FRET.     
Figure 5.14. a) Structure of maltose binding protein with maltodextrin bound. Circled are the 
residues for individual cysteine replacement (PDB code: 1ANF). b) Schematic representation of 
coupling the conformational change of maltose binding protein (MBP) to FRET. MBP doubly 
labeled with a donor and an acceptor fluorophore undergoes a protein conformational change, 
which in turn causes the FRET efficiency to change between two fluorophores. c) Four constructs 
with a Kemptide attached to either the N- or C-terminus of MBP. A single cysteine is introduced 
to the indicated residue in each construct by site-directed mutagenesis.    
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Table 5.3.   MBP constructs with different pairs of probe attachment sites  
Construct Name Site No. 1 Site No. 2 
Distance 
(closed form) 
Distance     
(open form) 
∆ Distance 
MBP-KP-D95C Cys 95 Kemptide 30.8 Å 32.1 Å 1.3 Å 
MBP-KP-A141C Cys 141 Kemptide 42.0 Å 44.5 Å 2.5 Å 
KP-MBP-A141C Kemptide Cys 141 59.2 Å 67.3 Å 8.1 Å 
E4C-MBP-KP Cys 4 Kemptide 43.8 Å 50.4 Å 6.6 Å 
 FRET pair: Alexa 488/ Alexa 568, R0= 62 Å. 
 The distance refers to the estimated separation between the donor and acceptor fluorophore. 
 
Here, an alternative design of the FRET-based maltose sensor using the kinase-
mediated protein labeling method was devised. The MBP was introduced with a cysteine 
and tagged with a Kemptide for attachment of two fluorescent probes, respectively. 
Based on the existing crystal structures of MBP, a FRET increase of the doubly labeled 
MBP would be predicted as a result of maltose binding (Fig. 5.14a and 5.14b). Because 
the reactivity of the cysteine and the thiophosphorylated Kemptide was controlled by the 
reaction pH, in principle no imperative order of probe incorporation was required to 
achieve the double labeling. More importantly, the donor and acceptor fluorophore 
should approximate a 1:1 ratio that is convenient for FRET analysis.  
Four recombinant MBP constructs were created, each with the Kemptide and the 
engineered cysteine inserted at different locations (Fig. 5.14c and Table 5.3). To 
demonstrate that the Kemptide-fused MBP constructs enable the kinase-mediated 
selective labeling in a pH-dependent manner, they were tested by labeling with OGM. 
Results are shown in Figure 5.15. Kemptide tagging in either C-terminus (MBP-D95C-
KP) or N-terminus (KP-MBP-141C) was accessible to PKA. Both constructs after 
thiophosphorylation were selectively labeled by OGM as a function of pH, consistent 
with the previous CFP-Kemp labeling results (Fig. 5.8c). Subsequently, two fluorophores, 
Alexa 488 maleimide and Alexa 568 maleimide, were chosen as the FRET pair with a 
given Förster radius ~62 Å.  The cysteine was first labeled with the acceptor fluorophore, 
Alexa 568 maleimide, with a reaction extent of >90 %. Subsequently, the labeled MBP 
was purified by gel filtration and subjected to PKA-mediated thiophosphorylation. After 
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conjugation of the donor fluorophore and purification of the doubly labeled MBP, the 
final product was tested in response to maltose binding. As a negative control, one sample 
in parallel was phosphorylated during the enzymatic reaction step under otherwise 
identical conditions. The preliminary result of the doubly labeled E4C-MBP-KP 
responding to maltose binding is shown in Figure 5.16.  Unfortunately, no FRET change 
of the doubly labeled protein was observed, in the presence or absence of maltose. In 
addition, the phosphorylated protein with its thiol labeled by Alexa 568 exhibited a 
labeling background when incubated with Alexa 488 maleimide in the second step (Fig. 
5.16, “Phos”), indicating the non-stringent labeling specificity.  
The densitometry analysis of Figure 5.15 showed a three-fold labeling extent of 
the thiophosphorylated protein than the phosphorylated one at pH 5.1 for both MBP-
D95C-KP and KP-MBP-A141C. This result suggested that ~70 % of the proteins could 
be selectively labeled at the thiophosphorylated group even in the presence of competing 
free thiols. In fact, the current protocol first labels the Kemptide-fused protein with the 
acceptor fluorophore at the free thiol and thus prevents its reactivity toward the 
subsequent conjugation with the donor fluorophore. Since the acceptor fluorophore-
labeled proteins do not contribute to acceptor emission upon illumination at the donor 
excitation wavelength, the major hurdle of the current FRET experiment may not be the 
lack of labeling specificity. Other factors including the low labeling extent of the donor 
fluorophore and choices of the FRET pair appear to be more important, and they should 
be considered for future optimization.  
Previous kinetic studies258 found that the reaction of N-ethylmaleimide and the 
acetylcholine receptor at pH 7 proceeded with a second-order rate constant k = 1620 ± 
130 M-1 s-1. Lower one unit of the reaction pH decrease the rate constant roughly by ten- 
fold259. Based on this number and the actual reaction condition for labeling protein in 
vitro (20 µM MBP bearing a single cysteine and 200 µM maleimide probe at pH 7.0), the 
alkylation should accomplish (>95 % product generation) within several minutes. In fact, 
the real experiment used a longer duration lasting for hours to ensure the maximal extent 
of protein labeling (80-90 %). This length of time could be further reduced since the 
similar MBP constructs were shown to be efficiently labeled (>90 %) within 10-30 
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min257. To determine the optimal reaction time, a fluorogenic probe for monitoring the 
reaction extent in real-time can be used in the future.  
Compared to PKA, much more known about the enzymatic thiophosphorylation is 
from the studies of the tyrosine kinase- Csk (C-terminal Src kinase). Csk undergoes 
phosphorylation (kcat = 108 ± 5 min-1) as well as thiophosphorylation (kcat = 0.792 ± 5 
min-1) with Mg2+ as the cofactor, and the KM value of the substrate for 
thiophosphorylation (1690 ± 234 µg/mL) is 2.6 times higher than for phosphorylation 
(654 ± 66 µg/mL). Different divalent ions as the cofactors in the kinase reactions pose 
different effects, and replace the Mg2+ by Mn2+ results in expediting the Csk 
thiophosphorylation with a 2.7-fold increased in kcat = (2.1 ± 0.2 min-1)260. Previously, the 
kinetic parameters of Kemptide (LRRASLG) for phosphorylation by the catalytic subunit 
of PKA were determined: KM = 52.0 ± 7.4 µM and kcat = 51.5 ± 10.3 s-1, in the presence 
of Mg2+ as the cofactor261. Although no Michalis-Menten constants of PKA 
thiophosphorylation have been reported, there are studies with the semi-quantitative 
measure. For instance, in the context of the substrate peptide LCGRTGRRNSI-NH2 
(biotinylated on the N-terminus), the PKA-mediated thiophosphorylation was quantitative 
in the presence of Mg2+. On the other hand, incubating this peptide in the competitive 
assay conditions containing ATP and ATPSγS (1:1 ratio) with Mg2+ showed ~10-15 % 
thiophosphopeptide formation. Using Co2+ in the reaction slightly improved the subsrate 
thiophosphorylation (15-20 % thiophosphopeptide produced)262. Future efforts will be 
required to fine-tune the current labeling conditions as well as explore other residues for 
introducing Kemptide and cysteine for probe attachment.  
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Figure 5.15. PKA-mediated selective labeling of two engineered MBP constructs tagging with a 
Kemptide: a) MBP-D95C-KP and b) KP-MBP-A141C.  Proteins were incubated with OGM for 
20 min at room temperature, and the fluorescence was detected using the Storm system with 
settings indicated above. 
 
 
 
 
 
Figure 5.16. a) Emission spectra of the doubly labeled E4C-MBP-KP. After attachment of the 
Alexa 568 maleimide to Cys4, samples were split and subjected to either thiophosphorylation 
(labeled as “Thio”) or phosphorylation (labeled as “Phos”) by PKA. After adding Alexa 488 
maleimide to the enzyme modified proteins and a subsequent purification, the emission spectra of 
these labeled proteins were measured by platereader. b) The ratios of Alexa 568 emission (I598nm) 
to Alexa 488 emission (I518nm) of both thiophosphorylated and phosphorylated proteins were 
recorded as a function of maltose concentration.  
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Experimental 
 
The sequences of all primers for construction of the histone phosphorylation reporters 
and site-directed mutagenesis are listed in Table 5.4.  
 
Experiments of DNA cloning, expression of reporter, protein purification, and 
immunoblot were based on the general protocols listed in the Appendix unless otherwise 
mentioned. The sequences of all constructs were confirmed using the Invitrogen 
sequencing service. 
 
Construction of the TAFII-H4 reporter 
To amplify the TAFII double bromodomain gene, the existing plasmid TAF-AB-
H4 plasmid (Sean Liu and Alice Y. Ting, unpublished data) was used as the template in 
the PCR with primers: hTAF-BD-H4.F and SfiI.SacI.Linker.R. The PCR product was 
digested with SphI and SfiI enzymes and ligated into the vector derived from the similarly 
cut TAF-AB-H4. This construct possesses a longer linker length (36 amino acids) than 
that of the TAF-AB-H4 (15 amino acids). The resultant plasmid was confirmed by DNA 
sequencing. 
 
Construction of the TAF-B-H4 reporter 
To amplify the second bromodomain of the TAFII gene, the TAF-AB-H4 plasmid 
was used as the template in the PCR with primers: hTAF-BDB-H4.F and 
SfiI.SacI.Linker.R. The PCR product containing a single bromodomain was digested with 
SphI and SfiI enzymes and ligated to the vector derived from the similarly cut TAFII-H4. 
The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the H4-TAFII reporter 
Two individual PCRs were performed to generate fragments 1 and 2, which were 
used together as inserts in the ligation reaction. To generate the fragment 1, TAFII-H4 
was used as the template in the PCR with primers: CFP-H4-SphI.F and H4-Linker-
SacII.R. To generate the fragment 2, TAFII-H4 was used as the template in the PCR with 
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primers: SacII-LK-TAFAB.F and TAFAB-SacI-YFP.R. The PCR product 1 was digested 
with SphI and SacII enzymes, and the product 2 was digested with SacII and SacI 
enzymes. Both products after digestion were incubated together and ligated into the 
vector derived from the SphI / SacI digested TAFII-H4 in a three-part ligation fashion. 
The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the H4-GCN5 reporter 
To amplify the GCN5 bromodomain, the GCN5-H4 reporter plasmid (Sean Liu 
and Alice Y. Ting, unpublished data) was used as the template in the PCR with the 
primers SacII-LK-GCN5.F and GCN5-SacI-YFP.R. The PCR product was digested with 
SacI and SacII, followed by ligation into a vector derived from the similarly cut H4-
TAFII. The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the H4-PCAF reporter 
To amplify the PCAF bromodomain, the PCAF-H4 reporter plasmid (Sean Liu 
and Alice Y. Ting, unpublished data) was used as the template in the PCR with the 
primers: SacII-LK-PCAF.F and PCAF-SacI-YFP.R. The PCR product was digested with 
SacI and SacII, followed by ligation into the vector derived from the similarly cut H4-
TAFII. The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the H4-BRG1 reporter 
To amplify the BRG1 bromodomain, the BRG1 gene (a gift from Theodora 
Agalioti, Alexander Fleming Biomedical Sciences Research Center, Greece) was used as 
the template in the PCR with the primers: H4-BRG1.F and H4-BRG1.R. After digestion 
with SacI and SacII, the PCR product was ligated into the vector derived from the 
similarly digested H4-PCAF plasmid. The resultant plasmid was confirmed by DNA 
sequencing. 
 
Expression and purification of reporters 
Reporter constructs resided in the pRSETB plasmids, which contained a (His)6 
epitope upstream the reporter gene for protein purification, were introduced into the 
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bacterial strain BL21(DE3) by heat-shock transformation. The cells were grown in Luria 
Broth supplemented with ampicillin (100 µg/mL) at 37 ºC until OD600 0.5. IPTG was 
then added to a final concentration of 0.4 mM to induce reporter protein expression. The 
cells were grown for an additional 3 hr at 30 ºC and then harvested by centrifugation. 
Cells were lysed by sonication at 4 ºC (six 30-sec pulses at half-maximal power with 1 
min in between each pulse) in lysis buffer (50 mM Tris pH 7.8, 300 mM NaCl, 4 mM 
PMSF, and ¼ EDTA-free protease inhibitor cocktail tablet per 10 mL of lysis buffer). 
The His6-tagged reporter was purified from the lysate using a Ni-NTA agarose column 
following the manufacturer’s protocol. Fractions containing the reporter were 
consolidated and transferred into TBS (140 mM NaCl, 3 mM KCl, 25 mM Tris pH 7.4) 
by two rounds of dialysis for storage in aliquots at -80 ºC. Typical yields were 0.5-1 mg 
of protein per 0.5 L culture. 
 
In vitro reporter acetylation assay 
 Reaction conditions for the in vitro methylation assays were as follows: 3–10 µM 
reporter, 33 µM acetyl-coenzyme A (AcCoA, Sigma), 20 mM Tris pH 8.0, 10 mM 
MgCl2, 20 mM KCl, 1 mM DTT, and 0.3-0.5 µg/µL of HAT (CBP or MOF) in 35 µL 
reaction volume. Reactions were incubated at 30 ºC for the indicated times. 
 
In vitro FRET measurement of histone acetylation reporter 
  The Safire plate reader operated with the XFluor software (Tecan, Durham, NC) 
was used to measure multiple samples of the histone acetylation reporter in vitro. Each 
sample solution (35 µL) incubated under a different assay condition was pipetted into the 
384-well plate. The plate was then monitored by the following settings: Z-position, 
calculated; integration time, 40 µs; gain, 100. The emission spectra were obtained by an 
excitation at 433 nm, with slit widths 5 nm for the excitation and 5 nm for the emission. 
YFP emission (527 nm) to CFP emission (476 nm) ratios were calculated from the peak 
intensity at the corresponding wavelengths.  
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Construction of the intermediate dopamine reporter plasmid (construct 2, cpV inserted 
D3R (Fig. 5.4b))  
 Insertion of the cpV into the D3R was performed by assembling three fragments: 
D3Rf, cpV, and D3Rb. The following primers were used to amplify the cpV gene: D3R-
cpV195.F and D3R-cpV195.R, using the cpVenus 195 plasmid (a gift from Atsushi 
Miyawaki, RIKEN, Japan) as the template. To prepare the D3Rf fragment (amino acids 
1-250), a PCR was performed with the FLAG-D3R plasmid (a gift from Robert 
Levenson, Penn State College of Medicine, PA) as the template and the following 
primers: Seq.pCB6.F and D3R-front.R. To prepare the D3Rb fragment (amino acids 271-
400), a PCR was performed with the FLAG-D3R plasmid as the template and the 
following primers: D3R-back.F and D3R-NheI.R. The D3Rb and cpV were assembled 
first by PCR, using 1:1 ratio of these fragments as templates and primers: D3R-cpV195.F 
and D3R-NheI-.R. The resultant product and the D3Rf fragment were mixed in 1:1 ratio 
as templates in the second PCR with primers: Seq.pCB6.F and D3R-NheI-.R. The PCR 
product, D3Rf-cpV-D3Rb, was digested with HindIII and XbaI enzymes and ligated into 
the similarly cut pCB6 vector derived from the FLAG-D3R plasmid. The resultant 
plasmid was confirmed by DNA sequencing.  
  
Construction of the intermediate dopamine reporter plasmid (construct 3, Ceru-appended 
D3R (Fig. 5.4c))  
 The following primers were used to amplify the Ceru gene: HidIII-NheI-
Cerulean.F and Cerulean.R, using mCerulean-C1 (a gift from David Piston, Vanderbilt 
University) as the template. The PCR product was digested with HindIII and XbaI 
enzymes and ligated into the similarly cut pCB6 vector derived from the FLAG-D3R 
plasmid. The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the dopamine reporter plasmid 
 The PCR product of amplified Ceru gene was digested with NheI and XbaI 
enzymes, and it was ligated to the similarly cut vector derived from the construct 2 (Fig. 
5.4). The resultant plasmid was confirmed by DNA sequencing. 
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Immunofluorescence detection of the FLAG-tagged dopamine reporter localization 
 HEK cells maintained in 10 % fetal bovine serum in DMEM at 37 ºC under 5 % 
CO2 were transfected with the dopamine reporter construct using Lipofectamine 2000. 
After 12-24 hr, the cells were incubated with 1 % BSA and anti-FLAG antibody (1:200 
dilution, Sigma) for 35 min at 37 ºC and subsequently probed against Alexa 568-
conjugated anti-mouse antibody (1:200 dilution) in DPBS for 20 min at room 
temperature. A cpVenus image (495DF10 excitation, 515DRLP dichroic, 530DF30 
emission), a Cerulean image (420DF20 excitation, 450DRLP dichroic, 475DF40 
emission), a DIC image (775DF50, emission), and an Alexa 568 image (560DF20 
excitation, 585DRLP dichroic, 605DF30 emission) for the anti-FLAG antibody detection 
from the microscope were taken and the results were shown in Figure 5.4a. 
 
Imaging of the dopamine reporter in cells 
HEK cells maintained in 10 % fetal bovine serum in DMEM at 37 ºC under 5 % 
CO2 were transfected with the dopamine reporter construct using Lipofectamine 2000. 
After 16-24 hr, cells were incubated in DPBS for imaging. Dopamine (5-10 µM) was 
added to the cells at the time indicated by a grey bar in Figure 5.5. For each data 
acquisition, four images were collected in rapid succession (automated, using SlideBook 
software): a Cerulean image, a cpVenus image, a DIC image, and a FRET image. 
Fluorescence images were background corrected. Image collection time ranges from 300 
to 500 ms with a 20 s interval between two acquisition events. The cpV/Ceru emission 
ratios were calculated by a pixel-by-pixel comparison, dividing the cpVenus image by the 
Cerulean image. To generate the time-course of the fluorescence intensity and the 
emission ratio, a region of interest overlapping the cell surface was selected. Values of 
fluorescence intensity and emission ratio from this region were recorded and plotted as a 
function of time.    
 
Construction of the CFP-H3 plasmid   
 The following primers were used to amplify the CFP gene: 5´-TAATACGACT 
CACTATAGGGAGA (T7 primer) and CFP-H3.R, using CFP-AP61 as the template. The 
PCR product was digested with EcoRI and BamHI enzymes and ligated into the similarly 
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cut pRSETB vector derived from the H4-PCAF histone aceetylation reporter plasmid. 
The resultant plasmid was confirmed by DNA sequencing.  
 
Construction of the CFP-Kemp plasmid   
 The following primers were used to amplify the CFP gene: T7 primer and CFP-
Kemptide.R, using CFP-AP61 as the template. The PCR product was digested with EcoRI 
and BamHI enzymes and ligated into the similarly cut pRSETB vector derived from the 
H4-PCAF histone acetylation reporter plasmid. The resultant plasmid was confirmed by 
DNA sequencing.  
 
Construction of the CFPQ204C-H3 plasmid   
 To construct the Q204C mutant, QuikChange reaction was performed with the 
CFP-H3 gene as the template and the primers: SDMQ204C.F and its reverse 
complement. The resultant plasmid was confirmed by DNA sequencing.  
 
Construction of the CFPQ204C-Kemp plasmid   
 The T7 and CFP-Kemptide.R primers were used to amplify the CFP (Q204C) 
gene, using CFPQ204C-H3 as the template. The PCR product was digested with EcoRI and 
BamHI enzymes and ligated into the similarly cut pRSETB vector derived from the H4-
PCAF histone acetylation reporter plasmid. The resultant plasmid was confirmed by 
DNA sequencing.  
 
Construction of the CFP-Kemp(Ala) plasmid   
 To construct the alanine mutant, QuikChange reaction was performed with the 
CFP-Kemp gene as the template and the primers: SDM CFP-KP S to A.F and its reverse 
complement. The resultant plasmid was confirmed by DNA sequencing.  
 
Construction of the Kemp-CFP-TM plasmid 
 The following primers were used to amplify the CFP gene: pDisplay Kemptide-
CFP.F and pDisplay Peptide-CFP.R, using CFP-AP61 as the template. The PCR product 
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was digested with SacII and XmaI enzymes and ligated into the similarly cut pDisplay 
(Invitrogen) vector. The resultant plasmid was confirmed by DNA sequencing.  
 
Construction of the MBP-D95C-KP plasmid 
 The following primers were used to amplify the MBP gene: PET-MBP.F and 
PET-MBP-Kemp.R, using MBP-D95C plasmid (a gift from Igor Medintz, Naval 
Research Laboratory) as the template. The PCR product was digested with BamH1 and 
NdeI enzymes and ligated into the similarly cut pET15-b vector. The resultant plasmid 
was confirmed by DNA sequencing. 
 
Construction of the MBP-A141C -KP plasmid 
 The QuikChange reaction was performed to construct the intermediate plasmid, 
wild-type MBP, using the MBP-D95C-KP gene as the template and the primers: MBP-
C95D.F and its reverse complement. A second QuikChange reaction was conducted to 
introduce the A141C mutation, using the wild-type MBP plasmid as the template and the 
primers: MBP A141C.F and its reverse complement. The resultant plasmid was 
confirmed by DNA sequencing. 
 
Construction of the KP-MBP-A141C plasmid 
 The following primers were used to amplify the MBP gene: P21 Kemptide-
MBP.F and P21 MBP.R, using the MBP-A141C-KP plasmid as the template. The PCR 
product was digested with XhoI and NheI enzymes and ligated into the similarly cut 
pET21a (Novagen) vector. The resultant plasmid was confirmed by DNA sequencing. 
 
Construction of the E4C-MBP-KP plasmid 
 The following primers were used to amplify the MBP gene: PET-MBP4C.F and 
PET-MBP-Kemp.R, using the wild-type MBP plasmid as the template. The PCR product 
was digested with BamHI and NdeI enzymes and ligated into the pET15b vector derived 
from the similarly cut wild-type MBP. The resultant plasmid was confirmed by DNA 
sequencing. 
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Protein expression and purification 
 Plasmids CFP-H3, CFPQ204C-H3, CFP-Kemp, CFP-Kemp(Ala), CFPQ204C-Kemp, 
MBP-D95C-KP, MBP-A141C-KP, KP-MBP-A141C, 4C-MBP-KP, and His6-tagged 
PKA (contains only the catalytic domain, a gift from Susan Taylor, UCSD) were 
individually expressed in E. coli., followed by Ni-NTA purification. The detailed 
procedure is the same as for expression and purification of FRET reporters. Typical 
yields were 1-3 mg of protein per 0.5 L culture. Proteins were then stored in aliquots at -
80 ºC.  
 
Labeling of CFPQ204C-H3 in vitro  
 Reaction conditions were as follows: 8.2 µM CFPQ204C-H3, 1 mM ATP or ATPγS, 
20 mM HEPES pH 7.7, 10 mM MgCl2, 0.1 mM EGTA, 1 mM DTT, and 4 µM Msk-1. 
OGM, AXM, and BTM were purchased from Molecular probes, and the IAB was 
purchased from Pierce. Reactions were incubated at 30 ºC for the indicated time. 
Fractions from each time points were subjected to immunoblot analysis, which examined 
the reaction extent using anti-phospho-H3-Ser10 antibody (1:1000 dilution). For testing 
the protein labeling with OGM, 33 CFPQ204C-H3 µM was first incubated with conditions 
listed above for thiophosphorylation and subsequently purified by TE midi Select-D, G-
25 spin column (Shelton Scientific, Shelton, CT) according to the manufacturer’s 
protocol. In the next step, 25 µM thiophosphorylated CFPQ204C-H3 before or after column 
purification was reacted with 1.1 mM OGM in 20 mM MES at pH 6 for 30 min at room 
temperature. The mixtures were separated on a 12 % SDS-PAGE, and the labeling results 
were analyzed by the Storm system detecting OGM fluorescence (excitation 450 nm, 520 
nm LP filter). For testing the protein labeling with IAB, CFPQ204C-H3 was similarly 
thiophosphorylated first. Subsequently, 6 µM of the thiophosphorylated CFPQ204C-H3 
(without purification) was incubated with 1 mM IAB at pH 6.5 in DPBS for 20 min at 
room temperature. The reaction mixture were separated on a 12 % SDS-PAGE and 
analyzed by immunoblot using streptavidin-conjugated HRP (1:2000 dilution). Results 
were visualized by Supersignal West Femto (Pierce).  
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The pH-dependent site-specific labeling of CFP-Kemp in vitro  
 CFP-Kemp was incubated with the reaction conditions as follows: 14 µM protein, 
DPBS pH 7.4, 0.42 mM ATP or ATPγS, 25 mM MgCl2, and 25 % PKA. Reaction was 
allowed to proceed at 30 ºC for 16 ~ 23 hr. The reaction extent was analyzed by 
immunoblot using anti-phospho-PKA substrate antibody (1:1:1000 dilution, New 
England BioLabs) and a subsequent incubation with HPR-conjugated anti-rabbit antibody 
(1:2000 dilution). To perform the second step of labeling reaction, 7 µM CFP-Kemp after 
the reaction (without purification) was incubated with 1 mM probe (OGM, AXM, IAB, 
or BTM) at various pHs (pH 5.5, 20 mM citrate; pH 6.2, 20 mM MES; pH 7.1, 20 mM 
Tris; pH 8.2, 20 mM HEPES; pH 9.6, 20 mM Tris) for 20 min at room temperature. The 
reaction mixture was separated on a 12 % SDS-PAGE, and the modified products were 
analyzed by either immunoblot (for proteins labeled with BTM and IAB) or Storm 
system (for proteins labeled with OGM and AXM). The immunoblot used streptavidin-
conjugated HRP (1:2000 dilution) and the results were visualized using Supersignal West 
Femto (Pierce). Results of labeling with fluorophores were visualized by detecting the 
fluorescence of OGM (excitation 450 nm, 520 nm LP filter) and AXM (excitation 635 
nm, 650 nm LP filter). 
 
Labeling of cell surface Kemp-CFP-TM with OGM, AXM, IAB, and ThioGlo1 
HeLa cells maintained in 10 % fetal bovine serum in DMEM at 37 ºC under 5 % 
CO2 were transfected with the Kemp-CFP-TM plasmid using Lipofectamine 2000. After 
12-24 hr, cells were washed two times with DPBS (pH 6.0). For labeling proteins with 
OGM, cells were incubated with 20 µM probe in DPBS (pH 6.0) for 20 min at room 
temperature. For comparison, cells were first labeled by enzymatic thiophosphorylation 
(1 mM ATPγS, 25 % PKA, and 10 % fetal bovine serum in DMEM) for 12 hr at 37 ºC 
and subsequently reacted with 20 µM OGM in DPBS (pH 6.0) for 20 min at room 
temperature. The cells were rinsed two times with DPBS (pH 6.0) and then imaged on a 
microscope. Images were taken with CFP, Oregon green (495DF10 excitation, 515DRLP 
dichroic, 530DF30 emission), and DIC filter sets. Results were shown in Figure 5.9.  
For labeling proteins with AXM, cells were first thiophosphorylated (1 mM 
ATPγS, 5 mM MgCl2, 25 % PKA, and DPBS pH 7.4) for 30 min at 37 ºC and 
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subsequently reacted with 50 µM AXM in DPBS (pH 6.1) for 20 min at 4 ºC with 0.1 % 
pluronic acid (Molecular probes). After rinsing two times with DPBS (pH 6.0), cells were 
imaged on a microscope with CFP, Alexa 568 (560DF20 excitation, 585DRLP dichroic, 
605DF30 emission), and DIC filter sets. Results were shown in Figure 5.10. 
For labeling proteins with IAB, cells were first thiophosphorylated (2 mM 
ATPγS, 5 mM MgCl2, 80 % PKA, and DMEM) for 1 hr at 37 ºC and subsequently 
reacted with 1 mM IAB in DPBS (pH 6.0) for 25 min at room temperature. To detect the 
labeling, cells were incubated with Alexa 568-conjugated streptavidin (1:200 dilution) 
and 1 % dialyzed BSA for 15 min at room temperature. After rinsing two times with 
DPBS (pH 6.0), cells were imaged on a microscope with CFP, Alexa, and DIC filter sets. 
Images were acquired for 0.5-0.9 s using OpenLab software. Results were shown in 
Figure 5.11. 
For labeling proteins with ThioGlo1, cells were incubated with 50~100 nM probe 
in DPBS for 15 min at 4 ºC and subsequently imaged on a microscope with CFP, 
ThioGlo1(405DF20 excitation, 425DRLP dichroic, 460DF30 emission), and DIC filter 
sets. Images were acquired for 0.5-0.9 s using OpenLab software. Results were shown in 
Figure 5.13. 
 
Immunofluorescence detecting of thiophosphorylation of Kemp-CFP-TM on the cell 
surface  
The Kemp-CFP-TM transfected HeLa cells were incubated with 1 mM ATPγS, 5 
mM MgCl2, and 20 % PKA in DPBS (pH 7.4) for 30 min at 37 ºC. Cells were rinsed with 
DPBS two times and then incubated with anti-phospho-PKA substrate antibody (1:100 
dilution) in DPBS (pH 7.4) for 30 min at 4 ºC. Subsequently, cells were incubated with 
TexasRed-conjugated anti- rabbit antibody (1:50) and 10 % dialyzed BSA in DPBS for 
30 min at 4 ºC. After rinsing two times with DPBS (pH 6.0), cells were imaged on a 
microscope with CFP, Texas Red (560DF20 excitation, 585DRLP dichroic, 605DF30 
emission), and DIC filter sets. Images were acquired for 1-3 s using OpenLab software. 
Results were shown in Figure 5.12. 
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The pH-dependent selective labeling of the Kemptide-fused MBP constructs in vitro  
 The Kemptide-fused MBP constructs were incubated with the reaction conditions 
as follows: 6-12 µM protein, 12.5 mM MES, 12.5 mM MOPS, 12.5 mM HEPES pH 7.4, 
0.4 mM ATP or ATPγS, 10 mM MgCl2, and 10 % PKA. Reaction was allowed to 
proceed at 37 ºC for 2 ~ 12 hr. To perform the second step of labeling reaction, 5-10 µM 
protein after the reaction (without purification) was incubated with 1 mM OGM at 
various pHs (pH 5 ~8, 12.5 mM MES/12.5 mM MOPS/12.5 mM HEPES; pH 9.6, 20 mM 
Tris) for 20 min at room temperature. The labeling results were detected by OGM 
fluorescence using the Storm system. 
 
Double labeling of the Kemptide-fused MBP constructs for FRET measurement upon 
maltose binding 
 The Kemptide-fused MBP proteins were first labeled by reacting with the single 
cysteine using conditions as follows: 25 µM protein, 120 µM TCEP, 125 mM MES, 125 
mM HEPES, and 125 mM MOPS pH 7 for 30 min at room temperature. Subsequently, 
150 µM Alexa 568 maleimide (Molecular probes) was added and the reaction was 
allowed to proceed an additional 16 hr. The Alexa 568 labeled protein was purified using 
NAP-5 column, followed by incubation with the thiophosphorylation conditions as 
follows: 10 µM protein, 0.4 mM ATPγS, 7 µM PKA in PBS pH 7.4 for 6 hr at 30 ºC. The 
reaction mixture was loaded to the NAP-5 column to remove excess ATPγS, and the 
solution was adjusted to pH 6. The donor fluorophore was then loaded to the 
thiophosphorylated Kemptide by incubating with the conditions as follows: 1~5 µM 
protein, 10~120 µM Alexa 488 maleimide (10 fold excess, Molecular probes), pH 6.0 for 
16~18 hr at room temperature. The doubly labeled product was separated by additional 
purification using the NAP-5 column. To test the FRET response of the dual modified 
protein, 0.4~1.5 µM protein samples were incubated with maltose in different 
concentrations ranging from 0 to 100 µM. These samples were pipetted into 384-well 
plate and monitored with the following settings: Z-position, calculated; integration time, 
40 µs; gain, 100. The emission spectra were collected by excitation at 490 nm, with slit 
width 5 nm for the excitation and 5 nm for the emission. Alexa 568 emission (600 nm) to 
 184
Alexa 488 emission (520 nm) ratios were calculated from the peak intensity at the 
corresponding wavelengths.  
 
Table 5.4. List of the primers for cloning the histone acetylation reporters, dopamine reporters, 
and constructs tagged with the histone H3 peptide or Kmeptide 
 
Primer name Primer sequence Restriction 
site 
included 
corresponding 
protein 
mutation site 
Application 
hTAF-BD-
H4.F 
5’-GCCGCCCGCATGCATGGAACCACTGT 
TCACTGTGACTA 
SphI  TAFII-H4 
reporter 
SfiI.SacI. 
Linker.R 
5’-CACCATGAGCTCGGCCCCTCCGGCCC 
CGGTAGAACCCTCACCAGAACCCGG 
SacI      
and       
SfiI 
 TAFII-H4 
reporter 
hTAF-BDB-
H4.F 
5’-GCCGCCCGCATGCATCCCTTGCTGGA 
TGATGATGACCAA 
SphI  TAF-B-H4 
reporter 
CFP-H4-
SphI.F 
5’-GCCCGCATGCATTCTGGTCGCGGCAA 
AGGC 
SphI  H4-TAFII 
Reporter 
H4-Linker-
SacII.R 
5’-CCCCGCGGAGAACCCTCACCAGAACC 
CGGCTTCCCAGATCCAGATGTAGACCCG
GTGATGCCTTGGATG 
SacII  H4-TAFII 
Reporter; linker 
sequence 
underlined 
SacII-LK-
TAFAB.F 
5’-CTCCGCGGGGGTCTACATCTGGATCT 
GGGAAGCCGGGTTCTGGTGAGGGTTCTG
GAACCACTGTTCAC 
SacII  H4-TAFII 
Reporter; linker 
sequence 
underlined 
TAFAB-
SacI-YFP.R 
5’-CATGAGCTCGGTCATTGGGTCCAGGC SacI  H4-TAFII 
Reporter 
SacII-LK-
GCN5.F 
5’-CTCCGCGGGGGTCTACATCTGGATCT 
GGGAAGCCGGGTTCTGGTGAGGGTAAG 
CGTGGTCCAC 
SacII  H4-GCN5 
Reporter; linker 
sequence 
underlined 
GCN5-SacI-
YFP.R 
5’-CATGAGCTCATCAATAAGGTGAG SacI  H4-GCN5 
Reporter 
SacII-LK-
PCAF.F 
5’-CTCCGCGGGGGTCTACATCTGGATCT 
GGGAAGCCGGGTTCTGGTGAGGGTAAA 
AGTAAAGAGCCCAG 
SacII  H4-PCAF 
Reporter; linker 
sequence 
underlined 
PCAF-SacI-
YFP.R 
5’-CATGAGCTCCTTGTCAATTAATCC SacI  H4-PCAF 
Reporter 
H4-BRG1.F 5’-CTCCGCGGGGGTCTACATCTGGATCT 
GGGAAGCCGGGTTCTGGTGAGGGTCTCA
GCGAGGTCTTC 
SacII  H4-BRG1 
Reporter; linker 
sequence 
underlined 
H4-BRG1.R 5’-GGGAGCTCGGTGAAGACCGACTGCAA SacI  H4-BRG1 
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Reporter 
D3R-
cpV195.F 
5´-CTCTCTCCTGACCGGGCACATCCGGA 
ATTCCTGCCCGACAACCACTACC 
  Insertion of 
cpVenus195 to 
D3R  
D3R-
cpV195.R 
5´-CTCTCTTTTCAACTCTCCTCCTCTTTCC 
CGCGGCAGCACGGGGCCGTCG 
  Insertion of 
cpVenus195 to 
D3R  
Seq.pCB6.F 5´-GGGCGGTAGGCGTGTACGG   Upstream of 
D3R 
D3R-front.R 5´-GATGTGCCCGGTCAGGAGAGAG   The first half of 
D3R; before the 
3rd intracellular 
loop 
D3R-back.F 5´-GAGGAGGAGAGTTGAAAAGAGAG   The second half 
of D3R; after 
the 3rd 
intracellular 
loop 
D3R-NheI.R 5’-GACGCTAGCTCCGCAGGACAGGATCT 
TG 
NheI  Annealing to 
the end of D3R 
HidIII-NheI-
Cerulean.F 
5´-GGAAGCTTGCTAGCGTGAGCAAGGG HindIII 
and     
NheI 
 Fusion of 
cerulean to the 
C-terminus of 
D3R 
Cerulean.R 5´-CAGTTATCTAGATCCGGTGGAT XbaI  Fusion of 
cerulean to the 
C-terminus of 
D3R 
CFP-H3.R 5´-CATGAATTCTTATGCCTTGCCGCCGG 
TAGACTTGCGAGCTGTCTGCTTCGTCCG
GGCGCCGCCGGAGGACTC 
EcoRI  CFP-H3 protein 
for Msk-1 
labeling 
CFP-
Kemptide.R 
5´-CATGAATTCTTAGCCTAGGGAGGCTC 
GTCGTAGGCCGCCGGAGGACTC 
EcoRI  CFP-Kemp 
protein for 
Msk-1 labeling 
SDMQ204C.
F 
5’-CACTACCTGAGCACCTGTTCCGCCC 
TGAGCAAAG 
 Q204C; 
sequence 
underlined 
Accessible 
cysteine on the 
CFP surface 
Reverse 
Coplement 
5’-CTTTGCTCAGGGCGGAACAGGTGCT 
CAGGTAGTG 
 Q204C; 
sequence 
underlined 
Accessible 
cysteine on the 
CFP surface 
SDM CFP-
KP S to A.F 
5’-CTACGACGAGCCGCCCTAGGCTAAG  Ser to Ala 
mutation; 
sequence 
underlined 
CFP-Kemp 
(Ala) control 
Reverse 
Complement 
5’-CTTAGCCTAGGGCGGCTCGTCGTAG  Ser to Ala 
mutation 
CFP-Kemp 
(Ala) control 
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sequence 
underlined 
pDisplay 
Kemptide-
CFP.F 
5’-CCCCCGGGCTACGACGAGCCTCCCTA 
GGCGAGTCCTCCGGCGGCATGGTGAGC
AAGGGC 
XmaI  Kemp-CFP-
TM. Kemptide 
sequence 
underlined  
pDisplay 
Peptide-
CFP.R 
5’-GGGCCGCGGCTTGTACAGCTCGTC SacII  Kemp-CFP-
TM. 
PET-MBP.F 5’-GCCATATGATGAAAACTGAAG NdeI  MBP-KP 
constructs 
PET-MBP-
Kemp.R 
5’-GCGGATCCTTAGCCTAGGGAGGCTC 
GTCGTAGAGTCTGCGCGTCTTTCAG 
BamHI  MBP-KP 
constructs; 
Kemptide 
sequence 
underlined 
MBP-
C95D.F 
5’-GTATCCGTTTACCTGGGACGCAGTAC 
GTTACAACGG 
 C95D of 
MBP 
Mutation 
sequence 
underlined 
Reverse 
Complement 
5’-CCGTTGTAACGTACTGCGTCCCAGGT 
AAACGGATAC 
 C95D of 
MBP 
Mutation 
sequence 
underlined 
MBP 
A141C.F 
5’-GGATAAAGAACTGAAATGTAAAGGT 
AAGAGCGCGC 
 A141C of 
MBP 
Mutation 
sequence 
underlined 
Reverse 
Complement 
5’-GCGCGCTCTTACCTTTACATTTCAGTT 
CTTTATCC 
 A141C of 
MBP 
Mutation 
sequence 
underlined 
P21 
Kemptide-
MBP.F 
5’-CGGCTAGCCTACGACGAGCCTCCCTA 
GGCGAAGGTAAACTGGTAA 
NheI  KP-MBP 
construct; 
Kemptide 
sequence 
underlined 
P21 MBP.R 5’-GGCTCGAGAGTCTGCGCGTCTTTCAG XhoI  KP-MBP 
construct 
PET-MBP-
4C.F 
5’-GCCATATGTGTGGTAAACTGGTAATC NdeI  E4C-MBP-KP;  
cysteine 
sequence 
underlined 
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Appendix 
 
Molecular cloning techniques related to the GFP-based FRET reporters  
(Based on Alice Y. Ting’s original protocol) 
 
1. Information of vectors: 
Each reporter gene can be integrated into two different vectors with engineered 
the DNA cassettes that are convenient for the cloning work: 
• pRSETB: from Invitrogen (Fig. A1) and for reporter expression in E. coli. 
The schematic sequence map is:   
(His)6 tag-BamHI- CFP-SphI- Insert-SacI-YFP-EcoRI 
  The expressed reporter protein contains an N-terminal (His)6 tag for Ni-NTA 
purification. Since the CFP and YFP moieties are commonly shared by all 
reporters, only the inserts for different reporter will be individually created and 
followed by ligation into the DNA cassette. 
• pcDNA3’: derived from commercial pcDNA3 (Fig. A2) and used for reporter 
expression in mammalian cells. 
 The schematic sequence map is:   
BamHI-CFP-SphI-Insert-SacI-YFP-EcoRI 
A CMV (cytomegalovirus) promoter is incorporated in the vector backbone 
upstream the reporter gene for a high-level protein expression in mammalian 
cells. The neomycin cassette downstream the reporter gene is for selection of the 
transfected cells. Note that the pcDNA3 differs from the commercial pcDNA3 
with the N-terminal Kozak sequence for additionally optimizing the mammalian 
protein expression. The reporter gene can be shuttled between pRSETB and 
pcDNA3’ by cutting and pasting the sequence with BamHI and EcoRI enzymes.     
 
2. Reagents: 
1) 1000x Ampicillin (CalBiochem, 0.1 g/mL):  
Dissolve 2.5 g ampicillin in 25 mL water.  
Filter-sterilize and store in 1 mL aliquots at –20 °C. 
2) 1000x IPTG (CalBiochem, 0.1g/mL):  
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Dissolve 2.5 g IPTG in 25 mL water.  
Filter-sterilize and store in 1 mL aliquots at –20 °C. 
3) 25 mM dNTPs: 
Combine equal volumes (e.g., 100 µL) of dATP, dCTP, dGTP, and dTTP 
from the 100 mM dNTP set (PCR Grade, Invitrogen, #10297-018). Make 
10 µL aliquots and store at –20 °C. 
4) 100x PMSF (100 mM): 
Dissolve 870 mg of PMSF (Sigma #P-7626) in 50 mL isopropanol. 
Store at –20°C in 300 µL aliquots. 
5) 1x Binding buffer (for Ni-NTA column): 
6.1 g Tris base (FW 121.1, 50 mM) 
17.5 g NaCl (FW 58.44, 300 mM) 
Add H2O to final volume of 1 L. Adjust pH to 7.4 with HCl. 
6) 1x Washing buffer (for Ni-NTA column): 
6.1 g Tris base (FW 121.1, 50 mM) 
17.5 g NaCl (FW 58.44, 300 mM) 
681 mg Imidazole (FW 68.08, 10 mM) 
Add H2O to final volume of 1 L. Adjust pH to 7.4 with HCl. 
7) 1x Stripping buffer (for Ni-NTA column):  
6.1 g Tris base (FW 121.1, 50 mM) 
17.5 g NaCl (FW 58.44, 300 mM) 
10.2 g Imidazole (FW 68.08, 150 mM) 
Add H2O to final volume of 1 L. Adjust pH to 7.4 with HCl. 
8) 1x PBS (Phosphate buffered saline): 
8.00 g NaCl 
0.20 g KCl 
0.91 g Na2HPO4 (anhydrous) 
0.12 g KH2PO4 
Dissolve the salts in 600-800 ml distilled H2O.   
Adjust the final volumn to 1 L with distilled H2O and autoclave at 10 psi 
(70 kPa) for 15 min.   
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9) 1x TBS (0.5 M Tris base, 9 % NaCl, pH 7.6):   
61 g Trizma base 
90 g NaCl 
Adjust the final volumn to 1 L, and adjust the pH 7.6 using HCl. 
3. Design primers for cloning reporter into pRSETB: 
The primers for amplifying your insert must incorporate an SphI site in the 
forward primer and a SacI site in the reverse primer. Use the following example (from the 
sequence of the Ca+2 reporter263) to make sure the reporter gene is placed in-frame:  
 SphI junction: 5’-Ala Ala Arg Met His Asp 
         GCT GCT CGC ATG CAT GAC 
    CFP… 226 227    SphI 
 SacI junction: 5’-Ala Leu Glu Leu Met Ser 
    GCA CTG GAG CTC ATG AGT 
        SacI    1   2 …YFP 
• If you must incorporate a linker or a peptide substrate into your reporter, you can 
include those amino acids in either the forward or reverse primer. For example, to 
make a reporter with the composition: CFP-Chromodomain-linker-H3-YFP, you 
would make a reverse primer that is reverse complement and covers part of (see 
next for the constraint of oligo length) the following geometry: 5’-[end of 
chromodomain]-[linker]-[H3]-[SacI site]-[three arbitrary nucleotide overhang]-3’.  
• Some oligo vendors are: MWG Biotech and Invitrogen. The longest primer can be 
commercially ordered is 100-nucleotide long. For a primer longer than 40-
nucleotide, request PAGE purification. 
• To assemble a sequence longer than 100 nucleotides, use two successive PCRs.  
For instance, amplify the region: 5’-[SphI site]-[chromodomain]-[linker]-3’ by the 
first PCR, using the chromodomain gene as the template with the forward primer 
and the reverse one, which anneals the end of chromodomain and extends to the 
linker region. The PCR product is then used as the template for the second PCR, 
using the same forward primer and the reverse one that is reverse complement to 
the sequence: 5’-[linker]-[H3]-[SacI site]-[nucleotide overhang]-3’. 
 
4. PCR programs for gene amplification: 
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 Set up the reaction mixture (100 µL) for PCR as follows: 
 85 µL H2O 
 10 µL 10x Reaction buffer containing Mg2+ 
 0.75 µL  200 µM Forward primer 
 0.75 µL  200 µM Reverse primer 
 2 µL  25 mM dNTPs 
 1 µL minipreped template DNA 
 0.5 µL Taq polymerase  
• The commercial sources of the enzyme are from NEB, Roche, or Promega. Use 
the corresponding pair of the enzyme and the reaction buffer. Do not mix reagents 
across different brands.  
Use the generic PCR program as follows (total running time ~2.5 hr): 
Step 1: 95 °C  5 min. 
Step 2: 95 °C  1 min. 
Step 3: 40 °C  1 min. 
Step 4: 72 °C  1 min. 
Step 5: Repeat step 2-4 for one more time. 
Step 6: 95 °C  1 min. 
Step 7: 43 °C  1 min. 
Step 8: 72 °C  2.5 min. 
Step 9: Repeat step 6-8 for 4 more times. 
Step 10: 95 °C  1 min. 
Step 11: 45 °C  1 min. 
Step 12: 72 °C  2.5 min. 
Step 13: Repeat step 10-12 for 4 more times.  
Step 14: 95 °C  1 min.  
Step 15: 52 °C  1 min.  
Step 16: 72 °C  2.5 min. 
Step 17: Repeat step 14-16 for 14 more times.  
Step 18: 72 °C  7 min.  
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Step 19: 4 °C  forever.  
 
5. Digest the PCR product and the pRSETB vector with SacI and SphI enzymes:   
To prepare the insert for ligation, the PCR product can be digested straight out of 
the crude PCR reaction. Also set up the digestion reaction in parallel to prepare the 
vector.  
6 µL  PCR reaction 
 2 µL  water 
 0.5 µL  SphI 
 0.5 µL  SacI 
 1 µL  10x NEB buffer No. 4 
 Incubate at 37 °C for 3 hr. 
For digesting the vector: 
 3 µL miniprepped pRSETB CFP/YFP construct (with any insert) 
 5 µL  water 
 0.5 µL SphI 
 0.5 µL  SacI 
 1 µL 10x NEB buffer No. 4 
 Incubate at 37 °C for 3 hr. 
After the reaction, purify both the insert and the vector using a 1 % agarose gel. 
Use the setting: 130 V for 25 min. The digested vector should run at 4.3 kb (pRSETB 
vector is 2.9 kb, add 0.7 kb for each of the GFP units). An incomplete digestion will give 
a faster running band of the vector in the 3.5-4 kb region. Excise the expected bands with 
a razor, and extract the DNA using the Qiagen gel extraction kit. 
 
6. Ligate vector and insert together: 
Set up three ligation reactions with 1:1, 1:10, and 10:1 (volume:volume) 
vector:insert ratios. The amounts of insert and vector are calculated based on their band 
intensity on the gel. Include an additional “control ligation” with only the vector DNA 
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present (no insert). This represents the self-ligation of vectors that contribute to the 
background. The condition for the ligation reaction is as follows: 
 x µL  insert 
 y µL  vector 
 1 µL  10x T4 DNA ligase buffer 
 0.5 µL T4 DNA ligase buffer 
 Add water to a final volume of 10 µL. 
 Incubate at room temperature for 2 hr – overnight. 
 
7. Heat shock transformation of the ligation product to competent E.coli.: 
• Thaw a single aliquot (25 µL) of DH5α competent bacteria slowly on ice.  
• Combine 5 µL of the ligation crude with DH5α in a 1.5 mL tube on ice. 
• Place this tube in a 42 °C heat shock water or oil bath for 45 seconds. 
• Quickly transfer the tube back onto ice. Allow to sit for 2 min. 
• Rescue the cells with 500 µL room temperature SOB. Incubate the culture at 37 
°C for 30 min. 
• Take 150 µL of the bacterial culture and spread it onto an LB-ampicillin plate. 
Grow the colonies at 37 °C for more than 12 hr. 
 
8. Miniprep the bacterial colonies for test digestion of the DNA: 
• Compare the numbers of colonies from the plates to that of the control ligation. 
• Proceed to the next step only if the control ligation plate produces 3-fold fewer 
colonies than the experimental plates with the actually number less than 20.  
• Select 5-10 colonies from the plate and use them to inoculate 1 mL LB-
ampicillin (1 mL LB + 1 µL of 1000x ampicillin stock) cultures. 
• Miniprep the DNA from these cultures using the Qiagen miniprep kit. 
• Set up a test digestion for each DNA sample: 
 5 µL of miniprepped DNA 
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 3 µL of water 
 0.5 µL of SphI 
 0.5 µL of SacI 
 1 µL of 10x NEB buffer 4 
 Incubate at 37 °C for 1 hr. 
• Run digestions on a 1 % gel and check to see that insert has dropped out. Keep 
only the samples that give the insert with the expected size.  
• Submit the amples for DNA sequencing. The sequencing primer must be 
properly designed to reveal the detailed gene information. For a forward read 
(from 5’ to 3’ of the gene), the primer should anneal 150 bp upstream the 
region of interest. This prevents the initially ambiguous sequence read due to 
the intrinsic sequencing limitation. For a reverse read, design a primer that 
anneals the 150 bp downstream (closer to the 3’ end) the gene of interest. Most 
critical location of the entire reporter gene to check is the conjugations 
containing the restriction sites, since they are derived from the cloning work 
that may most likely, if any, carry the mutation. Avoid the primer that anneals 
part of the CFP or YFP region, because the primer can recognize both units 
and complicate the sequence data. Some common primers are: 
T7 primer (for coding strand): 5’-AATACGACTCACTATAGGGA, and  
pRSETB.reverse (for noncoding strand): 5’-TAGTTATTGCTCAGCGGTGG. 
 
9. Protein expression in bacteria: 
• Transform the sequence-confirmed reporter plasmid into the heat-shock BL21 
(DE3) E. coli. for protein expression. The procedure is identical to the Session 
No. 7 of this protocol shown above. 
• Pick 3-5 colonies from the LB-ampicillin plate in which the BL21 (DE3) 
bateria have grown for more than 12 hr. 
• In a 1 L falsk, use these colonies to inoculate 100 mL LB-ampicillin cultures. 
Shake the culture at 37 °C until slightly turbid (OD ~0.5, usually 6-8 hr). 
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• Add 300 mL fresh LB-ampicillin to the culture, also add 600 µL of the 1000x 
IPTG stock to initiate the protein induction. Continue the induction at 30 °C for 
3 hr.  
• Spin down cells in 500 mL plastic bottles, using the floor centrifuge (Beckman 
Coulter) with the setting: 8000 rpm for 15 min at 4 °C. 
• Discard the supernatant and place cell pellet on ice. 
 
10. Purification of reporter from bacterial cells: 
• Prepare fresh lysis buffer (4 °C): Use 3 mL of the Ni-NTA binding buffer per 
bacterial pellet. To 10 mL solution, add ¼ Roche protease inhibitor cocktail 
tablet (EDTA-free) and 100 µL of 100x PMSF. Tablet dissolves slowly. The 
alternative to the tablet is the protease cocktail (Calbiochem, catalog no. 
539137), add 10 µL of this reagent to 10 mL of the solution.  
• Resuspend each pellet in 3 mL of lysis buffer by pipetting gently up and down. 
Transfer the suspended culture to a 15 mL Falcon conical (BD Biosciences). 
Place the tubes on ice. 
• Lyse the bacteria by sonicator (Branson, with a microtip) in the cold room. In 
the Falcon tube, submerge the microtip into solution close to but not touching 
the bottom. Use the setting for sonication: six 30-sec pulses at half-maximal 
power with 1 min between each pulse). 
• Aliqout the sonicated culture into several 1.5 mL eppendorf tubes; spin down 
cells for 15 min at 13,200 r.p.m. at 4 °C. 
• While tubes in are centrifuge, prepare and equilibrate a Ni-NTA column (4 
°C):  
Add 1-3 mL of Ni-NTA slurry (Qiagen) to a column ~ 1-1.5 cm in diameter. 
Pack the column with 1.5-2 cm height of the resin. Rinse the column with 5 
mL of binding buffer. 
• After spinning, load the protein supernatant onto the Ni-NTA column.  
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• To prevent any loss of proteins, be sure to collect the flow-through and all 
rinsed fractions. Keep all samples on ice. Rinse column with 3 mL binding 
buffer. 
 Wash column with two times using 5 mL washing buffer each. 
Through both steps above, green fluorescent color should remain on column. 
Elute reporter off column with 3 mL stripping buffer. Collect eluent every 0.5 
mL. Most protein should come off in fractions 3-6. 
• Check the fluorescence of all tubes under gel/culture plate setup. Consolidate 
fluorescent fractions and dialyze against either TBS or PBS. Dialyze at 4 °C at 
two times against 3 L buffer each time. Each dialysis must go for 6 hr. 
 
10. Analyze the purified protein: 
• SDS-PAGE analysis: check the elution fractions as well as those from the 
flow-through, binding, and washing fractions by PAGE. The presence of 
multiple bands in the lower molecular weight than expected indicates the 
possibility of proteolysis.  
• UV-Vis spectrometry: the reporter containing both CFP and YFP should 
exhibit their characteristic absorbance peaks corresponding to these two units. 
The CFP absorbance peaks at 434 nm (extinction coefficient ε = 34000 M-1 cm-
1), and the YFP absorbance peaks at 514 nm (extinction coefficient ε = 62000 
M-1 cm-1)50. For accurately measure the absorbance, do not trust the number 
that has the value larger than 1.0. In this case, dilute the sample so that a new 
absorbance falls into the range of 0.2-1.0. Calculate the protein concentration 
based on the YFP emission, and the typical protein concentration is in the 1-10 
µM range. 
• Measuring protein concentration by BCA (bicinchoninic acid)  kit: 
As alternative, the concentration of the reporter protein can be measured by the 
BCA kit (from Pierce). The BCA assay264 relies on the formation of a Cu2+-
protein complex under alkaline conditions, followed by reduction of the Cu2+ 
to Cu1+. The amount of reduction is proportional to the protein present, via 
residues such as cysteine, cystine, tryptophan, and tyrosine. BCA forms a 
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purple-blue stable complex with Cu1+ in alkaline environments at absorbance 
maximum 562 nm, which can be monitored by UV-Vis spectrometry. Use BSA 
with a known concentration as a reference and prepare 10 µL samples covering 
the concentration range 0.05-5 µg /µL. Prepare the Cu2+ solution as instructed 
by the manufacturer’s protocol, and incubate the solution with the references as 
well as 10 µL reporter protein sample. Monitor the 562 nm absorbance of all 
these samples and calculate the reporter concentration based on the standard 
curve.  
 
11. Clone the reporter gene into pcDNA3’ vector: 
Digest pRSETB construct with BamHI and EcoRI enzymes. 
 3 µL miniprepped pRSETB construct 
 4 µL water 
 1 µL BamHI 
 1 µL EcoRI 
 1 µL  10x NEB buffer No. 2 
 Incubate at 37 °C for 3 hr.  
Digest pcDNA3’ vector with BamHI and EcoRI enzymes.  
3 µL  miniprepped pcDNA3’ CFP/YFP construct (with any insert) 
 4 µL  water 
 1 µL BamHI 
 1 µL  EcoRI 
 1 µL  10x NEB buffer No. 2 
 Incubate at 37 °C for 3 hr. 
After the reaction, purify both the insert and the vector using a 1 % agarose gel. 
Use the setting: 130 V for 25 min. The digested vector should run at 6.8 kb (pcDNA3’ 
vector is 5.4 kb, add 0.7 kb for each of the GFP units). An incomplete digestion will give 
a faster running band of the vector in the 5-6 kb region. Excise the expected bands with a 
razor, and extract the DNA using the Qiagen gel extraction kit. For the subsequent 
procedures, including ligation of vector and insert together, heat-shock transformation of 
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the ligation products, miniprep and test digest the DNA, and submit samples for DNA 
sequencing, are identical to session 6-8 in this protocol.   
 
 
Figure A1. The multiple cloning site sequence and the schematic cloning map of the pRSETB 
vector.  
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       HindIII     Kozak     NcoI  
884 GACCCAAGCTTGCGGCCGCCACC ATG GTG CGG GGT TCT CAT CAT CAT CAT CAT CAT 
               Met   Val   Arg   Gly    Ser   His   His   His    His   His    His 
 
  T7 gene 10 leader 
GGT ATG GCT AGC ATG ACT GGT GGA CAG CAA ATG GGT CGG GAT CTG TAC GAC GAT      
Gly    Met   Ala   Ser    Met   Thr   Gly   Gly    Gln   Gln    Met   Gly   Arg   Asp   Leu   Tyr   Asp   Asp 
 
 BamHI                     EcoRI 
GAC GAT AAG GAT CCC AGC TCG AGA TCT GCA GCT GGT ACC ATG GAA TTC 
Asp   Asp   Lys    Asp   Pro    Ser    Ser   Arg    Ser   Ala   Ala    Gly   Thr    Met   Glu   Phe  
 
           NotI 
 
 
 
 
Figure A2. The multiple cloning site sequence of the pcDNA3’ vector (derived from the original 
pcDNA3 vector) and the schematic cloning map of the original pcDNA3 vector. 
 
 
584 CATCTACGTA TTAGTCATCG CTATTACCAT GGTGATGCGGTTTTGGCAGT ACATCAATGG
644 GGCGTGGATA CGGTTTGACT CACGGGGATT TCCAAGTCTC CACCCCATTG ACGTCAATGG
704 GAGTTTGTTT TGGCACCAAA ATCAACGGGACTTTCCAAAA TGTCGTAACA ACTCCGCCCC
764 ATTGACGCAA ATGGGCGGTA GGCGTGTACG GTGGGAGGTCTATATAAGCA GAGCTCTCTG
                     Putative transcriptional start  T7 Promoter 
824 GCTAACTAGA GAACCCACTG CTTACTGGCT TATCGAAATT AATACGACTC ACTATAGGGA
994 TGCAGATATC CATCACACTG GCGGCCGCTCGAGCATGCAT CTAGAGGGCC CTATTCTATA
            Sp6 Promoter     
1004 GTGTCACCTA AATGCTAGAGCTCGCTGATC AGCCTCGACT GTGCCTTCTA GTTGCCAGCC
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The protocol for immunoblot: 
 
1. Reagents:  
1) 6x Protein sample buffer (SDS reducing buffer): 
 3.5 mL water 
 3.5 mL 1 M Tris-HCl pH 6.8 
 3.6 mL glycerol 
 1.0 g SDS 
 930 mg DTT 
 1.2 mg bromophenol blue 
 Make 300 uL aliquots and store at –80 °C 
2) 10 L 10x immunoblot transfer buffer: 
 1.41 kg Glycine 
 300 g Tris base 
 Adjust to 10 L with water 
3) 10 L of 20x TBS-T: 
 484 g Tris 
1.6 kg NaCl 
200 mL Tween 
Add water until the volume is 10 L 
Adjust the pH to 7.6 with HCl 
4) Blocking buffer:  
 1.5 g Bovine Serum Albumin  
 50 ml 1x TBS-T 
 
2. Run protein gel: 
Prepare the protein samples (typically 10 µL with 2 µL of 6x SDS reducing loading 
buffer). 
Boil samples at 100 °C in heat block for 7 min. 
Samples can now be stored at -20 °C or analyzed immediately as follows: 
(Boil again if samples were stored at -20 °C)  
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Spin down samples with maximum speed (13.2 k r.p.m.) for 30 sec. 
Squirt fresh running buffer into each well of the pre-cast gel.  
* Use 8 % gel to visualize entire 30-170 kD range.  
* Use 12-16 % gel to detect proteins ~30 kD. 
Load the each sample into wells. 
Run gel at 80 mA until the dye front has reached the bottom of the gel (usually ~45 min 
to 1 hr).  
* To observe the GFP fluorescence, mix the GFP-based proteins with the typical protein 
loading buffer containing SDS but do not boil the samples. After running the gel, place in 
water (not destaining solution) and visualize under the fluorescence gel/plate setup. 
 
3. Transfer proteins onto nitrocellulose: 
Clip a nitrocellulose paper with the size that can cover the gel.   
Soak the gel and nitrocellulose paper in the immunoblot transfer buffer with gentle 
rocking for 3 min. 
Make a sandwich with multiple layers in the immunoblot transfer buffer: sponge, filter 
paper, nitrocellulose, gel, filter paper, sponge.  
• Trim the filter papers so that top and bottom papers do not touch; otherwise 
current will go through the filter paper-filter paper contact point rather than 
through gel. 
• Make sure that the gel and the nitrocellulose paper is in tight contact; squeeze any 
air bubble between these two layers. 
• Remember that proteins will “run to red” – make sure orientation of sandwich. 
Fit the sandwich into the plastic module of the gel running apparatus (Invitrogen).   
Run blot at room temperature at 250 V for 1.5 to 3 hr. 
 
4. Blotting: 
After transferring, soak the nitrocellulose in 50 mL blocking buffer with gentle shaking 
for 25-30 min.  
Stain with 1° antibody:  
Clip a piece of parafilm with a size bigger than the nitrocellulose. 
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Place the parafilm on the flat surface of the benchtop and fill in the gap with water. 
Prepare 1 mL antibody solution (the dilution is individually determined by following 
the manufacturer’s protocol or empirical optimization) and pour this on top of the 
parafilm.  
Place the blot face down on top of the antibody solution.  
Press the blot gently with tweezers to ensure that there are no air bubbles.  
Cover the blot with a damp tray to prevent any evaporation of the solution. 
Incubate with 1° antibody at room temperature for 45 min - 3 hr. 
Rinse the blot with TBS-T (no BSA) for 5 min on shaker at room temperature. Repeat the 
rinse for two more times.  
Stain with 2° antibody (the procedure is similar to the one as shown above).  
Incubate with 2° antibody at room temperature for 45 min. 
Rinse the blot with TBS-T (no BSA) for three times, 5 min on shaker at RT for each 
rinse. 
 
5. Develop blot: 
Place the parafilm on the flat surface of the benchtop and fill in the gap with water. 
Prepare the development reagent by mixing the luminol solution and the stable peroxide 
solution in a 1:1 ratio (SuperSignal West Pico kit from Pierce, typically 500 µL each). 
Add development reagent (1 mL) on top of the parafilm.  
Place the blot face down on top of the solution and make sure the liquid covers the entire 
blot surface. Wait 1-2 min. 
Visualize the chemiluminescence of the blot by gel imager, set up three different 
exposure times to make sure the signal is not saturated.  
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The protocol for QuikChange site-directed mutagenesis: 
 
1. Design of primers:  
To introduce the mutation of a given amino acid residue, the corresponding DNA 
sequence differing in 1-3 nucleotides than the wide-type will be incorporated in the pair 
of primers. The mutation site should be fairly centered in the middle of the oligo and in 
its reverse complement. Oligos are usually about 30-40 nucleotide long in total, and their 
melting temperature is greater than 78 ºC. Use this equation to calculate the melting 
temperature of the oligo: 81.5 + 0.41 (%GC) – (675/N) - % mismatch, where N = number 
of nucleotides in total and %GC = the GC content of the oligo.   
 
2. Set up the PCR:  
Pfu turbo polymerase (Strategene), but not other polymerase such as Taq, must be 
used. This high-fidelity enzyme can amplify DNA larger than several kilobases. Set up 
PCR as follows: 
 2.5 µL 10x cloned Pfu buffer 
10-50 ng template plasmid  
 0.75 µL of 200 pmol/µL forward primer 
 1-5 µL of 200 pmol/µL reverse primer 
 2.5 µL of 2.5 mM dNTPs  
 0.5 µL Pfu Turbo enzyme 
 Add sterile water to final volume of 25 µL 
For setting up multiple PCR reactions, it is better to make a master stock of 
everything, except the oligos and/or template, and equally distribute them into several 
PCR tubes. This procedure helps in evenly loading reagents with the minimized pipetting 
error.  
The PCR program is critical, and it depends on the length of the template. The Pfu 
enzyme needs to amply the whole plasmid, and the typical extension time is 1-2 min per 
kilobase. A generic program, Quick 15, for both pRSETB (vector size = 2.9 kb) and 
pcDNA3 (vector size = 5.4 kb) is a good starting point as follows: 
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Step 1: 95 ºC, 30 sec. 
Step 2: 95 ºC, 30 sec. 
Step 3: 55 ºC, 1 min. 
Step 4: 68 ºC, 15 min. 
Step 5: Repeat Step 2-4 for 17 times. 
Step 6: 68 ºC, 10 min. 
Step 7: 10 ºC, for ever. 
 
3. DpnI digestion and heat-shock transformation of the PCR product:  
The purpose of this step is to selectively digest the template DNA so that only the 
PCR product remains intact for further transformation to E. coli. It is important for the 
thorough digestion to prevent any carry over from the uncut wild-type plasmid. For each 
25 µL PCR reaction, add 1 µL of the DpnI restriction enzyme into the tube. Flick the tube 
to spread out the enzyme everywhere in contact will all DNA. Subsequently, spin down 
the tubes and incubate the reaction at 37 ºC for 3 hr.  
 After digestion, transform 5 µL of the crude mix into the heat-shock XL1 Blue or 
DH5α E. coli. cells for 42 sec. Rescue them with 500 µL SOB media and incubate at 37 
ºC for 30 min. Take 150 µL of the bacterial culture and spread them onto the LB-
ampicillin plates. 
 
4. Miniprep individual colonies and perform test digestion:  
For each QuikChange reaction, pick 1-3 colonies from the corresponding plate 
and miniprep them. NEVER mix colonies, because each colony may represents a 
different DNA clone. Perform test digestion of these purified DNA with restriction 
enzymes. Submit the samples that have passed the digestion test for DNA sequencing to 
confirm the exact identity of these clones. 
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Figure A3. 1H NMR spectrum of benzophenone spermine 
Figure A4. ESI-MS analysis of benzophenone spermine 
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